<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.65, http://www.edgar-online.com -->
<TITLE> CESCA THERAPEUTICS INC. (Form: 10-K, Received: 09/21/2016 06:05:32) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_PART_I **FIS_BUSINESS **FIS_RISK_FACTORS **FIS_UNRESOLVED_STAFF_COMMENTS **FIS_PROPERTIES **FIS_LEGAL_PROCEEDINGS **FIS_MINE_SAFETY_DISCLOSURE **FIS_PART_II **FIS_MARKET **FIS_FINANCIAL_DATA **FIS_MANAGEMENTS_DISCUSSION **FIS_RESULTS_OF_OPERATIONS **FIS_LIQUIDITY_CAPITAL **FIS_MARKET_RISK **FIS_FINANCIAL_STATEMENTS **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_ACCOUNTING_CHANGES **FIS_CONTROL_AND_PROCEDURES **FIS_AUDITORS_OPINION_2 **FIS_OTHER_INFORMATION **FIS_PART_III **FIS_DIRECTORS_AND_OFFICERS **FIS_COMPENSATION **FIS_SECURITY_OWNERS **FIS_OFFICER_TRANSACTIONS **FIS_ACCOUNTANT_FEES **FIS_PART_IV **FIS_EXHIBITS **FIS_EXHIBIT_INDEX **FIS_SIGNATURES FIS_EXHIBIT_23 **FIS_EXPERTS_CONSENT FIS_EXHIBIT_31 **FIS_CERTIFICATION FIS_EXHIBIT_31_2 **FIS_CERTIFICATION_2 FIS_EXHIBIT_32 **FIS_CERTIFICATION_3 ">
<META NAME="DETECTED PAGES" CONTENT="83">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="KOOL20160630_10K_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<A ID=TOCLINK6585 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<P ID=PARA3305 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
</P>
<P ID=PARA3306 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Washington, D.C. 20549
</FONT>
</P>
<P ID=PARA3307 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3308 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	FORM 10-K
</B>
</FONT>
</P>
<P ID=PARA3309 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3310 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
</FONT>
</P>
<P ID=PARA3311 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SECURITIES EXCHANGE ACT OF 1934
</FONT>
</P>
<P ID=PARA3312 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3313 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For the Fiscal Year Ended:
<B>
	June 30, 201
</B>
<B>
	6
</B>
</FONT>
</P>
<P ID=PARA3314 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3315 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Commission File Number: 000-16375
</FONT>
</P>
<P ID=PARA3316 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<TABLE ID=TBL3328 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 51%; VERTICAL-ALIGN: TOP" COLSPAN=3>
<P ID=PARA3317 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA3318 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(Exact name of registrant as specified in its charter)
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
<P ID=PARA3319 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Delaware
</B>
</FONT>
</P>
<P ID=PARA3320 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(State of incorporation)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
<P ID=PARA3321 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	94-3018487
</B>
</FONT>
</P>
<P ID=PARA3322 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(I.R.S. Employer Identification No.)
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 51%; VERTICAL-ALIGN: TOP" COLSPAN=3>
<P ID=PARA3323 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2711 Citrus Road
</B>
</FONT>
</P>
<P ID=PARA3324 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<U>
<B>
	Rancho Cordova, California 95742
</B>
</U>
</FONT>
</P>
<P ID=PARA3325 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(Address of principal executive offices) (Zip Code)
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 51%; VERTICAL-ALIGN: TOP" COLSPAN=3>
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 51%; VERTICAL-ALIGN: TOP" COLSPAN=3>
<P ID=PARA3326 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<U>
<B>
	(916) 858-5100
</B>
</U>
</FONT>
</P>
<P ID=PARA3327 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(Registrant&#8217;s telephone number, including area code)
</FONT>
</P>
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA3329 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3330 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Securities Registered Pursuant to Section 12(b) of the Act:
</FONT>
</P>
<TABLE ID=TBL3335 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 50.6%; VERTICAL-ALIGN: TOP">
<P ID=PARA3331 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Title of each class
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 50.6%; VERTICAL-ALIGN: TOP">
<P ID=PARA3332 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Name of each exchange on which registered
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 50.6%; VERTICAL-ALIGN: TOP">
<P ID=PARA3333 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common Stock, $0.001 par value
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 50.6%; VERTICAL-ALIGN: TOP">
<P ID=PARA3334 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Nasdaq Stock Market, LLC
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3336 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3337 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3338 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Securities Registered Pursuant to Section 12(g) of the Act: None
</FONT>
</P>
<P ID=PARA3339 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3340 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT>
</P>
<P ID=PARA3341 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3342 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&nbsp; &nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT>
</P>
<P ID=PARA3343 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3344 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&nbsp; &nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT>
</P>
<P ID=PARA3346 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3347 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X] Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&nbsp; &nbsp;] No
</FONT>
</P>
<P ID=PARA3348 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3349 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K, is not contained herein, and will not be contained, to the best of the registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment of this Form 10-K.&nbsp;[&nbsp; &nbsp;]
</FONT>
</P>
<P ID=PARA3350 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3351 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer&#8221; and &#8220;small reporting company&#8221; in Rule 12b-2 of the Exchange Act.
</FONT>
</P>
<P ID=PARA3352 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3353 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Large accelerated filer [&nbsp; &nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer [&nbsp; &nbsp;]
</FONT>
</P>
<P ID=PARA3354 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-accelerated filer [&nbsp;&nbsp; ] (Do not check if a smaller reporting company)
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller reporting company [X]
</FONT>
</P>
<P ID=PARA3355 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3356 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
</FONT>
</P>
<P ID=PARA3357 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&nbsp; &nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[X] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT>
</P>
<P ID=PARA3358 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3359 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The aggregate market value of the common stock held by non-affiliates as of December 31, 2015 (the last business day of the most recently completed second quarter) was $5,975,000 based on the closing sale price on such day.
</FONT>
</P>
<P ID=PARA3360 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3361 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	As of September 16, 2016,&nbsp;9,790,500 shares of the registrant&#8217;s Common Stock were outstanding.
</FONT>
</P>
<P ID=PARA3362 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3363 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Documents Incorporated By Reference: Portions of the registrant&#8217;s proxy statement for its 2016 Annual Meeting of Stockholders are incorporated by reference into Part III hereof.
</FONT>
</P>
<P ID=PARA6339.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6339 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6339 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6339 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage2"></A>
<A ID=TOCLINK6339 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6339 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6339.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL6410 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 90%; VERTICAL-ALIGN: TOP" COLSPAN=3>
<P ID=PARA6340 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=TOC NAME="KOOL20160630_10K_HTM_TOC">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	TABLE OF CONTENTS
</B>
</FONT>
</A>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
<P ID=PARA6341 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Part I
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
<P ID=PARA6342 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER">
<U>
	Page Number
</U>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6343 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 1.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6344 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6586 HREF="#KOOL20160630_10K_HTM_BKMK6606">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Business
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6345 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	4
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6346 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 1A.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6347 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6587 HREF="#KOOL20160630_10K_HTM_BKMK6607">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risk Factors
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6348 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	16
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6349 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 1B.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6350 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6588 HREF="#KOOL20160630_10K_HTM_BKMK6608">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Unresolved Staff Comments
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6351 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	28
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6352 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 2.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6353 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6589 HREF="#KOOL20160630_10K_HTM_BKMK6609">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Properties
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6354 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	28
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6355 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 3.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6356 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6590 HREF="#KOOL20160630_10K_HTM_BKMK6610">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Legal Proceedings
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6357 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	28
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6358 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 4.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6359 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6591 HREF="#KOOL20160630_10K_HTM_BKMK6611">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mine Safety Disclosures
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6360 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	29
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6361 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Part II
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6362 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 5.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6363 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6592 HREF="#KOOL20160630_10K_HTM_BKMK6612">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Market for the Registrant&#8217;s Common Equity and Related Stockholder Matters
</FONT>
	and Issuer Purchases of Equity Securities
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: #FFFFFF">
	29
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6366 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 6.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6367 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6593 HREF="#KOOL20160630_10K_HTM_BKMK6613">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Selected Financial Data
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6368 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	29
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6369 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 7.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6370 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6594 HREF="#KOOL20160630_10K_HTM_BKMK6614">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Management&#8217;s Discussion and Analysis of Financial Condition and
</FONT>
	Results of Operations
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: #FFFFFF">
	30
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6373 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 7A.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6374 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6595 HREF="#KOOL20160630_10K_HTM_BKMK6615">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Quantitative and Qualitative Disclosures about Market Risk
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6375 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	38
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6376 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 8.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6377 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6596 HREF="#KOOL20160630_10K_HTM_BKMK6616">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Financial Statements and Supplementary Data
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6378 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	38
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6379 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 9.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6380 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6597 HREF="#KOOL20160630_10K_HTM_BKMK6617">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Changes in and Disagreements with Accountants on Accounting
</FONT>
	and Financial Disclosure
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: #FFFFFF">
	71
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6383 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 9A.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6384 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6598 HREF="#KOOL20160630_10K_HTM_BKMK6618">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Controls and Procedures
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6385 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	71
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6386 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 9B.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6387 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6599 HREF="#KOOL20160630_10K_HTM_BKMK6619">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other Information
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6388 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	72
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6389 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Part III
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6390 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 10.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6391 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6600 HREF="#KOOL20160630_10K_HTM_BKMK6620">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Directors, Executive Officers and Corporate Governance
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6392 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	72
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6393 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 11.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6394 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6601 HREF="#KOOL20160630_10K_HTM_BKMK6621">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Executive Compensation
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6395 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	72
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6396 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 12.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6397 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6602 HREF="#KOOL20160630_10K_HTM_BKMK6622">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Security Ownership of Certain Beneficial Owners and Management and Related
</FONT>
	Stockholder Matters
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER; BACKGROUND-COLOR: #FFFFFF">
	72
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6400 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 13.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6401 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6603 HREF="#KOOL20160630_10K_HTM_BKMK6623">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certain Relationships and Related Transactions, and Director Independence
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6402 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	72
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6403 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 14.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6404 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6604 HREF="#KOOL20160630_10K_HTM_BKMK6624">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Principal Accounting Fees and Services
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6405 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	72
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6406 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Part IV
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6407 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ITEM 15.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6408 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6605 HREF="#KOOL20160630_10K_HTM_BKMK6625">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibits and Financial Statement Schedules
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6409 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	73
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3364 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK3402 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3402 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3402 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	2
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage3"></A>
<A ID=TOCLINK3402 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3402 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3402.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_PART_I>
<A NAME="FIS_PART_I"></A>
<P ID=PARA3403 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PART I
</B>
</FONT>
</P>
<P ID=PARA3404 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	All dollar amounts are presented in thousands except as otherwise noted.
</FONT>
</P>
<P ID=PARA3405 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3406 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3407 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS
</B>
</FONT>
</P>
<P ID=PARA3408 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3409 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	This report contains forward-looking statements within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included in this report, are forward-looking statements. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking statements included in this report. Such statements may be identified by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;ongoing,&#8221; or similar terms, variations of such terms, or the negative of such terms, and include, but are not limited to, statements regarding projected results of operations, capital expenditures, earnings, management&#8217;s future strategic plans, development of new technologies and services, litigation, regulatory matters, market acceptance and performance of our services, the success and effectiveness of our technologies and services, our ability to retain and hire key personnel, the competitive nature of and anticipated growth in our markets, market position of our services, marketing efforts and partnerships, liquidity and capital resources, our accounting estimates, and our assumptions and judgments. Such statements are based on management&#8217;s current expectations, estimates and projections about our industry, management&#8217;s beliefs, and certain assumptions made by us, all of which are subject to change.
</FONT>
</P>
<P ID=PARA3410 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3411 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	These forward looking statements are not guarantees of future results and are subject to a number of risks, uncertainties and assumptions that are difficult to predict and that could cause actual results to differ materially and adversely from those described in the forward-looking statements, including:
</FONT>
</P>
<P ID=PARA3412 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3414 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3415 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3416 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	the sufficiency and source of capital required to fund our operations and in furtherance of our business plan;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3418 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3419 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3420 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	our ability to remain listed on NASDAQ and remain in compliance with its listing standards;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3422 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3423 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3424 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	the global perception of the clinical utility of banked cord blood and the amount of investment in research and development supporting clinical data for additional applications;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3426 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3427 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3428 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	delays in commencing or completing clinical testing of products;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3430 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3431 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3432 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	the success of any collaborative arrangements to commercialize our products;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3434 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3435 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3436 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	our reliance on significant distributors or end users;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3438 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3439 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3440 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	the availability and sufficiency of commercial scale manufacturing facilities and reliance on third party contract manufacturers; and
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3442 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3443 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3444 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	our ability to protect our patents and trademarks in the U.S. and other countries.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3445 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3446 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	These forward-looking statements speak only as of the date of this report and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the expectations with regard thereto or any change in events, conditions, or circumstances on which any such statement is based, except as otherwise required by law. Additional factors that could cause such results to differ materially from those described in the forward-looking statements are set forth in connection with the forward-looking statements.
</FONT>
</P>
<P ID=PARA3447 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3448 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	TRADEMARKS
</B>
</FONT>
</P>
<P ID=PARA3449 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3450 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	This report contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report, including logos, artwork and other visual displays, may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
</FONT>
</P>
<P ID=PARA3451.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3451 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3451 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3451 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	3
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage4"></A>
<A ID=TOCLINK3451 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3451 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3451.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS"></A>
<P ID=PARA3452 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6606 NAME="KOOL20160630_10K_HTM_BKMK6606">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<U>
<B>
	BUSINESS
</B>
</U>
</FONT>
</P>
<P ID=PARA3453 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3454 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics Inc. (&#8220;Cesca Therapeutics&#8221;, &#8220;Cesca&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221;), is a clinical stage biotechnology company which develops and markets integrated cellular therapies and delivery systems that advance the safe and effective practice of regenerative medicine. We are a leader in the development and manufacture of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. Our two subsidiaries based in India, TotipotentRX and TotipotentSC, have a pipeline of human point of care experimental therapies in early stage clinical studies using bone marrow and blood derived cells and growth factors. We were founded in 1986 and are headquartered in Rancho Cordova, California. Our strategy is to continue to enhance the performance and competitiveness of our flagship product lines in the cord blood banking arena while expanding into significant new growth opportunity areas in point of care therapeutics. We are developing a number of offerings for the delivery of autologous cell therapies that address significant unmet medical needs and expect to partner with other pioneers in the stem cell arena to accelerate clinical evaluations, expedite regulatory approvals and penetrate the market.
</FONT>
</P>
<P ID=PARA3455 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3456 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<U>
<B>
	Our Strategy
</B>
</U>
</FONT>
</P>
<P ID=PARA3457 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3458 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our business strategy involves:
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<TABLE ID=TBL6654 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
<P ID=PARA6658 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6656>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6657>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sustaining our leadership position in automated devices for the separation and concentration of stem cell preparation from cord blood and bone marrow.
</P>
</FONT>
</TD>
</TR>
</TABLE>
<P ID=PARA6655 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
	&nbsp;
</P>
<TABLE ID=MTAB3461 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3462 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3463 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expansion into development of cell therapies targeting insufficiently met medical needs: our initial focus is on ischemic cardiovascular indications (critical limb ischemia (&#8220;CLI&#8221;) and acute myocardial infarction (&#8220;AMI&#8221;)) with oncology and orthopedic protocols to follow.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3464 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3466 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3467 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3468 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A unique point of care approach; our CLI and AMI cell therapies require a single visit to the operating room for a treatment lasting only 90-120 minutes.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3469 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3471 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3472 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3473 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Delivery of a fully integrated offering: We deliver all the hardware, software and disposable components necessary for the aspiration and processing of autologous bone marrow to prepare a therapeutic dose of stem cells for re-injection into the patient at the point of care.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3474 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3476 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3477 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3478 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The use of autologous, bone marrow derived stem cells: Our protocols are potentially safer than alternative allogeneic approaches because, in our case, the donor and the recipient of the stem cell preparation is the same individual.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3479 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3481 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3482 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3483 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A simpler regulatory path: Cesca&#8217;s protocols are autologous and the stem cell preparations are minimally manipulated, allowing an investigational device exemption pre-market approval approach. This reduces costs and time to market when compared to investigational new drug or new drug application approaches.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3484 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3486 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3487 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3488 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A highly resource efficient operating model: We leverage our India based clinical research organization embedded within the Fortis Healthcare network of hospitals in Asia, as a highly cost-effective approach to conducting feasibility studies and early stage clinical trials.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3489 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3491 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3492 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3493 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Multiple shots on goal: We currently have 9 protocols at various stages of clinical development.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3494 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3496 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3497 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3498 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Patent protection: We have over 25 issued patents globally with several more applications in the pipeline.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3499 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK3500 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3500 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3500 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	4
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage5"></A>
<A ID=TOCLINK3500 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3500 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3500.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3501 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Recent Key Events and Accomplishments
</B>
</I>
</FONT>
</P>
<P ID=PARA3502 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca&#8217;s 2016 financial year ran from July 1, 2015 to June 30, 2016. The following are key events and accomplishments that occurred in fiscal 2016:
</FONT>
</P>
<P ID=PARA3503 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3505 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3506 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
<I>
</I>
<I>
</I>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<I>
</I>
</SUP>
<I>
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3507 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Submitted Investigational Device Exemption (&#8220;IDE&#8221;) Supplement
</I>
<I>
	for the
</I>
<I>
	Surgwerks
</I>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<I>
	TM
</I>
</SUP>
<I>
	CLI Pivotal Trial&nbsp;
</I>
</FONT>
	In May 2016 we submitted an IDE Supplement to the U.S. FDA for our previously approved pivotal trial for the treatment of patients with CLI using our SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
	system. In the supplement, we proposed Transcutaneous Oxygen Pressure (TcPO2) as a surrogate endpoint for limb salvage as an alternative to Amputation-Free Survival. Subsequently, the FDA approved commencement of the Phase III pivotal trial as amended, but indicated that it would require additional validation of TcPO2 as a surrogate to support future PMA approval.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3508 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3511 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3512 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
<I>
</I>
<I>
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3513 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Regained Compliance with Nasdaq
</I>
<I>
	Minimum
</I>
<I>
	Bid Price Requirement
</I>
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
	On March 21, 2016, we received notification from the Nasdaq Listing Qualifications Staff indicating that we had regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. In order to regain compliance, we effected a one-for-twenty reverse stock split effective as of the close of business on March 4, 2016.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3514 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<TABLE ID=MTAB3517 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3518 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3519 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Closed a $15 Million Strategic Investment from Boyalife Group
</I>
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In February 2016
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	, in exchange for aggregate proceeds of $15 million, we sold and issued to Boyalife Investment Inc. and Boyalife (Hong Kong) Limited (i) 735,294 shares of common stock at a per share purchase price of $3.4
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	0 and (ii) senior secured convertible debentures for $12.5 million. From the proceeds, we repaid existing senior secured convertible debentures (see below) and the remaining proceeds are providing additional working capital to fund ongoing operations and strategic initiatives. In August 2016, we subsequently converted all of the principal and interest under the convertible debentures into 6,102,941 shares of our common stock, thereby cancelling all of our indebtedness to Boyalife Investment, Inc.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3520 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 7.7PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<TABLE ID=MTAB3523 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3524 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3525 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Restructured Existing Senior Secured Convertible Debentures and Retired Series B Warrants
</I>
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
	In connection with the Boyalife financing transaction, we repaid existing thirty-year debentures and all related interest and liquidated damages. In addition, we terminated the related registration rights agreement, the exercise price of the associated Series A warrants was changed from $13.60 to $8.00 and all remaining Series B warrants which contained a cashless exercise feature were retired.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3526 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<TABLE ID=MTAB3529 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3530 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3531 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Implemented a Restructuring Initiative to Realign Resources Behind High Impact Clinical Programs.
</I>
</FONT>
	&nbsp; In September 2015, we implemented a restructuring initiative to reduce costs and better align our workforce with the evolving needs of our business. We reduced approximately 15 positions, which, combined with the elimination of a number of open positions that were not back-filled, reduced annual operating costs primarily related to our cord blood banking products by approximately $3.3 million.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3532 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
</I>
</FONT>
	&nbsp;
</P>
<TABLE ID=MTAB3535 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3536 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
<I>
</I>
<I>
</I>
<I>
</I>
<I>
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3537 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Facilitated Ground-Breaking
</I>
<I>
	Haploidenti
</I>
<I>
	cal Bone Marrow T
</I>
<I>
	ransplantations
</I>
<I>
	(BMT)
</I>
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
	Our clinical cell therapy laboratory at the Fortis Memorial Research Institute (FMRI) in India performed three ex-vivo Haploidentical BMT cell therapy services for the treatment of thalassemia, acute myeloid leukemia (AML) and chronic myeloid leukemia and four ex-vivo cell enrichment cell therapy processing services for relapse AML.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3538 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK6411 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6411 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6411 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	5
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage6"></A>
<A ID=TOCLINK6411 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6411 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6411.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3543 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3544 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&#9679;
</I>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3545 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Secured Additional Sites for Cesca&#8217;s Flagship AXP Technology or Cord Blood Processing Services.
</I>
</FONT>
	&nbsp; Among others, Houston based Texas Stem Cell, the first hybrid cord&nbsp;blood and tissue bank in Texas,&nbsp;adopted the AutoXpress (&#8220;AXP&#8221;) technology for cord blood processing. Additionally, TotipotentRX expanded its private cord blood banking services to several additional hospitals in the Fortis Healthcare network throughout India.
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3546 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<P ID=PARA3548 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<U>
<B>
	The Markets We Serve
</B>
</U>
</FONT>
</P>
<P ID=PARA3549 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3550 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Regenerative Medicine
</I>
</FONT>
</P>
<P ID=PARA3551 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
</P>
<P ID=PARA3552 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Regenerative cell therapy relies on the delivery of specific types of stem cells that have been shown to enable the repair, restoration or regeneration of diseased or damaged tissue.&nbsp; A broad range of cell types has been investigated, including cells found in peripheral blood, umbilical cord blood and bone marrow.
</FONT>
</P>
<P ID=PARA3553 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3554 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The field continues to contribute to meaningful advances in the practice of medicine, as evidenced by numerous FDA and European Union (&#8220;EU&#8221;) therapeutic product approvals and the commercialization of a growing number of cell-based therapies. Most of the progress has been achieved through the broader application of adult stem cells, reflecting a greater awareness and appreciation of their therapeutic potential.
</FONT>
</P>
<P ID=PARA3555 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3556 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The market for regenerative medicine is supported by companies that develop devices or methods for harvesting, processing, purifying, expanding, modifying, cryopreserving, storing or administering cells, or by companies that develop and commercialize the therapeutic agents themselves. Key success factors for such companies include:
</FONT>
</P>
<P ID=PARA3557 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3559 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3560 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3561 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The ability to achieve high recovery and concentration of target cell types
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3563 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3564 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3565 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Device ease-of use, efficiency and speed
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3567 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3568 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3569 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cell product purity, viability and potency
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3571 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3572 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3573 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cost effectiveness
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3575 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3576 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3577 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Regulatory approval / FDA clearance
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3578 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3579 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The delivery of a cell therapy typically involves a process whereby target cells are harvested from a donor or patient, processed or expanded (grown) either within a hospital laboratory or by an FDA regulated, therapeutic manufacturer, formulated into an effective, safe dose, and delivered to a patient through a specific delivery device. Cell preparations may also be formulated in a point of care setting such as an operating room.
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Requirements for the preparation and use of cell therapies at the point of care include system portability, sterile field packaging, minimal manipulation, swift cell processing and predictable target cell recovery rates.
</FONT>
</P>
<P ID=PARA3580 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3581 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our growth strategy is focused on the development of autologous cell therapies for treatments intended to be carried out at the point of care.
</FONT>
</P>
<P ID=PARA3582 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3583 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We believe that commercial opportunities for such therapies will develop first in cardiology, orthopedics, dermatology/wound healing and selective areas of oncology, followed by more complex pathologies such as those found in diabetes and central nervous system disorders.
</FONT>
</P>
<P ID=PARA3584 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3585 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We also believe that developments in the field of regenerative medicine will be critical in helping to address the global increase in health care costs. As emerging cell therapies are proven to be safe, effective, and a cost-effective alternative to current standards of care, adoption will accelerate. A fundamental requirement, however, will be the continued development of baseline clinical and cost-effectiveness data through comprehensive clinical studies.
</FONT>
</P>
<P ID=PARA6412.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6412 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6412 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6412 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	6
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage7"></A>
<A ID=TOCLINK6412 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6412 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6412.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA3587 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Cord Blood Banking
</B>
</I>
</FONT>
</P>
<P ID=PARA3588 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cord blood, the&nbsp;blood&nbsp;that remains in the umbilical&nbsp;cord&nbsp;after a baby is born, is rich in stem cells. Since the first cord blood transplant was carried out in 1988, stem cells derived from umbilical cord blood have become widely accepted for medical use and have been used regularly in medical procedures worldwide for the treatment of a wide range of blood diseases, genetic and metabolic disorders, immune-deficiencies and cancers. Cord blood use in clinical applications is now widely accepted and cord blood banks exist in nearly every developed country as well as a growing number of developing nations.
</FONT>
</P>
<P ID=PARA3589 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3590 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics (formerly ThermoGenesis) is an established leader in the development and manufacture of automated systems that enable the separation, processing and cryopreservation of stem cell preparations from cord blood. In recent years, however, the overall number of cord blood samples being collected has decreased; Bioinformant reported in their 2015 Global Strategic Report on the U.S. Cord Blood Market that the number of cord blood transplants had declined year-over-year in spite of the fact that the number of scientific publications on cord blood stem cells had grown by 7.8%.
</FONT>
</P>
<P ID=PARA3591 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3592 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Nevertheless, there have been several recent examples of significant pharma companies entering the space. In August 2014, Novartis committed up to $435 million to Gamida Cell for development of an expanded cord blood stem cell product as a treatment for hematological malignancies such as leukemia and lymphoma, and in June 2015, AMAG Pharmaceuticals (&#8220;Nasdaq: AMAG&#8221;) announced a definitive agreement to acquire Cord Blood Registry (an existing Cesca Therapeutics customer), from GTCR, a private equity firm, for $700 million.
</FONT>
</P>
<P ID=PARA3593 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3594 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<U>
<B>
	Our Clinical Programs
</B>
</U>
</FONT>
</P>
<P ID=PARA3595 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3596 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our therapeutic development initiatives, focused in the fields of cardiovascular medicine and orthopedic regeneration, are based on a flexible platform of equipment and optimized disposable components for the harvesting, processing, testing and delivery of cells and growth factors from either blood or bone marrow.
</FONT>
</P>
<P ID=PARA3597 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3598 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our proprietary SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	&#8482;
</SUP>
	System (in development) includes a broadly-capable processing platform of devices and analytics designed for use at the point of care, coupled with indication-specific, single use, disposable procedure kits for a variety of vascular and orthopedic conditions. The performance of SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	&#8482;
</SUP>
	is enabled by the availability of a next generation cell processing device (referred to as the VXP System), derived from our existing and well established AutoXpress (AXP) and MarrowXpress (MXP) platforms. A key advantage of an optimized and integrated system such as SurgWerks is that it is intended to maintain high cell viability and potency through each and every step of the 90-120 minute intra-operative procedure, including bone marrow collection, target cell selection, characterization of the final cell concentrate, and re-injection into the patient.
</FONT>
</P>
<P ID=PARA3599 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3600 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We made the following advancements in the SurgWerks System&#8217;s clinical development in fiscal 2016:
</FONT>
</P>
<P ID=PARA3601 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB3603 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3604 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3605 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	An IDE Supplement was submitted to the FDA proposing a change in primary endpoint to a surrogate endpoint of TcPO2, with associated changes in the statistical plan.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3607 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3608 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3609 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Significant progress was made in assessment and engagement of clinical trial sites for our phase III pivotal clinical trial (CLIRST III). Over 30 sites are currently involved in various stages of engagement and Institutional Review Board (&#8220;IRB&#8221;) approvals and trial agreements have already been finalized for a subset of these 30 sites.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3611 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3612 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3613 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Training programs to support the study were defined for our clinical team and the site staff involved in the study.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3614.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3614 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3614 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3614 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	7
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage8"></A>
<A ID=TOCLINK3614 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3614 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3614.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3615 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3616 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We intend to initiate the following SurgWerks System&#8217;s clinical trials in fiscal 2017:
</FONT>
</P>
<TABLE ID=MTAB3618 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3619 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3620 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	U.S.: SurgWerks-CLI and VXP System pivotal IDE trial for patients with critical limb ischemia (CLIRST III).
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3622 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3623 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3624 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	India: SurgWerks-AMI feasibility (Phase II) trial on AMI patients having low ejection fractions three to ten days after the heart attack and having successful reperfusion of the affected heart artery (AMIRST II)
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3625 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3626 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Also in development is our CellWerks&#8482; offering, an integrated collection of devices and disposables that we believe represents a significant advance in enabling routine bone marrow transplantation procedures. The CellWerks&#8482; System is being developed to enable the processing of a stem cell aspirate or mobilized blood harvest unit while allowing the clinical laboratory to &#8220;dial in&#8221; the transplant physician&#8217;s cellular prescription, thereby achieving an optimized granulocyte, monocyte and red blood cell (RBC) cocktail composition. The CellWerks&#8482; platform and software package is being evaluated for use on minimally manipulated as well as targeted, specific cell depleted units of mobilized peripheral stem cells and bone marrow aspirate.
</FONT>
</P>
<P ID=PARA3627 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3628 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	To advance the approval of both SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	&#8482;
</SUP>
	and CellWerks&#8482;, we are pursuing a rigorous, science-based clinical development program, designed around two models of clinical delivery:
</FONT>
</P>
<TABLE ID=MTAB3630 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3631 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3632 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SurgWerks&#8482; &#8211; intended for rapid intra-operative use
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3634 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3635 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3636 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	CellWerks&#8482;&#8211; intended for rapid laboratory use for specialized stem cell preparation under the direction of a GMP cellular laboratory protocol or a licensed physician.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3637 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3638 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our intention is to provide fully optimized therapeutic &#8220;kits&#8221; and highly specialized equipment for each clinical indication (in the case of SurgWerks) and flexible cell preparation devices for clinical laboratory use (in the case of CellWerks), ultimately seeking marketing approval from the FDA and/or the equivalent regulatory authorities in markets outside the U.S.
</FONT>
</P>
<P ID=PARA3639 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
</P>
<TABLE STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0>
<TR>
<TD STYLE="WIDTH: 33%; VERTICAL-ALIGN: TOP">
<P STYLE="TEXT-ALIGN: CENTER">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/09/21/0001437749-16-038939_IMG.JPG" WIDTH=279 HEIGHT=277>
</P>
</TD>
<TD STYLE="WIDTH: 33%">
<P STYLE="TEXT-ALIGN: CENTER">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/09/21/0001437749-16-038939_KOOL20160630_10KIMG002.GIF" WIDTH=151 HEIGHT=197>
</P>
</TD>
<TD STYLE="WIDTH: 33%">
<P STYLE="TEXT-ALIGN: CENTER">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/09/21/0001437749-16-038939_KOOL20160630_10KIMG003.GIF" WIDTH=206 HEIGHT=155>
</P>
</TD>
</TR>
<TR>
<TD>
<P ID=PARA6416 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PT">
<I>
	SurgWerks O.R. Procedure
</I>
</P>
</TD>
<TD>
<P ID=PARA6417 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PT">
<I>
	Disposable SurgWerks Kit
</I>
</P>
</TD>
<TD>
<P ID=PARA6418 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PT">
<I>
	VXP Equipment System
</I>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3640 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK3652 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3652 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3652 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	8
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage9"></A>
<A ID=TOCLINK3652 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3652 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3652.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3653 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Our Products
</U>
</B>
</FONT>
</P>
<P ID=PARA3654 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3655 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We design, manufacture and sell advanced devices created specifically for the separation, concentration and cryopreservation of cell types used in the practice of regenerative medicine. Such automated devices are essential to the successful development of cell therapies because they ensure a high degree of quality control over both the preparation and storage of stem cell concentrate. Our current and future product offerings include:
</FONT>
</P>
<TABLE ID=MTAB3657 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3658 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3659 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The SurgWerks&#8482; System (in development) - a proprietary system comprised of the SurgWerks Processing Platform, including devices and analytics, and indication-specific SurgWerks Procedure Kits for use in regenerative stem cell therapy at the point of care for vascular and orthopedic diseases.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3661 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3662 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3663 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The CellWerks&#8482; System (in development) - a proprietary cell processing system with associated analytics for intra-laboratory preparation of adult stem cells from bone marrow or blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3665 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3666 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3667 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The AutoXpress&#174; System (AXP&#174;) - a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3669 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3670 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3671 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The MarrowXpress&#8482; System (MXP&#8482;) - a derivative product of the AXP and its accompanying sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3673 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3674 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3675 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The BioArchive&#174; System - an automated cryogenic device used by cord blood banks for the cryopreservation and storage of cord blood stem cell concentrate for future use.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3677 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3678 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3679 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Manual bag sets for use in the processing and cryogenic storage of cord blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3680 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3681 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Cell Manufacturing and Banking Services
</U>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3682 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3683 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Through our TotipotentRX subsidiary in Gurgaon, India, we operate an advanced clinical cell manufacturing, processing, testing, and storage facility, compliant with current Good Manufacturing Practices (&#8220;GMP&#8221;), Good Tissue Practices (&#8220;GTP&#8221;), and Good Laboratory Practices (&#8220;GLP&#8221;). We can support the production of a small, personalized medicine cell prescription or carry out a large scale batch process. Patient samples, batch samples, and therapeutic aliquots are all labeled in accordance with ISBT 128 and stored in our own cryogenics facility. In addition, our clinical research organization (CRO), also located in Gurgaon, is, to our knowledge, the only specialized, in-hospital, cell therapy CRO in the world. We have unique expertise in the design and management of cell based clinical trials, including the ability to support the device prototyping and validation typically required for a combination product. These services ensure patient safety under Good Clinical Practices (&#8220;GCP&#8221;), quality laboratory documentation under GLP, and quality cell processing and handling under both GMP and GTP.&nbsp; In partnership with Fortis Healthcare we have assembled what is, to our knowledge, the industry&#8217;s only fully integrated cell therapy CRO team capable of executing all elements of our in-house clinical trials, providing complete and seamless cellular drug and device clinical services. Through this advanced clinical infrastructure we also operate commercial service programs supporting bone marrow transplantation (hematopoietic stem cell transplantation) for hematological and oncological disorders as well as a licensed umbilical cord blood and tissue bank (&#8220;NovaCord&#8221;).
</FONT>
</P>
<P ID=PARA3684.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3684 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3684 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3684 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	9
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage10"></A>
<A ID=TOCLINK3684 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3684 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3684.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3685 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Sales and Distribution Channels
</U>
</B>
<B>
<U>
	&nbsp;
</U>
</B>
</FONT>
</P>
<P ID=PARA3686 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3687 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We market and sell our products through independent distributors, except in North America and India, where we sell direct to end-user customers.
</FONT>
</P>
<P ID=PARA3688 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3689 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Competition
</U>
</B>
</FONT>
</P>
<P ID=PARA3690 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3691 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The regenerative medicine market is characterized by rapidly evolving technology and intense competition from medical device companies, pharmaceutical companies and stem cell companies operating in the fields of cardiac, vascular, orthopedic and neural medicine. The primary competitors for our current device offerings include BioSafe, SynGen and MacoPharma (for automated cell processing systems), and BioE, Terumo Harvest, Zimmer Biomet and Pall Corporation (for manual cell processing systems). Our competitors in the field of cell therapeutics development include MesoBlast, Osiris Therapeutics, Baxter International, Athersys, Caladrius, Capricor, Celyad, Juventas Therapeutics, Vericel, Cytori Therapeutics, Pluristem Therapeutics, Zimmer BioMet, and Bioheart.&nbsp;
</FONT>
</P>
<P ID=PARA3692 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3693 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Research and Development
</U>
</B>
</FONT>
</P>
<P ID=PARA3694 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3695 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our research and development activities in fiscal 2016 were geared towards achieving key development milestones for our SurgWerks-CLI and SurgWerks-AMI clinical trial programs and the CellWerks laboratory device program. Each of these development initiatives leveraged our existing AXP and MXP platforms, with a focus on both performance improvements and ease of use in intraoperative applications. Emphasis was also placed on enhancing the capabilities of our contract manufacturing partners and building on our product quality leadership position. CLI efforts focused on
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	development of an IDE supplement aimed at streamlining and simplifying our already approved Phase 3 (&#8220;Pivotal&#8221;)
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	clinical trial (CLIRSTIII) and AMI activities focused on protocol design and optimization. We also invested effort in optimizing cell processing and delivery methods as well as advancing methods pertaining to our cell quality (cell analysis) technology.
</FONT>
</P>
<P ID=PARA3696 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3697 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Collectively, research and development expenses were $3,230 and $5,939 for the years ended June 30, 2016 and June 30, 2015, respectively. Research and development activities include expenses associated with the engineering, regulatory, scientific and clinical affairs functions.
</FONT>
</P>
<P ID=PARA3698 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3699 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Manufacturing
</U>
</B>
</FONT>
</P>
<P ID=PARA3700 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3701 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We expect to continue to use contract manufacturers for high volume, disposable products and in-house manufacturing for low volume, high complexity devices. In addition, we are exploring the potential for the development of in-house capabilities relating specifically to pilot scale disposable manufacturing in support of our clinical programs.
</FONT>
</P>
<P ID=PARA3702 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3703 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Quality System
</U>
</B>
</FONT>
</P>
<P ID=PARA3704 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3705 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our quality system is compliant with domestic and international standards and is appropriate for the specific devices we manufacture. Our corporate quality policies govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. Such policies are intended to ensure that the products we market are safe, effective, and otherwise in compliance with the FDA Quality System Regulation (&#8220;QSR&#8221;) (21 C.F.R. Part 820) and the applicable rules of other governmental agencies.
</FONT>
</P>
<P ID=PARA3706.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3706 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3706 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3706 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	10
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage11"></A>
<A ID=TOCLINK3706 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3706 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3706.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3707 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We and our contract manufacturers are subject to inspections by the FDA and other regulatory agencies to ensure compliance with applicable regulations, codified in the FDA&#8217;s Quality System Regulations (&#8220;QSRs&#8221;). Compliance requirements relate to manufacturing processes, product testing, documentation control and other quality assurance procedures. Our facilities have undergone International Organization of Standards (&#8220;ISO&#8221;) 13485:2012 and EU Medical Device Directive (&#8220;MDD&#8221;) (93/42/EEC) inspections and we have obtained approval to CE-Mark our products.
</FONT>
</P>
<P ID=PARA3708 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3709 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Regulatory Scheme and Strategy
</U>
</B>
</FONT>
</P>
<P ID=PARA3710 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3711 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The development, manufacture and marketing of our cell therapy products, as well as the design and implementation of our clinical trials, are subject to regulation by the FDA as well as the equivalent agencies of other countries including the countries of the European Union and India.
</FONT>
</P>
<P ID=PARA3712 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3713 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The trials we conduct in India are compliant with the applicable rules of the Indian Council for Medical Research, Ministry of Health Order No. V.25011/375/2010-HR and requisite institutional ethics committee (IEC) and institutional committee for stem cell research and therapy (IC-SCRT) approvals. Both the U.S. and E.U. regulatory agencies are experienced in dealing with and accepting Indian clinical trial data. GCP necessitates review and approval by an IRB before initiation of a study, continuing review of an ongoing study by an IRB, and the documented receipt of a freely given informed consent prior to participation in the study from each subject participant.
</FONT>
</P>
<P ID=PARA3714 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3715 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have a quality and regulatory compliance management system that meets the requirements of the ISO 13485: 2003 standard, the FDA&#8217;s QSRs, the EU MDD, Canadian Medical Device Regulations (&#8220;SOR 98-282&#8221;), and all other applicable local, state, national and international regulations.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<P ID=PARA3716 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Medical Devices.
</I>
	The FDA regulates medical devices to ensure their safety and efficacy under the Federal Food Drug and Cosmetic (&#8220;FD&amp;C&#8221;) Act. Medical devices are defined by language within the FD&amp;C Act which essentially states that a product is considered a medical device if it is intended to provide a diagnosis or basis for treatment. Once a company determines that its product is a medical device, it is required to comply with a number of federal regulations. These include the following:
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<TABLE ID=MTAB3718 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3719 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3720 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	510(k) clearance or PMA approval from the FDA, prior to commercialization (unless the device is classified as &#8220;exempt&#8221;)
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3722 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3723 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3724 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Registration of the company and listing of the medical device with the FDA (within 30 days prior to commercialization)
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3726 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3727 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3728 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Establishment and adherence to the FDA&#8217;s labeling requirements, and
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3730 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3731 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3732 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Establishment and adherence to the FDA&#8217;s Quality Systems and Medical Device Reporting regulations.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3733 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3734 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The FDA classifies medical devices into three groups: Class I, II or III. These are stratified from lowest to highest safety risk, and regulatory controls increase based on Class.
</FONT>
</P>
<P ID=PARA3735 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3736 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Class I Devices
</I>
</B>
</FONT>
</P>
<P ID=PARA3737 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Some of our products are considered to pose little or no risk when used as directed and have been deemed by the FDA to be &#8220;exempt&#8221; from FDA approval or clearance processes prior to commercialization. While pre-marketing FDA review is not mandatory for Exempt Class I medical devices, the manufacturer&#8217;s compliance with QSR is nevertheless a requirement.
</FONT>
</P>
<P ID=PARA3738.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3738 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3738 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3738 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	11
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage12"></A>
<A ID=TOCLINK3738 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3738 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3738.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3739 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Class II Devices
</I>
</B>
</FONT>
</P>
<P ID=PARA3740 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Several of our products, including the BioArchive and the AXP are categorized as US Class II medical devices and require premarket notification, also known as a section 510(k) clearance, prior to commercialization. Data submitted as part of a 510(k) process must demonstrate a device is &#8220;substantially equivalent&#8221; with a predicate device that is already on the market. Once 510(k) clearance has been secured, the new medical device may be marketed for its intended use and distributed in the U.S.
</FONT>
</P>
<P ID=PARA3741 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3742 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Class III Devices
</I>
</B>
</FONT>
</P>
<P ID=PARA3743 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If a product is considered a Class III device, as is the case with the CLI SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
	- System, the FDA approval process is more stringent and time-consuming, and includes the following:
</FONT>
</P>
<P ID=PARA3744 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL3745 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
<P ID=PARA6421 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6419>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6420>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Extensive pre-clinical laboratory and animal testing
</FONT>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3747 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3748 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3749 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Submission and approval of an IDE application prior to the conduct of a clinical study
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3751 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3752 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3753 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Human clinical studies (or trials) to establish the safety and efficacy of the medical device for the intended use, and
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3755 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3756 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3757 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Submission and approval of a PMA application to the FDA.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3758 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3759 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Pre-clinical testing typically involves in vitro laboratory analysis and in vivo animal studies to obtain information related to such things as product safety, feasibility, biological activity and reproducibility. The results of pre-clinical studies are submitted to the FDA as part of an IDE application and are reviewed by the Agency before human clinical trials can begin. We use external third parties, as well as our own facility in Gurgaon, India (GLP Compliant) to conduct pre-clinical studies.
</FONT>
</P>
<P ID=PARA3760 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3761 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The CLIRST III trials will involve treatment of patients with bone marrow harvested and processed by company medical devices, employing critical quality control steps. The study will commence only after approval of an IRB. Higher risk clinical trials conducted inside the U.S. are subject to FDA IDE regulation (21 C.F.R. Part 812), or an IND application (21 C.F.R. Part 312). Clinical trials conducted outside the U.S., and the data collected therefrom are allowed in accordance with applicable FDA requirements. The FDA or the Sponsor may suspend a clinical trial at any time if either believes that study participants may be exposed to an unacceptable health risk.
</FONT>
</P>
<P ID=PARA3762 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3763 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For certain Class III devices, data generated during product development, pre-clinical studies, and human clinical studies must be submitted to the FDA as a PMA application in order to secure approval for commercialization in the U.S. The FDA may deny the approval of a PMA application if applicable regulatory criteria are not satisfied and in some cases may mandate additional clinical testing. Product approvals, once obtained, can be withdrawn if compliance with regulatory standards is not maintained or if safety concerns arise after the product reaches the market. The FDA might also require post-marketing testing and surveillance programs to monitor the safety and efficacy of a medical device and has the power to forbid or limit future marketing of the product based on the results of such programs.
</FONT>
</P>
<P ID=PARA3764 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3765 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Other U.S. Regulatory Information
</I>
</B>
</FONT>
</P>
<P ID=PARA3766 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Medical device manufacturers must register with the FDA and submit their manufacturing facilities to biennial inspections to ensure compliance with applicable regulations. Failure to comply with FDA requirements can result in withdrawal of marketing clearances, fines, injunctions, civil penalties, recall or seizure of products, total or partial suspension of production or loss of distribution rights. In addition, device manufacturing facilities in the state of California must be registered with the California State Food and Drug Branch of the California Department of Public Health and submit to an annual inspection by the State of California to ensure compliance with applicable state regulations. We are also subject to a variety of environmental laws as well as workplace safety, hazardous material, and controlled substances regulations.
</FONT>
</P>
<P ID=PARA6422.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6422 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6422 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6422 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	12
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage13"></A>
<A ID=TOCLINK6422 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6422 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6422.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3767 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The California State Food and Drug Branch of the California Department of Public Health completed a quality system compliance inspection at our Rancho Cordova facility in 2011 resulting in two minor observations which have since been corrected. The FDA inspected us in 2015 resulting in zero non-conformances.
</FONT>
</P>
<P ID=PARA3768 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3769 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If we are successful in securing Medicare reimbursement, we will be subject to federal and state laws, such as the Federal False Claims Act, state false claims acts, the illegal remuneration provisions of the Social Security Act, the federal anti-kickback laws, state anti-kickback laws, and the federal &#8220;Stark&#8221; laws, that govern financial and other arrangements among healthcare providers, their owners, vendors and referral sources, and that are intended to prevent healthcare fraud and abuse. Among other things, these laws prohibit kickbacks, bribes and rebates, as well as other direct and indirect payments or fee splitting arrangements that are designed to induce the referral of patients to a particular provider for medical products or services payable by any federal healthcare program, and prohibit presenting a false or misleading claim for payment under a federal or state program. They also prohibit some physician self-referrals. These laws are liberally interpreted and aggressively enforced by multiple state and federal agencies and law enforcement (including individual &#8220;qui tam&#8221; plaintiffs) and such enforcement is increasing. For example, the Affordable Care Act increased funding for federal enforcement actions and many states have established their own Medicare/Medicaid Fraud Units and require providers to conspicuously post the applicable Unit&#8217;s hotline number. Possible sanctions for violation of any of these restrictions or prohibitions include loss of eligibility to participate in federal and state reimbursement programs and civil and criminal penalties.
</FONT>
</P>
<P ID=PARA3770 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3771 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Also, federal transparency requirements, sometimes referred to as the &#8220;Sunshine Act&#8221; under the Patient Protection and Affordable Care Act, require manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to report to the Department of Health and Human Services information related to physician payments and other transfers of value and physician ownership and investment interests.
</FONT>
</P>
<P ID=PARA3772 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3773 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Changes in these laws at all levels of government are frequent and could increase our cost of doing business. If we fail to comply, even inadvertently, with any of these requirements, we could be required to alter our operations, refund payments to the government, lose our licensure or accreditation, enter into corporate integrity, deferred prosecution or similar agreements with state or federal government agencies, and become subject to significant civil and criminal penalties.
</FONT>
</P>
<P ID=PARA3774 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA3775 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	International Regulatory Requirements
</I>
</B>
</FONT>
</P>
<P ID=PARA3776 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	International regulatory requirements differ somewhat from those of the U.S. In the EU, a single regulatory approval process has been created and approval is represented by CE-Marking. To be able to affix the CE-Mark to our medical devices and distribute them in the EU, we must meet minimum standards for safety and quality (known as the essential requirements) and comply with one or more conformity rules. A notified body assesses our quality management system and compliance with the Medical Device Directive. Marketing authorization can be revoked by the applicable governmental agency or notified body in the event of an unsuccessful quality system annual audit.
</FONT>
</P>
<P ID=PARA3777 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3778 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In India, the regulatory body having oversight of medical devices, therapies, and cell banking is the Central Drugs Standard Control Organization (&#8220;CDSCO&#8221;), and specifically the Drugs Controller General India office. Our marketing and facilities licenses are subject to revocation by the applicable state Drug Controller in Haryana or DCGI. The Haryana State Drug Controller and the DCGI completed the latest blood banking license inspection of TotipotentRX GMP cord blood banking facility within Fortis Memorial Research Institute on November 11, 2014. No non-conformances were observed.
</FONT>
</P>
<P ID=PARA3779.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3779 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3779 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3779 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	13
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage14"></A>
<A ID=TOCLINK3779 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3779 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3779.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3780 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Patents and Proprietary Rights
</U>
</B>
</FONT>
</P>
<P ID=PARA3781 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3782 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We believe that patent protection is important for our products and current and proposed business. We have over 25 issued patents globally.
</FONT>
</P>
<P ID=PARA3783 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3784 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The patent positions of regenerative medicine companies, such as ours, are uncertain because they involve interpretation of complex factual information and an evolving legal environment. The coverage sought in a patent application can be denied or significantly reduced either before or after the patent is issued. There can be no assurance that any of our pending patent applications will actually result in an issued patent. Furthermore, there can be no assurance that any existing or future patent will provide significant protection or commercial advantage, or that any existing or future patent will not be circumvented by a more basic patent. Generally, patent applications can be maintained in secrecy for at least 18 months after their earliest priority date. In addition, publication of discoveries in the scientific or patent literature often lags behind actual discoveries. Therefore, we cannot be certain that we were the first to invent or the first to file a patent application for the subject matter covered by each of our pending U.S. and foreign patent applications.
</FONT>
</P>
<P ID=PARA3785 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3786 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If a third party files a patent application relating to an invention claimed in our patent application, we may be required to participate in an interference or derivation proceeding conducted by the U.S. Patent and Trademark Office to determine who owns the patent. Such proceeding could involve substantial uncertainties and cost, even if the eventual outcome is favorable to us. There can be no assurance that our patents, if issued, would be upheld as valid in court.
</FONT>
</P>
<P ID=PARA3787 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3788 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Licenses
</U>
</B>
</FONT>
</P>
<P ID=PARA3789 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3790 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following are certain agreements involving our business.
</FONT>
</P>
<P ID=PARA3791 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3792 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Fortis Healthcare Limited (&#8220;Fortis&#8221;)
</I>
</B>
</FONT>
</P>
<P ID=PARA3793 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 1, 2014 we entered into an agreement with Fortis which renews and expands our existing services agreement with them in areas including, but not limited to, cord blood banking, point of care technology sales and support, bone marrow transplant and clinical/patient management. The term of the agreement is for three years.
</FONT>
</P>
<P ID=PARA3794 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA3795 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Cord Blood Registry Systems, Inc. (&#8220;CBR&#8221;)
</I>
</B>
</FONT>
</P>
<P ID=PARA3796 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On December 31, 2013, we entered into a Sale and Purchase Agreement with CBR in which we agreed to supply CBR with the AXP cord blood processing system and disposables. The term of the agreement is for 5 years with automatic two-year renewal options unless CBR provides a 6 month notice of non-renewal. On September 30, 2015, we entered into a Fifth Amended and Restated Technology License and Escrow Agreement with CBR which modified the financial covenant that we must meet in order to avoid an event of default. We must maintain a cash balance coupled with short-term investments net of debt or borrowed funds that are payable within one year of not less than two million dollars. We were in compliance with this covenant at June 30, 2016.
</FONT>
</P>
<P ID=PARA3797 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3798 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In June 2010, we entered into a License and Escrow Agreement in order to alleviate CBR&#8217;s concerns about potential long term supply risk. We are the sole supplier of critical devices and disposables used in the processing of cord blood samples in CBR&#8217;s operations. Under the License and Escrow Agreement, we granted CBR a perpetual, non-exclusive, royalty-free license to certain intellectual property necessary for the manufacture of AXP devices and disposables. The license is for the sole and limited purpose of ensuring continued supply of the AXP and related disposables for use by CBR. The licensed intellectual property is held in escrow and available to CBR only in the event of a default under the agreement.
</FONT>
</P>
<P ID=PARA6423.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6423 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6423 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6423 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	14
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage15"></A>
<A ID=TOCLINK6423 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6423 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6423.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA3800 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Golden Meditech
</I>
</B>
</FONT>
</P>
<P ID=PARA3801 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In August 2012, we entered into a Product Purchase and International Distributor Agreement with Golden Meditech. Under the terms of the agreement, Golden Meditech obtained the exclusive, subject to existing distributors and customers, rights to develop an installed base for our AXP System in specified countries. This includes the right to distribute AXP Disposable Blood Processing Sets and use the AXP System, and other accessories used for the processing of stem cells from cord blood. Golden Meditech has rights in the People&#8217;s Republic of China (excluding Hong Kong and Taiwan), India, Singapore, Indonesia, and the Philippines and may begin selling once relevant approval has been obtained in each respective country. Additionally, Golden Meditech is subject to certain annual minimum purchase commitments. The term of the agreement is for 5 years with one year renewal options by mutual agreement.
</FONT>
</P>
<P ID=PARA3802 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3803 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	BioParadox LLC (&#8220;BioParadox&#8221;)
</I>
</B>
</FONT>
</P>
<P ID=PARA3804 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In October 2010, we entered into a License and Distribution Agreement with BioParadox. Under the terms of the agreement BioParadox obtained exclusive world-wide rights for the use, research and commercialization of the Res-Q technology in the production of PRP in the diagnosis, treatment and prevention of cardiovascular disease. The term of the agreement was to depend on the satisfaction by BioParadox of certain milestones, or the payment of extension fees. On December 22, 2015, we gave 30 days written notice to BioParadox, terminating the agreement effective January 21, 2016.
</FONT>
</P>
<P ID=PARA3805 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA3806 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	New York Blood Center (&#8220;NYBC&#8221;)/Pall Medical
</I>
</B>
</FONT>
</P>
<P ID=PARA3807 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In March 1997, we and NYBC, as licensors, entered into a license agreement with Pall Medical, a subsidiary of Pall Corporation, as a licensee through which Pall Medical became the exclusive worldwide manufacturer (excluding Japan) for a system of sterile, disposable bag sets developed by us and NYBC for the processing of hematopoietic stem cells sourced from umbilical cord blood. The system is designed to simplify and streamline the harvesting concentration, cryopreservation (freezing) and transfusion of cells while maintaining the highest stem cell population and viability from each cord blood donation. In May 1999, we and Pall Medical amended the original agreement such that we regained the rights to distribute the bag sets outside North America and Europe under our own name. In fiscal 2012, we signed an agreement with NYBC which provides for the equal sharing of royalties between the two parties through the remaining term of the licenses, or June 2016. Therefore, we will not be receiving royalties on these products after June 2016.
</FONT>
</P>
<P ID=PARA3808 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 1PT">
	&nbsp;
</FONT>
</P>
<P ID=PARA3809 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA3810 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Employees
</U>
</B>
</FONT>
</P>
<P ID=PARA3811 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3812 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	As of June 30, 2016, we had 89 employees, 46 of whom were employed in the U.S. and 43 of whom were employed in India. We also utilize temporary employees throughout the year to address business needs and significant fluctuations in orders and product manufacturing. None of our employees are covered by a collective bargaining agreement, nor have we experienced any work stoppage.
</FONT>
</P>
<P ID=PARA3813 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3814 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Foreign Sales and Operations
</U>
</B>
</FONT>
</P>
<P ID=PARA3815 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3816 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	See footnote 9 of our Notes to Consolidated Financial Statements for information on our sales and operations outside of the U.S.
</FONT>
</P>
<P ID=PARA3817.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3817 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3817 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3817 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	15
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage16"></A>
<A ID=TOCLINK3817 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3817 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3817.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3818 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Where you can Find More Information
</U>
</B>
</FONT>
</P>
<P ID=PARA3819 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3820 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are required to file annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other information, including our proxy statement, with the Securities and Exchange Commission (&#8220;SEC&#8221;). The public can obtain copies of these materials by visiting the SEC&#8217;s Public Reference Room at 100 F Street, NE, Room 1580, Washington, DC 20549, by calling the SEC at 1-800-732-0330, or by accessing the SEC&#8217;s website at http://www.sec.gov. In addition, as soon as reasonably practicable after these materials are filed with or furnished to the SEC, we will make copies available to the public free of charge through its website, www.cescatherapeutics.com. The information on its website is not incorporated into, and is not part of, this annual report.
</FONT>
</P>
</EFX_BUSINESS>
<P ID=PARA3821 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS"></A>
<P ID=PARA3822 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6607 NAME="KOOL20160630_10K_HTM_BKMK6607">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	1A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	RISK FACTORS
</U>
</B>
</FONT>
</P>
<P ID=PARA3823 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3824 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	An investment in our common stock is subject to risks inherent to our business. The material risks and uncertainties that management believes affect us are described below. Before making an investment decision, you should carefully consider the risks and uncertainties described below together with all of the other information included or incorporated by reference in this report. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are not aware of or focused on or that we currently deem immaterial may also impair our business operations. This report is qualified in its entirety by these risk factors.
</FONT>
</P>
<P ID=PARA3825 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3826 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	If any of the following risks actually occur, our financial condition and results of operations could be materially and adversely affected. If this were to happen, the value of our common stock could decline significantly, and you could lose all or part of your investment.
</FONT>
</P>
<P ID=PARA3827 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3828 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Risks Related to Our Business
</I>
</B>
</FONT>
</P>
<P ID=PARA3829 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Lack of Demonstrated Clinical Utility of Cord Blood Derived Stem Cells Beyond Hematopoietic Transplantation May Result in a Decline in Demand for Cord Blood Banking Services, Adversely Affecting Sales of Our Products.
</I>
	Transplants using stem cells derived from cord blood and cord tissue have become a standard procedure for treating blood cell lineage disorders including leukemia, lymphoma and anemia. However, clinical research demonstrating the utility of cord blood stem cells for use in treating other diseases or injuries has been minimal, leaving claims of broad clinical utility of cord blood stem cells by cord blood banks largely unsubstantiated. The low utilization rate of banked cord blood samples coupled with the lack of demonstrated clinical results for multiple treatment indications has led to consumer skepticism regarding the benefits of cord blood banking and in turn, a significant reduction in collection rates in a number of geographies in Europe and the U.S. A continued lack of investment in the research and development of supporting clinical data for additional applications may lead to greater skepticism globally, further adversely affecting demand for cord blood banking services and our revenues.
</FONT>
</P>
<P ID=PARA3830 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3831 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We May Be Unable to Obtain Marketing Approval from the FDA For Our SurgWerks
</I>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<I>
	TM
</I>
</SUP>
<I>
	System.
</I>
	At the end of May 2016, we submitted to the U.S. Food and Drug Administration (FDA) an Investigational Device Exemption (IDE) Supplement for a phase III pivotal trial related to our SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
	system for the treatment of late stage, no option, critical limb ischemia (CLI) patients, which proposed a change in the primary efficacy endpoint from Amputation Free Survival to Change in Transcutaneous Oxygen Pressure (TcPO2). Upon completion of its review of the IDE Supplement, the FDA approved the changes in our pivotal trial design as proposed in the IDE Supplement, including the use of Change in TcPO2 as the primary measure of efficacy. However, in its feedback, the FDA also indicated that regardless of the outcome of the study, it would require us to further validate TcPO2 as a surrogate for clinical outcome for the proposed indication prior to granting marketing approval (PMA). As a result of the FDA&#8217;s feedback, a successful outcome of the study will not, in and of itself, result in obtaining a PMA for the SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
	system. We may be unable to further validate TcPO2 as a surrogate for clinical outcome for the proposed indication necessary to obtain a PMA approval.
</FONT>
</P>
<P ID=PARA6424.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6424 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6424 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6424 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	16
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage17"></A>
<A ID=TOCLINK6424 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6424 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6424.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA3833 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We have
</I>
<I>
	Limited Operating History In the Emerging Regenerative Medicine Industry.
</I>
	Through the merger with TotipotentRX, we are in the business of research, development and commercialization of autologous cell-based therapeutics for use in the emerging regenerative medicine industry, and therefore, we have a limited operating history in such industry on which to base an evaluation of our business and prospects.&nbsp; We will be subject to the risks inherent in the operation of a company in an emerging industry such as regulatory setbacks and delays, fluctuations in expenses, competition, and governmental regulation.
</FONT>
</P>
<P ID=PARA3834 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3835 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Controlling Stockholder Has Significant Influence Over Us Which Could Limit Your Ability to Influence the Outcome of Key Transactions, Including a Change of Control, and Could Negatively Impact the Market Price of Our Common Stock By Discouraging Third Party Investors.
</I>
	As of
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	August 22, 2016, approximately 70% of our outstanding common stock is owned by Boyalife (Hong Kong) Limited and Boyalife Investment Inc. On a fully-diluted basis Boyalife (Hong Kong) Limited and Boyalife Investment Inc. collectively own 72% of our common stock based on the right to acquire an aggregate of 3,529,412 shares of our common stock upon exercise of outstanding warrants. We would receive $28 million upon the exercise of the warrants. In addition, pursuant to the terms of a Nomination and Voting Agreement we entered into with Boyalife (Hong Kong) Limited and Boyalife Investment Inc. in February 2016, Boyalife (Hong Kong) Limited and Boyalife Investment Inc. have the right to designate up to three of the seven members to our board of directors until such time as they collectively no longer hold at least 50% of our common stock.
</FONT>
</P>
<P ID=PARA3836 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3837 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Boyalife (Hong Kong) Limited is 100% owned by Yishu Li, the spouse of Dr. Xiachun Xu, a member of our board of directors. Boyalife Investment, Inc., is also controlled by Dr. Xu. As a result of their ownership and ability to designate up to three members of our board of directors, Boyalife (Hong Kong) Limited and Boyalife Investment Inc. (including Dr. Xu and his spouse Ms. Li) will be able to exercise significant influence over all matters affecting us, including the election of directors, formation and execution of business strategy and approval of mergers, acquisitions and other significant corporate transactions, which may have an adverse effect on our stock price and ability to execute our strategic initiatives. They may have conflicts of interest and interests that are not aligned with those of other investors in all respects. As a result of the concentrated ownership of our common stock, a relatively small number of stockholders, acting together, are able to control all matters requiring stockholder approval. This concentration of ownership may delay or prevent a change in control and may have a negative impact on the market price of our common stock by discouraging third party investors.
</FONT>
</P>
<P ID=PARA3838 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK3839 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3839 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3839 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	17
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage18"></A>
<A ID=TOCLINK3839 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3839 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3839.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
	&nbsp;
</P>
<P ID=PARA6659 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Have Received Proposals to Sell Our Cord Blood Banking
</I>
<I>
	Product Lines
</I>
<I>
	in the Past, and We May Receive Additional Proposals in the Future, Which If Accepted Would Resu
</I>
<I>
	l
</I>
<I>
	t in the Loss of Significant
</I>
<I>
	Product Lines
</I>
<I>
	and Revenue Source.
</I>
	On June 23, 2016, we received from Boyalife Investment Inc. and Boyalife (Hong Kong) Limited, our controlling shareholders and affiliates of Dr. Xiachun Xu, one of our directors, a non-binding term sheet (the &#8220;Proposal&#8221;), relating to a proposed additional investment in Cesca, which also contemplated among other things the sale of our cord blood product lines to Boyalife Investment Inc., Boyalife (Hong Kong) Limited or one of their affiliates (the &#8220;Boyalife Affiliates&#8221;) at a cost equal to its annual revenue. The independent directors had reservations about a number of aspects of the Proposal, and the Proposal expired by its terms on June 30, 2016. The Boyalife Affiliates may submit additional proposals to acquire our cord blood product lines in the future on similar or different terms as to those set forth in the original Proposal. Any proposal for the acquisition of our cord banking product lines by the Boyalife Affiliates or any other third party will need to be evaluated by our board of directors at the time such proposal is received based on the condition, financial and otherwise, of Cesca at the time such proposal is received. We cannot assure what terms and conditions would be acceptable to our board of directors with respect to the receipt of any future proposal to acquire our cord blood banking product lines, nor whether, based upon the then existing condition of Cesca, whether the prior Proposal would have been superior to what the board of directors may ultimately approve. Additionally, in the event the board of directors receives a proposal from a third party to acquire its cord blood banking product lines that it determines is superior to the Proposal or a subsequent competing proposal from the Boyalife Affiliates, the Boyalife Affiliates may use their significant control over us as our controlling shareholder to prevent the sale of our cord blood banking business unit to such third party. In any event, the sale or our cord blood banking product lines, if any and regardless of the terms, would result in the loss of a significant revenue source and operations.
</FONT>
</P>
<P ID=PARA6660 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3842 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Potential Products and Technologies Are In Early Stages Of Development.
</I>
	The development of new cell therapy products is a highly risky undertaking, and there can be no assurance that any future research and development efforts we may undertake will be successful. Our potential products in vascular, orthopedic, hematological/oncological and wound care indications will require extensive additional research and development and regulatory approval before any commercial introduction.&nbsp; There can be no assurance that any future research, development and clinical trial efforts will result in viable products or meet efficacy standards.
</FONT>
</P>
<P ID=PARA3843 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3844 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We
</I>
<I>
	Intend To Rely On Third Parties For Certain Functions In Conducting Clinical Trials Of Our Product Candidates.
</I>
	We intend to rely on third parties for certain clinical trial activities of its products.&nbsp; In this regard, we have an agreement with Fortis Healthcare Limited, a hospital chain networked throughout India and Asia, for contract clinical trial services programs among other services. The agreement expires in August 2017. Termination, or the non-renewal upon expiration, of this agreement could jeopardize or delay development of our products.
</FONT>
</P>
<P ID=PARA3845.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3845 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3845 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3845 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	18
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage19"></A>
<A ID=TOCLINK3845 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3845 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3845.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3846 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Delays In The Commencement Or Completion Of Clinical Testing Of Our Products Could Result In Increased Costs To Us And Delay Our Ability To Generate Revenues.
</I>
	Delays in the commencement or completion of clinical testing could significantly impact our product development costs.&nbsp; We do not know whether current or planned clinical trials will begin on time or be completed on schedule, if at all.&nbsp; The commencement of clinical trials can be delayed for a variety of reasons, including delays in:
</FONT>
</P>
<P ID=PARA3847 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 72PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL3848 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6448 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6446>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6447>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Obtaining regulatory approval to commence a clinical trial;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3849 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6445 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6443>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6444>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Having the necessary funding in place to conduct the clinical trial;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3850 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6442 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6440>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6441>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Reaching agreement on acceptable terms with prospective contract research organizations&nbsp;and clinical trial sites for Phase II and III trials;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3851 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6439 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6437>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6438>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Obtaining proper devices for any or all of the product candidates;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3852 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6436 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6434>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6435>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Obtaining institutional review board approval to conduct a clinical trial at a prospective&nbsp;site; and
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3853 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6433 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6431>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6432>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Recruiting participants for a clinical trial.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3855 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3854 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In addition, once a clinical trial has begun, it may be suspended or terminated by&nbsp;us or the FDA or other regulatory authorities due to a number of factors, including:
</FONT>
</P>
<P ID=PARA3856 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL3857 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6430 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6428>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6429>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Failure to conduct the clinical trial in accordance with regulatory requirements;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=TBL3859 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
<P ID=PARA6427 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6425>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6426>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Inspection of the clinical trial operations or clinical trial site by the FDA or other&nbsp;regulatory authorities resulting in the imposition of a clinical hold;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3862 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3863 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3864 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Failure to achieve certain efficacy and/or safety standards;
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3867 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3868 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3869 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Reports of serious adverse events including but not limited to death of trial subjects; or
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB3872 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA3873 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA3874 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Lack of adequate funding to continue the clinical trial.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA3875 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA3877 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our clinical therapy candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs that we expect to pursue.
</FONT>
</P>
<P ID=PARA3878 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3879 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We
</I>
<I>
	May Seek To Enter Into Collaborative Arrangements To Develop and Commercialize Products Which May Not Be Successful.
</I>
	We may seek to enter into collaborative arrangements to develop and commercialize some of our potential products both in North America and international markets.&nbsp; There can be no assurance that we will be able to negotiate collaborative arrangements on favorable terms or at all or that current or future collaborative arrangements will be successful.
</FONT>
</P>
<P ID=PARA3880 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3881 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	A Significant Portion of
</I>
<I>
	Revenue is Derived from Customers Outside the United States.
</I>
<I>
	We
</I>
<I>
	may Lose Revenues, Market Share, and Profits due
</I>
<I>
	to Exchange Rate Fluctuations and
</I>
<I>
	Political and
</I>
<I>
	Economic Changes Related to its
</I>
<I>
	Foreign Business.
</I>
	In the year ended June 30, 2016, sales to customers outside the U.S. comprised approximately 57% of revenues. This compares to 47% in fiscal 2015. Our foreign business is subject to economic, political and regulatory uncertainties and risks that are unique to each area of the world. Fluctuations in exchange rates may also affect the prices that foreign customers are willing to pay, and may put us at a price disadvantage compared to other competitors. Potentially volatile shifts in exchange rates may negatively affect our financial position and results.
</FONT>
</P>
<P ID=PARA3882 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3883 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	The Loss of a Significant Distributor or End User Cu
</I>
<I>
	stomer may Adversely Affect
</I>
<I>
	Financial Condition and Results of Operations.
</I>
	Revenues from two significant distributors/customers comprised 44% of revenues for the year ended June 30, 2016. The loss of a large end user customer or distributor may decrease revenues.
</FONT>
</P>
<P ID=PARA3884.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3884 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3884 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3884 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	19
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage20"></A>
<A ID=TOCLINK3884 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3884 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3884.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3885 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We may be Exposed to Liabilities under the Foreign Corrupt Practices Act and any Determination that we Violated these Laws could have a Material Adverse Effect on our Business.
</I>
	We are subject to the Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties by U.S. persons and issuers as defined by the statute, for the purpose of obtaining or retaining business. It is our policy to implement safeguards to discourage these practices by our employees. However, our existing safeguards and any future improvements may prove to be less than effective and our employees, consultants, sales agents or distributors may engage in conduct for which we might be held responsible. Violations of the FCPA may result in severe criminal or civil sanctions and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition.
</FONT>
</P>
<P ID=PARA3886 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3887 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Adverse Results of Legal Proceedings could have a Material Adverse Effect on Us.
</I>
	We are subject to, and may in the future be subject to, a variety of legal proceedings and claims that arise out of the ordinary conduct of our business. Results of legal proceedings cannot be predicted with certainty. Irrespective of their merits, legal proceedings may be both lengthy and disruptive to our operations and may cause significant expenditure and diversion of management attention. We may be faced with significant monetary damages or injunctive relief against us that could have a material adverse effect on a portion of our business operations or a material adverse effect on our financial condition and results of operations.
</FONT>
</P>
<P ID=PARA3888 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA3889 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Risks Related to Our Operations
</I>
</B>
</FONT>
</P>
<P ID=PARA3890 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Ability to Conduct
</I>
<I>
	a
</I>
<I>
</I>
<I>
	CLIRST III Clinical Trial
</I>
<I>
</I>
<I>
	I
</I>
<I>
	s Substantially Dependent
</I>
<I>
	o
</I>
<I>
	n Our Ability to
</I>
<I>
	Secure Additional Funding and There Are No Assurances That Such Funding will Materialize.
</I>
	Although a portion of the net proceeds we received from the February 2016 and August 2016 financings is expected to be used to fund our ongoing operations and CLIRST III trial, these proceeds will not be sufficient, and we will need to raise additional funding. We cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at all.
</FONT>
</P>
<P ID=PARA3891 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3892 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Do Not Have Commercial-Scale Manufacturing Capability And Lack Commercial Manufacturing Experience.
</I>
	We operate GMP manufacturing facilities for both devices and cellular production; however, they are not of sufficient size for medium to large commercial production of product candidates.&nbsp; We will not have large scale experience in cell-drug formulation or manufacturing, and will lack the resources and the capability to manufacture any of our product candidates on a clinical or commercial scale.&nbsp; Accordingly, we expect to depend on third-party contract manufacturers for the foreseeable future.&nbsp; Any performance failure on the part of our contract manufacturers could delay clinical development, regulatory approval or commercialization of our current or future products, depriving us of potential product revenues and resulting in additional losses.
</FONT>
</P>
<P ID=PARA3893 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3894 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Have Limited Sales, Marketing and Distribution Experience in Pharmaceutical Products.
</I>
	We have limited experience in the sales, marketing, and distribution of pharmaceutical products.&nbsp; There can be no assurance that we will be able to establish sales, marketing, and distribution capabilities or make arrangements with&nbsp;current collaborators or others to perform such activities or that such effort will be successful.&nbsp; If we decide to market any of our new products directly, we must either partner, acquire or internally develop a marketing and sales force with technical expertise and with supporting distribution capabilities.&nbsp; The acquisition or development of a sales, marketing and distribution infrastructure would require substantial resources, which may not be available to us or, even if available, divert the attention of our management and key personnel, and have a negative impact on further product development efforts.
</FONT>
</P>
<P ID=PARA3895.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3895 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3895 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3895 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	20
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage21"></A>
<A ID=TOCLINK3895 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3895 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3895.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3896 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Inability to Protect our Patents, Trademarks, Trade Secrets and other Proprietary Rights could Adversely Impact our Competitive Position.
</I>
	We believe that our patents, trademarks, trade secrets and other proprietary rights are important to our success and our competitive position. Accordingly, we commit substantial resources to the establishment and protection of our patents, trademarks, trade secrets and proprietary rights. We use various methods, including confidentiality agreements with employees, vendors, and customers, to protect our trade secrets and proprietary know-how for our products. We currently hold patents for products, and have patents pending in certain countries for additional products that we market or intend to market. However, our actions to establish and protect our patents, trademarks, and other proprietary rights may be inadequate to prevent imitation of our products by others or to prevent others from claiming violations of their trademarks and proprietary rights by us. If our products are challenged as infringing upon patents of other parties, we may be required to modify the design of the product, obtain a license, or litigate the issues, all of which may have an adverse business effect on us.
</FONT>
</P>
<P ID=PARA3898 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3897 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We may be Subject to Claims that our Products or Processes Infringe the Intellectual Property Rights of Others, which may Cause us to Pay Unexpected Litigation Costs or Damages, Modify our Products or Processes or Prevent us from Selling our Products.
</I>
	Although it is our intention to avoid infringing or otherwise violating the intellectual property rights of others, third parties may nevertheless claim that our processes and products infringe their intellectual property and other rights. Our strategies of capitalizing on growing international demand as well as developing new innovative products across multiple business lines present similar infringement claim risks both internationally and in the U.S. as we expand the scope of our product offerings and markets. We compete with other companies for contracts in some small or specialized industries, which increase the risk that the other companies will develop overlapping technologies leading to an increased possibility that infringement claims will arise. Whether or not these claims have merit, we may be subject to costly and time-consuming legal proceedings, and this could divert management&#8217;s attention from operating our business. In order to resolve such proceedings, we may need to obtain licenses from these third parties or substantially re-engineer or rename our products in order to avoid infringement. In addition, we might not be able to obtain the necessary licenses on acceptable terms, or at all, or be able to re-engineer or rename our products successfully.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA6661 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We C
</I>
<I>
	ommercially
</I>
<I>
	, in Co-B
</I>
<I>
	randing with Fortis Healthcare,
</I>
<I>
	Bank and Store Private Cord Blood Stem C
</I>
<I>
	ells in our Totip
</I>
<I>
	otentRX GMP F
</I>
<I>
	acility. We could be
</I>
<I>
	Subject to Unexpected Litigation Costs or D
</I>
<I>
	amages
</I>
<I>
	for L
</I>
<I>
	oss of
</I>
<I>
	One or M
</I>
<I>
	ore
</I>
<I>
	Family O
</I>
<I>
	wned
</I>
<I>
	U
</I>
<I>
	nits
</I>
<I>
	of Cord B
</I>
<I>
	lood
</I>
<I>
	or if one of the Cord Blood Units We Store Causes Bodily I
</I>
<I>
	njury.
</I>
	We face an inherent business risk of exposure to product liability claims if our products or product candidates are alleged or found to have caused injury, or cannot be used for some reason within our control and are found to result in injury or death. While we believe that our current liability insurance coverage is adequate for our present clinical and commercial activities we may not be able to maintain insurance on acceptable terms or at all. If we are unable to obtain insurance or any claims against us substantially exceed our coverage, then our business could be adversely impacted.
</FONT>
</P>
<P ID=PARA6663 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA3902 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	If our Cord Blood Processing and Storage F
</I>
<I>
	acility in Gurgaon, India is
</I>
<I>
	Damaged or Destroyed, our Business, P
</I>
<I>
	rograms and
</I>
<I>
	Prospects could be Negatively A
</I>
<I>
	ffected.
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We process and store our customers&#8217; umbilical cord blood at our facility within Fortis Memorial Research Institute (a hospital) in Gurgaon, India. If this facility or the equipment in the facility were to be significantly damaged or destroyed, we could suffer a loss of some or all of the stored cord blood units. Depending on the extent of loss, such an event could reduce our ability to provide cord blood stem cells when requested, could expose us to significant liability from our cord blood banking customers and could affect our ability to continue to provide umbilical cord blood preservation services.
</FONT>
</P>
<P ID=PARA3903 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK3904 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3904 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3904 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	21
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage22"></A>
<A ID=TOCLINK3904 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3904 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3904.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3905 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We may not be able to Protect our Intellectual Property in Countries Outside the United States.
</I>
	Intellectual property law outside the United States is uncertain and in many countries is currently undergoing review and revisions. The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws. This is particularly relevant to us as a significant amount of our current and projected future sales are outside of the United States. Third parties may attempt to oppose the issuance of patents to us in foreign countries by initiating opposition proceedings. Opposition proceedings against any of our patent filings in a foreign country could have an adverse effect on our corresponding patents that are issued or pending in the United States. It may be necessary or useful for us to participate in proceedings to determine the validity of our patents or our competitors&#8217; patents that have been issued in countries other than the U.S. This could result in substantial costs, divert our efforts and attention from other aspects of our business, and could have a material adverse effect on our results of operations and financial condition.
</FONT>
</P>
<P ID=PARA3906 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3907 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Any Failure to Achieve and Maintain the High Design and Manufacturing Standards that our Products Require may Seriously Harm our Business.
</I>
	Our products require precise, high-quality manufacturing. Achieving precision and quality control requires skill and diligence by our personnel as well as our vendors. Our failure to achieve and maintain these high manufacturing standards, including the incidence of manufacturing errors, design defects or component failures could result in patient injury or death, product recalls or withdrawals, delays or failures in product testing or delivery, cost overruns or other problems that could seriously hurt our business. Additionally, the large amount of AXP disposable inventory certain distributors and end-users maintain may delay the identification of a manufacturing error and expand the financial impact. A manufacturing error or defect, or previously undetected design defect, or uncorrected impurity or variation in a raw material component, either unknown or undetected, could affect the product. Despite our very high manufacturing standards, we cannot completely eliminate the risk of errors, defects or failures. If we or our vendors are unable to manufacture our products in accordance with necessary quality standards, our business and results of operations may be negatively affected.
</FONT>
</P>
<P ID=PARA3908 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3909 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Revenues and Operating Results may be Adversely Affected as a Result of our Required Compliance with the Adopted EU Directive on the Restriction of the Use of Hazardous Substances in Electrical and Electronic Equipment, as well as other Standards Around the World.
</I>
	A number of domestic and foreign jurisdictions seek to restrict the use of various substances, a number of which have been or are currently used in our products or processes. For example, the EU Restriction of Hazardous Substances in Electrical and Electronic Equipment (&#8220;RoHS&#8221;) Directive now requires that certain substances, which may be found in certain products we have manufactured in the past, be removed from all electronics components. Other countries, such as China, have enacted or may enact laws or regulations similar to RoHS. Eliminating such substances from our manufacturing processes requires the expenditure of additional research and development funds to seek alternative substances for our products, as well as increased testing by third parties to ensure the quality of our products and compliance with the RoHS Directive. While we have implemented a compliance program to ensure our product offerings meet these regulations, there may be instances where alternative substances will not be available or commercially feasible, or may only be available from a single source, or may be significantly more expensive than their restricted counterparts. Therefore, we have focused our compliance efforts on those products and geographical areas in which we have the highest revenue potential. Our failure to comply with past, present and future similar laws could result in reduced sales of our products, substantial product inventory write-offs, reputation damage, penalties and other sanctions, any of which could harm our business and operating results.
</FONT>
</P>
<P ID=PARA3910.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3910 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3910 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3910 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	22
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage23"></A>
<A ID=TOCLINK3910 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3910 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3910.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3911 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Compliance with Government Regulations Regarding the Use of &#8220;Conflict Minerals&#8221; may Result in Additional Expense and Affect our Operations.
</I>
	The SEC has adopted a final rule to implement Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, which imposes new disclosure requirements regarding the use of &#8220;conflict minerals&#8221; mined from the Democratic Republic of Congo and adjoining countries. These minerals include tantalum, tin, gold and tungsten. We may incur significant costs associated with complying with the new disclosure requirements, including but not limited to costs related to determining which of our products may be subject to the rules and identifying the source of any &#8220;conflict minerals&#8221; used in those products. Additionally, implementing the new requirements could adversely affect the sourcing, supply and pricing of materials used in the manufacture of our products. We may also face reputational challenges if we are unable to verify through our compliance procedures the origins for all metals used in our products.
</FONT>
</P>
<P ID=PARA3912 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3913 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Products may be Subject to Product Recalls which may Harm our Reputation and Divert our Managerial and Financial Resources
</I>
	. The FDA and similar governmental authorities in other countries have the authority to order the mandatory recall of our products or order their removal from the market if the governmental entity finds our products might cause adverse health consequences or death. The FDA may also seize product or prevent further distribution. A government-mandated or voluntary recall by us could occur as a result of component failures, manufacturing errors or design defects (including labeling defects). In the past we have initiated voluntary recalls of some of our products and we could do so in the future. Any recall of our products may harm our reputation with customers, divert managerial and financial resources and negatively impact our profitability.
</FONT>
</P>
<P ID=PARA3914 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3915 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We are Dependent on our Suppliers and Manufacturers to Meet Existing Regulations.
</I>
	Certain of our suppliers and manufacturers are subject to heavy government regulations, including FDA QSR compliance, in the operation of their facilities, products and manufacturing processes. Any adverse action by the FDA against our suppliers or manufacturers could delay supply or manufacture of component products required to be integrated or sold with our products. Although we attempt to mitigate this risk through inventory held directly or through distributors, and audit our suppliers, there are no assurances we will be successful in identifying issues early enough to allow for corrective action or transition to an alternative supplier, or in locating an alternative supplier or manufacturer to meet product shipment or launch deadlines. As a result, our sales, contractual commitments and financial forecasts may be significantly affected by any such delays.
</FONT>
</P>
<P ID=PARA3916 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3917 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Dependence on Suppliers for Disposable Products and Custom Components
</I>
<I>
	M
</I>
<I>
	ay Impact the Production Schedule.
</I>
	We obtain certain disposable products and custom components from a limited number of suppliers. If the supplier raises the price or discontinues production, we may have to find another qualified supplier to provide the item or re-engineer the item. In the event that it becomes necessary for us to find another supplier, we would first be required to qualify the quality assurance systems and product quality of that alternative supplier. Any operational issues with re-engineering or the alternative qualified supplier may impact the production schedule, therefore delaying revenues, and this may cause the cost of disposables or key components to increase.
</FONT>
</P>
<P ID=PARA3918 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3919 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Failure to Meet the Financial Covenant in our Technology License and Escrow Agreement could Decrease our AXP Revenues.
</I>
	Under our license and escrow agreement with Cord Blood Registry (&#8220;CBR&#8221;) if we fail to meet the financial covenant of cash balance and short-term investments net of debt or borrowed funds that are payable within one year of not less than $2,000 must be maintained, they may take possession of the escrowed intellectual property and initiate manufacturing of the applicable device and disposables. If this were to occur, our revenues would be negatively impacted. In order to remain compliant we may have to do additional financings or provide consideration to the counter party to modify the obligations.
</FONT>
</P>
<P ID=PARA3920.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK3920 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3920 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3920 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	23
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage24"></A>
<A ID=TOCLINK3920 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3920 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3920.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3921 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Failure to Retain or Hire Key Personnel may Adversely Affect our Ability to Sustain or Grow our Business.
</I>
	Our ability to operate successfully and manage our potential future growth depends significantly upon retaining key research, technical, clinical, regulatory, sales, marketing and managerial personnel. Our future success partially depends upon the continued services of key technical and senior management personnel. Our future success also depends on our continuing ability to attract, retain and motivate highly qualified managerial and technical personnel. The inability to retain or attract qualified personnel could have a significant negative effect upon our efforts and thereby materially harm our business and future financial condition.
</FONT>
</P>
<P ID=PARA3922 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA6664 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Most of Our Operations Are Conducted At A Single Location. Any Disruption At Our Facilities Could Delay Revenues Or Increase Our Expenses
</I>
	. Our U.S. device operations are conducted at a single location although we contract the manufacturing of certain devices, disposables and components. We take precautions to safeguard our facilities, through insurance, health and safety protocols, and off-site storage of computer data. However, a natural disaster, such as a fire, flood or earthquake, could cause substantial delays in our operations, damage or destroy our manufacturing equipment or inventory, and cause us to incur additional expenses. The insurance we maintain against fires, floods, and other natural disasters may not be adequate to cover our losses in any particular case.
</FONT>
</P>
<P ID=PARA6665 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3925 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Failure to Maintain and/or Upgrade Our Information Technology Systems May Have an Adverse Effect on Our Operations.
</I>
	We rely on various information technology systems to manage our operations, and we evaluate these systems against our current and expected requirements
<I>
	.
</I>
	Although we have no current plans to implement modifications or upgrades to our systems, we will eventually be required to make changes to legacy systems and acquire new systems with new functionality. Any information technology system disruptions, if not anticipated and appropriately mitigated, could have an adverse effect on our business and operations.
</FONT>
</P>
<P ID=PARA3926 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3927 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Risks Related to Our Industry
</I>
</B>
</FONT>
</P>
<P ID=PARA3928 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Business is Heavily Regulated, Resulting in Increased Costs of Operations and Delays in Product Sales
</I>
	.
<B>
</B>
	Many of our products require FDA approval or clearance to sell in the U.S. and will require approvals from comparable agencies to sell in foreign countries. These authorizations may limit the U.S. or foreign markets in which our products may be sold. Further, our products must be manufactured under requirements of our quality system for continued CE-Marking so they can continue to be marketed and sold in Europe. These requirements are similar to the QSR of both the FDA and California Department of Public Health. Failure to comply with or incorrectly interpret these quality system requirements and regulations may subject us to delays in production while we correct deficiencies found by the FDA, the State of California, or our notifying body as a result of any audit of our quality system. If we are found to be out of compliance, we could receive a Warning Letter or an untitled letter from the FDA or even be temporarily shut down in manufacturing and product sales while the non-conformances are rectified. Also, we may have to recall products and temporarily cease their manufacture and distribution, which would increase our costs and reduce our revenues. The FDA may also invalidate our PMA or 510(k) if appropriate regulations relative to the PMA or 510(k) product are not met. The notified bodies may elect to not renew CE-Mark certification. Any of these events would negatively impact our revenues and costs of operations.
</FONT>
</P>
<P ID=PARA3929 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3930 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Changes in Governmental Regulations may Reduce Demand for our Products or Increase our Expenses.
</I>
	We compete in many markets in which we and our customers must comply with federal, state, local and international regulations, such as environmental, health and safety and food and drug regulations. We develop, configure and market our products to meet customer needs created by those regulations. Any significant change in regulations could reduce demand for our products or increase our expenses. For example, many of our instruments are marketed to the industry for enabling new regenerative therapies. Changes in the FDA&#8217;s regulation of the devices and products directed at regenerative medicine, and development process for new therapeutic applications could have an adverse effect on the demand for these products.
</FONT>
</P>
<P ID=PARA6449.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6449 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6449 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6449 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	24
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage25"></A>
<A ID=TOCLINK6449 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6449 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6449.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
</I>
</FONT>
</P>
<P ID=PARA3932 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	To Sell in International Markets, we will be Subject to Regulation in Foreign Countries.
</I>
	In cooperation with our distribution partners, we intend to market our current and future products both domestically and in many foreign markets. A number of risks are inherent in international transactions. In order for us to market our products in certain non-U.S. jurisdictions, we need to obtain and maintain required regulatory approvals or clearances and must comply with extensive regulations regarding safety, manufacturing processes and quality. These regulations, including the requirements for approvals or clearances to market, may differ from the FDA regulatory scheme. International sales also may be limited or disrupted by political instability, price controls, trade restrictions and changes in tariffs. Additionally, fluctuations in currency exchange rates may adversely affect demand for our products by increasing the price of our products in the currency of the countries in which the products are sold.
</FONT>
</P>
<P ID=PARA3933 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3934 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	There can be no assurance that we will obtain regulatory approvals or clearances in all of the countries where we intend to market our products, or that we will not incur significant costs in obtaining or maintaining foreign regulatory approvals or clearances, or that we will be able to successfully commercialize current or future products in various foreign markets. Delays in receipt of approvals or clearances to market our products in foreign countries, failure to receive such approvals or clearances or the future loss of previously received approvals or clearances could have a substantial negative effect on our results of operations and financial condition.
</FONT>
</P>
<P ID=PARA3935 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3936 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	To Operate In Foreign Jurisdictions, We Are Subject to Regulation by Non-U.S. Authorities.
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have operations in India, and as such are subject to Indian regulatory agencies. A number of risks are inherent in conducting business and clinical operations overseas. In order for us to operate as a majority owned foreign corporation in India, we are subject to financial regulations imposed by the Reserve Bank of India. This includes the rules specific to the capital funding, pledging of assets, repatriation of funds and payment of dividends from and to the foreign subsidiaries and from and to us in the U.S.
</FONT>
</P>
<P ID=PARA3937 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3938 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In order for us to manufacture and/or market our services and products in India, we need to obtain and maintain required regulatory approvals or clearances and must comply with extensive regulations regarding safety, manufacturing processes and quality. These regulations, including the requirements for approvals or clearances to market, and/or export may differ from the FDA regulatory scheme. Additionally, in order for us to complete clinical trials, clinical trial services and cell banking in India, and other foreign jurisdictions, we need to obtain and maintain approvals and licenses which comply with extensive regulations of the appropriate regulatory body.
</FONT>
</P>
<P ID=PARA3939 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3940 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	International operations also may be limited or disrupted by political, economic or social instability, price controls, trade restrictions and changes in tariffs as ordered by various governmental agencies. Additionally, fluctuations in currency exchange rates may adversely affect the cost of production for our products by increasing the price of materials and other inputs for our products in the currency of the countries in which the products are sold.
</FONT>
</P>
<P ID=PARA3941 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK3942 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3942 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3942 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	25
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage26"></A>
<A ID=TOCLINK3942 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3942 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3942.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3943 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	If Our Competitors Develop and Market Products That Are More Effective Than Our Product Candidates Or Obtain Regulatory and Market Approval For Similar Products Before We Do, Our Commercial Opportunity May Be Reduced Or Eliminated
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	.
</I>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The development and commercialization of new pharmaceutical products which target cardiovascular, orthopedic, chronic dermal wounds and other conditions addressed by our current and future products is competitive, and we will face competition from numerous sources, including major biotechnology and pharmaceutical companies worldwide. Many of our competitors have substantially greater financial and technical resources, and development, production and marketing capabilities than we do. In addition, many of these companies have more experience than we do in pre-clinical testing, clinical trials and manufacturing of compounds, as well as in obtaining FDA and foreign regulatory approvals. As a result, there is a risk that one of the competitors will develop a more effective product for the same indications for which we are developing a product or, alternatively, bring a similar product to market before we can. With regards to the BioArchive and AXP Systems, numerous larger and better-financed medical device manufacturers may choose to enter this market as it develops.
</FONT>
</P>
<P ID=PARA3944 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3945 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Influence by the Government and Insurance Companies may Adversely Impact Sales of our Products.
</I>
	Our business may be materially affected by continuing efforts by government, third party payers such as Medicare, Medicaid, and private health insurance plans, to reduce the costs of healthcare. For example, in certain foreign markets the pricing and profit margins of certain healthcare products are subject to government controls. In addition, increasing emphasis on managed care in the U.S. will continue to place pressure on the pricing of healthcare products. As a result, continuing efforts to contain healthcare costs may result in reduced sales or price reductions for our products. To date, we are not aware of any direct impact on our pricing or product sales due to such efforts by governments to contain healthcare costs, and we do not anticipate any impact in the near future.
</FONT>
</P>
<P ID=PARA3946 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3947 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Product Liability and Uninsured Risks May Adversely Affect the Continuing Operations
</I>
	. We operate in an industry susceptible to significant product liability claims. We may be liable if any of our products cause injury, illness, or death. These claims may be brought by individuals seeking relief or by groups seeking to represent a class. We also may be required to recall certain of our products should they become damaged or if they are defective. We are not aware of any material product liability claims against us. However, product liability claims may be asserted against us in the future based on events we are not aware of at the present time. We maintain a product liability policy and a general liability policy that includes product liability coverage. However, a product liability claim against us could have a material adverse effect on our business or future financial condition.
</FONT>
</P>
<P ID=PARA3948 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA3949 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Commercially Process Stem Cells under a Physician&#8217;s Order for use in Clinical Applications in India.
</I>
	Our GMP laboratory within Fortis Memorial Research Institute in Gurgaon, India, processes stem cells for certain uses under a physician&#8217;s order, and we charge for these services. This service is primarily focused on our growing initiative in bone marrow transplant. We could face product or service liability claim(s) for a bodily injury asserted by a claimant as a result from our GMP services. We mitigate our risks by adhering to international standards, maintain international certification by BSI to GMP, are U.S FDA registered for such activities and are inspected by the Drugs Controller General of India. We believe our global liability insurance is sufficient to cover claims, but in the event it is not it could materially impact our financial health.
</FONT>
</P>
<P ID=PARA3950 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK3951 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3951 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3951 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	26
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage27"></A>
<A ID=TOCLINK3951 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3951 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3951.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3952 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Risks Related to Operating Results and Financial Markets
</B>
</I>
</FONT>
</P>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<P ID=PARA6667 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Have Incurred Net Losses and Losses will Continue.
</I>
	We have not been profitable for a significant period. For the fiscal years ended June 30, 2016 and 2015, we had a net loss of $18,588 and $14,852 respectively and an accumulated deficit at June 30, 2016, of $156,262. We will continue to incur significant costs as we develop and market our current products and related applications. Although we are executing our business plan to develop, market and launch new products, continuing losses may impair our ability to fully meet our objectives for new product sales or threaten our ability to continue as a going concern in future years.
</FONT>
</P>
<P ID=PARA6668 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA6669 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We Will Need to Raise Additional Capital to Fund our Operations and in Furtherance of Our Business Plan.
</I>
	We will need to raise additional capital in the near future to fund our future operations and in furtherance of our business plan, including progression of the CLI and Acute Myocardial Infarction Rapid Stem Cell Therapy (&#8220;AMIRST&#8221;) clinical trials and development of other new products. The proposed financing may include shares of common stock, shares of preferred stock, warrants to purchase shares of common stock or preferred stock, debt securities, units consisting of the forgoing securities, equity investments from strategic development partners or some combination of each. Any additional equity financings may be financially dilutive to, and will be dilutive from an ownership perspective to our stockholders, and such dilution may be significant based upon the size of such financing. Additionally, we cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at all.
</FONT>
</P>
<P ID=PARA6670 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA6671 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Our Future Financial Results Could be Adversely Impacted by Asset Impairment Charges.
</I>
	We are required to test both goodwill
<I>
</I>
	and intangible assets for impairment on an annual basis. We have chosen to perform our annual impairment reviews of goodwill and other intangible assets during the fourth quarter of each fiscal year. We also are required to test for impairment between annual tests if events occur or circumstances change that would more likely than not reduces our fair value below book value. These events or circumstances could include results of our on-going clinical trials, activities and results of our competitor&#8217;s clinical trials, a significant change in the regulatory climate, legal factors, operating performance indicators, or other factors. If the fair market value is less than the book value, we could be required to record an impairment charge. The valuation requires judgment in estimating future cash flows, discount rates and estimated product life cycles. In making these judgments, we evaluate the financial health of the business, including such factors as industry performance, changes in technology and operating cash flows.
</FONT>
</P>
<P ID=PARA6672 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6673 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	As of June 30, 2016 we have a goodwill balance of $13,195 and a net intangible assets balance of $20,821, out of total assets of $49,899. As a result, the amount of any annual or interim impairment could be significant and could have a material adverse effect on our reported financial results for the period in which the charge is taken.
</FONT>
</P>
<P ID=PARA6674 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
</P>
<P ID=PARA6675 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We may Incur Significant Non-operating, Non-cash Charges Resulting from Changes in the Fair Value of W
</I>
<I>
	arrants.
</I>
	Our Series A warrants are a derivative instrument; as such they have been recorded at their respective relative fair values at the issuance date and will be recorded at their respective fair values at each subsequent balance sheet date. Any change in value between reporting periods will be recorded as a non-operating, non-cash charge at each reporting date. The impact of these non-operating, non-cash charges could have an adverse effect on the Company&#8217;s financial results. The fair value of the warrants is tied in large part to our stock price. If the stock price increases between reporting periods, the warrants become more valuable. As such, there is no way to forecast what the non-operating, non-cash charges will be in the future or what the future impact will be on our financial statements.
</FONT>
</P>
<P ID=PARA6676 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
</I>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK3963 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR3963 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM3963 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	27
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage28"></A>
<A ID=TOCLINK3963 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR3963 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA3963.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA3964 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Risks Related to Our Common Stock
</I>
</B>
</FONT>
</P>
<P ID=PARA3965 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	If the Price of our Common Stock does not Meet the Requirements of the NASDAQ Capital Market Stock Exchange (&#8220;NASDAQ&#8221;), Our Shares may be Delisted. Our Ability to Publicly or Privately Sell Equity Securities and the Liquidity of Our Common Stock Could be Adversely Affected if We Are Delisted.
</I>
	The listing standards of NASDAQ provide, among other things, that a company may be delisted if the bid price of its stock drops below $1.00 for a period of 30 consecutive business days. Delisting from NASDAQ could adversely affect our ability to raise additional financing through the public or private sale of equity securities, would significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our common stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional investor interest and fewer business development opportunities.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<P ID=PARA3966 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	Liquidity of our Common Stock.
</I>
	Although there is a public market for our common stock, trading volume has been historically low, which could impact the stock price and the ability to sell shares of our common stock. We can give no assurance that an active and liquid public market for the shares of the common stock will continue in the future. In addition, future sales of large amounts of common stock could adversely affect the market price of our common stock and our ability to raise capital. The price of our common stock could also drop as a result of the exercise of options for common stock or the perception that such sales or exercise of options could occur. These factors could also have a negative impact on the liquidity of our common stock and our ability to raise funds through future stock offerings.
</FONT>
</P>
<P ID=PARA3967 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3968 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	We do not Pay Cash Dividends.
</I>
	We have never paid any cash dividends on our common stock and may not pay cash dividends in the future. Instead, we intend to apply earnings to the expansion and development of our business. Thus, the liquidity of your investment is dependent upon your ability to sell stock at an acceptable price. The price can go down as well as up and may limit your ability to realize any value from your investment, including the initial purchase price.
</FONT>
</P>
</EFX_RISK_FACTORS>
<P ID=PARA3969 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNRESOLVED_STAFF_COMMENTS>
<A NAME="FIS_UNRESOLVED_STAFF_COMMENTS"></A>
<P ID=PARA3970 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6608 NAME="KOOL20160630_10K_HTM_BKMK6608">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	1B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	UNRESOLVED STAFF COMMENTS
</U>
</B>
</FONT>
</P>
<P ID=PARA3971 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3972 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	None.
</FONT>
</P>
</EFX_UNRESOLVED_STAFF_COMMENTS>
<P ID=PARA3973 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_PROPERTIES>
<A NAME="FIS_PROPERTIES"></A>
<P ID=PARA3974 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6609 NAME="KOOL20160630_10K_HTM_BKMK6609">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	PROPERTIES
</U>
</B>
</FONT>
</P>
<P ID=PARA3975 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3976 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We lease a facility with approximately 28,000 square feet of space located in Rancho Cordova, California. The facility is devoted to warehouse space, manufacturing of products, office space, a biologics lab, and a research and development lab. The lease expires May 31, 2019.
</FONT>
</P>
<P ID=PARA3977 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3978 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We also sub-lease approximately 7,819 square feet for an office and research facility located in Emeryville, California. The sub-lease originally expired April 30, 2020, however, we have entered into an amendment in August 2016 and the sub-lease now expires September 30, 2016.
</FONT>
</P>
<P ID=PARA3979 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3980 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In Gurgaon India we lease approximately 5,800 square feet for an office facility. The lease expires March 1, 2018.
</FONT>
</P>
<P ID=PARA3981 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3982 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Additionally in Gurgaon India, as part of our agreement with Fortis Healthcare, we occupy and manage a 2,800 square foot cord blood banking and cellular therapy processing facility in the Fortis Memorial Research Institute.
</FONT>
</P>
</EFX_PROPERTIES>
<P ID=PARA3983 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_LEGAL_PROCEEDINGS>
<A NAME="FIS_LEGAL_PROCEEDINGS"></A>
<P ID=PARA3984 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6610 NAME="KOOL20160630_10K_HTM_BKMK6610">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	LEGAL PROCEEDINGS
</U>
</B>
</FONT>
</P>
<P ID=PARA3985 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3986 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In the normal course of operations, we may have disagreements or disputes with distributors, vendors or employees. Such potential disputes are seen by management as a normal part of business.
</FONT>
</P>
<P ID=PARA6450.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6450 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6450 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6450 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	28
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage29"></A>
<A ID=TOCLINK6450 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6450 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6450.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA6678 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Effective June 1, 2015, Cesca, Harvest Technologies Corp. (Harvest) and Celling signed an agreement settling the complaint Harvest filed on October 24, 2012 against the Company and the counter complaint Cesca and Celling asserted against Harvest. In the settlement agreement, we agreed to an immaterial settlement payment, which was accrued during the quarter ended March 31, 2015. The Company and Celling also agreed not to make, sell, import or license the Res-Q product in the United States after May 31, 2016.
</FONT>
</P>
<P ID=PARA6679 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6680 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On September 9, 2014, we filed a complaint against SynGen Inc., PHC Medical Inc., Philip Coelho and others (the Defendants) in the case captioned as
<I>
	Cesca Therapeutics, Inc. v. SynGen, Inc., et al,
</I>
	United States District Court, Eastern District of California, Case No. 2:14-cv-02085-GEB-KJN
<I>
	.
</I>
	In the complaint, we contend that SynGens&#8217; product the SynGenX-1000 and the patent application entitled &#8220;System for Purifying Certain Cell Populations in Blood or Bone Marrow by Depleting Others&#8221; were developed using our confidential information and that we are the equitable owner. The complaint is based on misappropriation of trade secrets, breach of contract and other claims. Mediation has failed to result in a mutually agreeable settlement of the case and we have therefore entered the discovery phase in order to further press our claim.
</FONT>
</P>
</EFX_LEGAL_PROCEEDINGS>
<P ID=PARA6681 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_MINE_SAFETY_DISCLOSURE>
<A NAME="FIS_MINE_SAFETY_DISCLOSURE"></A>
<P ID=PARA3992 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6611 NAME="KOOL20160630_10K_HTM_BKMK6611">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	MINE SAFETY DISCLOSURES
</U>
</B>
</FONT>
</P>
<P ID=PARA3993 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3994 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Not applicable.
</FONT>
</P>
</EFX_MINE_SAFETY_DISCLOSURE>
</EFX_PART_I>
<P ID=PARA3995 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_PART_II>
<A NAME="FIS_PART_II"></A>
<P ID=PARA3996 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PART II
</B>
</FONT>
</P>
<P ID=PARA3997 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_MARKET>
<A NAME="FIS_MARKET"></A>
<TABLE ID=MTAB3999 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4000 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<A ID=BKMK6612 NAME="KOOL20160630_10K_HTM_BKMK6612">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	5.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4001 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4002 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4003 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our common stock, $0.001 par value, is listed on the NASDAQ Capital Market under the symbol KOOL. The following table sets forth the range of high and low closing bid prices for our common stock for the past two fiscal years as reported on the NASDAQ Capital Market.
</FONT>
</P>
<P ID=PARA4004 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<TABLE ID=TBL4035 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 95%; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 5%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4035.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 23.4%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA4005 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fiscal 2016
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4006 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	High
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4007 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Low
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 24.6%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT">
<P ID=PARA4008 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fiscal 2015
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4009 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	High
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.LEAD.D6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.1.AMT.D6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4010 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Low
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.1.TRAIL.D6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4035.FINROW.2>
<TD>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.LEAD.B2>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.SYMB.B2>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.AMT.B2>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.TRAIL.B2>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.LEAD.B3>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.SYMB.B3>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.AMT.B3>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.TRAIL.B3>
	&nbsp;
</TD>
<TD>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.LEAD.B5>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.SYMB.B5>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.AMT.B5>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.TRAIL.B5>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.LEAD.B6>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.SYMB.B6>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.AMT.B6>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.2.TRAIL.B6>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4035.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4011 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	First Quarter (Sep. 30)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	16.44
</TD>
<TD ID=TBL4035.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	10.60
</TD>
<TD ID=TBL4035.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4014 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	First Quarter (Sep. 30)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	28.40
</TD>
<TD ID=TBL4035.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.3.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.3.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	23.40
</TD>
<TD ID=TBL4035.FINROW.3.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4035.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4017 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Second Quarter (Dec. 31)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	12.40
</TD>
<TD ID=TBL4035.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	3.64
</TD>
<TD ID=TBL4035.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4020 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Second Quarter (Dec. 31)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	25.80
</TD>
<TD ID=TBL4035.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.4.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.4.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	20.00
</TD>
<TD ID=TBL4035.FINROW.4.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4035.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4023 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Third Quarter (Mar. 31)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6.20
</TD>
<TD ID=TBL4035.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2.12
</TD>
<TD ID=TBL4035.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4026 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Third Quarter (Mar. 31)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	22.00
</TD>
<TD ID=TBL4035.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.5.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4035.FINROW.5.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	15.80
</TD>
<TD ID=TBL4035.FINROW.5.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4035.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4029 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fourth Quarter (June 30)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4.01
</TD>
<TD ID=TBL4035.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1.91
</TD>
<TD ID=TBL4035.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4032 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fourth Quarter (June 30)
</FONT>
</P>
</TD>
<TD ID=TBL4035.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	19.80
</TD>
<TD ID=TBL4035.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4035.FINROW.6.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4035.FINROW.6.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	15.20
</TD>
<TD ID=TBL4035.FINROW.6.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA4036 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4037 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have not paid cash dividends on our common stock and do not intend to pay a cash dividend in the foreseeable future. There were approximately 216 stockholders of record on June 30, 2016 (not including street name holders).
</FONT>
</P>
</EFX_MARKET>
<P ID=PARA4038 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_FINANCIAL_DATA>
<A NAME="FIS_FINANCIAL_DATA"></A>
<P ID=PARA4039 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6613 NAME="KOOL20160630_10K_HTM_BKMK6613">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	SELECTED FINANCIAL DATA
</U>
</B>
</FONT>
</P>
<P ID=PARA4040 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4041 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Not applicable for Smaller Reporting Companies.
</FONT>
</P>
<P ID=PARA4042 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK4043 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4043 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4043 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	29
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage30"></A>
<A ID=TOCLINK4043 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4043 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_FINANCIAL_DATA>
<P ID=PARA4043.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_MANAGEMENTS_DISCUSSION>
<A NAME="FIS_MANAGEMENTS_DISCUSSION"></A>
<TABLE ID=MTAB4045 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 54PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4046 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<A ID=BKMK6614 NAME="KOOL20160630_10K_HTM_BKMK6614">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	7
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4047 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4048 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	amounts in thousands, except share and per share amounts
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	)
</FONT>
</P>
<P ID=PARA4049 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4050 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certain statements contained in this section and other parts of this annual report on Form 10-K which are not historical facts are forward looking statements and are subject to certain risks and uncertainties. Our actual results may differ significantly from the projected results discussed in the forward looking statements. Factors that might affect actual results include, but are not limited to, those discussed in ITEM 1A &#8220;RISK FACTORS&#8221; and other factors identified from time to time in our reports filed with the SEC. The following discussion should be read in conjunction with our consolidated financial statements contained in this report.
</FONT>
</P>
<P ID=PARA4051 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4052 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Overview
</U>
</B>
</FONT>
</P>
<P ID=PARA4053 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4054 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We develop and market integrated cellular therapies and delivery systems that advance the safe and effective practice of regenerative medicine. We are a leader in the development and manufacture of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. We were founded in 1986 and are headquartered in Rancho Cordova, California. Our strategy is to continue to enhance the performance and competitiveness of our flagship product lines in the cord blood banking arena while expanding into significant new growth opportunity areas in point of care therapeutics. We are developing a number of offerings for the delivery of autologous cell therapies that address significant unmet medical needs and expect to partner with other pioneers in the stem cell arena to accelerate clinical evaluations, expedite regulatory approvals and penetrate the market.
</FONT>
</P>
<P ID=PARA4055 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4056 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In September 2015, we undertook a restructuring initiative to reduce the costs associated with our traditional cord blood banking products. The restructuring resulted in a reduction of approximately 15 positions in various functions. This action, combined with the elimination of a number of open positions that were not back-filled, has reduced annual operating costs primarily related to cord blood banking products by approximately $3.3 million.
</FONT>
</P>
<P ID=PARA4057 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4058 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On March 4, 2016, the Company effected a one (1) for twenty (20) reverse split of its issued and outstanding common stock. There were no changes to its authorized number of shares of common stock of 350,000,000. All historical share amounts disclosed herein have been retroactively recast to reflect the reverse split and subsequent share exchange.
</FONT>
</P>
<P ID=PARA4059 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4060 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Stem Cell Therapies
</B>
</FONT>
</P>
<P ID=PARA4061 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have nine cell therapies at various stages of clinical development, all but one with human data. These include critical limb ischemia (CLI), acute myocardial infarction (AMI), non-healing ulcers, ischemic stroke, spinal fusion, osteoarthritis, non-union fractures and avascular necrosis. We also have an active bone marrow transplantation (BMT) program. The current emphasis is in three particular areas, as follows:
</FONT>
</P>
<P ID=PARA4062 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB4064 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4065 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&#9679;
</B>
<B>
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
</SUP>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4066 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Critical Limb Ischemia (CLI) &#8211;
</B>
	We
<B>
</B>
	received FDA approval on June 12, 2015 for an Investigational Device Exemption (&#8220;IDE&#8221;) for our pivotal clinical trial (the &#8220;CLIRST III&#8221; study) to evaluate our SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	&#8482;
</SUP>
	- CLI System for the treatment of patients with late-stage, no option, critical limb ischemia. CLI is the last progressive phase of peripheral artery disease, where the leg is so deprived of blood flow and oxygen, that it has visible signs of gangrenous ulceration. We have supported or completed two prior feasibility studies in CLI, one delivering a Cesca platform prepared autologous bone marrow cell dose into the afflicted leg artery of 13 human subjects and the other delivering a similar Cesca platform produced cell dose into the afflicted limb muscles of 17 human subjects. We submitted an IDE supplement in May 2016 which proposed a change in the primary efficacy endpoint from Amputation Free Survival to Change in Transcutaneous Oxygen Pressure (TcPO2). Subsequently, the FDA approved commencement of the Phase III pivotal trial as amended, but requires additional validation of TcPO2 as a surrogate to support subsequent PMA approval. We are currently engaged in an active dialog with the FDA regarding our options to move forward with this trial.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4067 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK6451 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6451 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6451 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	30
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage31"></A>
<A ID=TOCLINK6451 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6451 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6451.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB4069 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4070 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&#9679;
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
</SUP>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4071 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Acute Myocardial Infarction (AMI)
</B>
	&#8211; The SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
	&#8211; AMI System has been designed to facilitate an adjunct treatment for patients who have suffered an acute ST-elevated myocardial infarction (&#8220;STEMI&#8221;), a particular and most threatening type of heart attack.&nbsp;Therapies delivered using the SurgWerks-AMI system are intended to minimize the adverse remodeling of the heart post-STEMI.&nbsp;The entire 4-step bedside treatment is designed to take less than 120 minutes to complete, in a single surgical procedure, in the heart catheterization laboratory of a hospital.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4072 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB4074 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4075 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&#9679;
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4076 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Bone Marrow Transplant (BMT)
</B>
	&#8211;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have two initiatives within our BMT program: development of the CellWerks&#8482; technology platform for clinical and intra-laboratory use, and the delivery of BMT laboratory services through the our TotipotentRX subsidiary in India. The CellWerks
<B>
</B>
	Platform is designed for optimal laboratory preparation of hematopoietic stem cells used in BMT and bio-banking.&nbsp;The technology platform includes a &#8220;smart vision&#8221; control module, a corresponding disposable for processing blood and bone marrow sourced tissue and sample tracking software enabling GMP compliance. Cell analytics for laboratory and point of care use are under development and will complete the CellWerks offering
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	. TotipotentRX laboratory services, a collaboration with Fortis Healthcare, are aimed at serving the Indian clinical market for cell therapy under good tissue practices compliance.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4077 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4078 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Products
</B>
</FONT>
</P>
<P ID=PARA4079 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4080 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our product offerings include:
</FONT>
</P>
<P ID=PARA4081 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB4083 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4084 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
<B>
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4085 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The
<B>
	SurgWerks&#8482; System
</B>
	(in development) - a proprietary system comprised of the SurgWerks Processing Platform, including devices and analytics, and indication-specific SurgWerks Procedure Kits for use in regenerative stem cell therapy at the point of care for vascular and orthopedic diseases.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB4087 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4088 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
<B>
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4089 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The
<B>
	CellWerks&#8482; System
</B>
	(in development) - a proprietary cell processing system with associated analytics for intra-laboratory preparation of adult stem cells from bone marrow or blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB4091 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4092 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
<B>
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<B>
</B>
</SUP>
<B>
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<B>
</B>
</SUP>
<B>
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4093 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The
<B>
	AutoXpress
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<B>
	&#174;
</B>
</SUP>
<B>
	System (AXP
</B>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
<B>
	&#174;
</B>
</SUP>
<B>
	)
</B>
	- a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB4095 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4096 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
<B>
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4097 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The
<B>
	MarrowXpress&#8482; System (MXP&#8482;)
</B>
	- a derivative product of the AXP and its accompanying sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB4099 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4100 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#9679;
<B>
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4101 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The
<B>
	BioArchive&#174; System
</B>
	- an automated cryogenic device used by cord blood banks for the cryopreservation and storage of cord blood stem cell concentrate for future use.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB4103 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4104 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&#9679;
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4105 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Manual Disposables
</B>
	- bag sets for use in the processing and cryogenic storage of cord blood.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4106 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_RESULTS_OF_OPERATIONS>
<A NAME="FIS_RESULTS_OF_OPERATIONS"></A>
<P ID=PARA4107 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Results of Operations
</U>
</B>
</FONT>
</P>
<P ID=PARA4108 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4109 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following is Management&#8217;s discussion and analysis of certain significant factors which have affected our financial condition and results of operations during the periods included in the accompanying consolidated financial statements.
</FONT>
</P>
<P ID=PARA6452.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6452 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6452 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6452 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	31
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage32"></A>
<A ID=TOCLINK6452 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6452 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6452.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA4111 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Results of Operations for the
</I>
</B>
<B>
<I>
	Fiscal Year Ended June 30, 2016
</I>
</B>
<B>
<I>
</I>
</B>
<B>
<I>
	versus
</I>
</B>
<B>
<I>
	the
</I>
</B>
<B>
<I>
	Fiscal Year Ended June 30, 2015
</I>
</B>
</FONT>
</P>
<P ID=PARA4112 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4113 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Net Revenues
</I>
</B>
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
</I>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net revenues for 2016 were $11,929 compared to $16,042 for 2015, a decrease of $4,113. Primary contributors to the decline were BioArchive devices as we shipped ten fewer devices during the year ended June 30, 2016 versus the year ended June 30, 2015, and Res-Q as a result of reduced purchase from our largest distributor following our decision to withdraw the product from the United States market. The decision to withdraw Res-Q from the United States market was made in 2015 in accordance with a settlement agreement reached with Harvest Technologies Corp. related to a long-standing intellectual property dispute.
</FONT>
</P>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<P STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
</FONT>
	&nbsp;
</P>
<P ID=PARA4116 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following represents our revenues by product platform for the years ended:
</FONT>
</P>
<P ID=PARA4117 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<TABLE ID=TBL4137 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-RIGHT: 20%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4137.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4118 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30,
<BR>
	2016
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4119 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30,
<BR>
	2015
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 62%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4120 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	AXP
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4137.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6,932
</TD>
<TD ID=TBL4137.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4137.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6,612
</TD>
<TD ID=TBL4137.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4123 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	BioArchive
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,465
</TD>
<TD ID=TBL4137.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4,241
</TD>
<TD ID=TBL4137.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4126 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Manual Disposables
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,507
</TD>
<TD ID=TBL4137.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,810
</TD>
<TD ID=TBL4137.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4129 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Bone Marrow (including Res-Q)
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	459
</TD>
<TD ID=TBL4137.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,621
</TD>
<TD ID=TBL4137.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4132 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other
</FONT>
</P>
</TD>
<TD ID=TBL4137.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	566
</TD>
<TD ID=TBL4137.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	758
</TD>
<TD ID=TBL4137.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4137.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4137.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	11,929
</TD>
<TD ID=TBL4137.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4137.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4137.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	16,042
</TD>
<TD ID=TBL4137.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA4138 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4139 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4140 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Gross
</B>
</I>
<I>
<B>
	Profit
</B>
</I>
</FONT>
</P>
<P ID=PARA6684 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross profit was $2,744 or 23% of revenues for 2016 compared to $4,749 or 30% of revenues for 2015. Our gross profit declined primarily due to changes in the mix of products sold and increases in inventory reserves primarily associated with the BioArchive product line. We expect gross margin to return to normal levels in fiscal 2017.
</FONT>
</P>
<P ID=PARA6685 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
</P>
<P ID=PARA6686 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Sales and Marketing Expenses
</B>
</I>
</FONT>
</P>
<P ID=PARA6687 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and Marketing expenses include costs primarily associated with generating revenues from the sale of cord blood and bone marrow disposables and BioArchive devices.
</FONT>
</P>
<P ID=PARA6688 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6689 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and Marketing expenses were $2,148 for 2016, compared to $2,974 for 2015, a decrease of $826. The decrease was primarily due to lower personnel costs as a result of our September 2015 restructuring initiative, lower medical device excise taxes and reduction in travel expenses.
</FONT>
</P>
<P ID=PARA6690 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6691 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Research and Development Expenses
</B>
</I>
</FONT>
</P>
<P ID=PARA6692 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Research and development expenses include costs associated with our engineering, regulatory, scientific and clinical functions.
</FONT>
</P>
<P ID=PARA6693 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6694 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Research and development expenses for 2016, were $3,230 compared to $5,939 for 2015, a decrease of $2,709 or 46%.
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The decrease was primarily due to lower personnel costs driven by our September 2015 restructuring initiative and reduced spending associated with deferral of planned activities in our CLI program. Research and development expenses are expected to increase when we initiate the CLIRST III clinical trial.
</FONT>
</P>
<P ID=PARA6695 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK4153 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4153 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4153 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	32
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage33"></A>
<A ID=TOCLINK4153 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4153 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4153.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4154 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	General and Administrative Expenses
</I>
</B>
</FONT>
</P>
<P ID=PARA4155 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General and administrative expenses include costs associated with our accounting, finance, human resources, information system and executive functions.
</FONT>
</P>
<P ID=PARA4156 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4157 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General and administrative expenses were $8,231 for 2016, compared to $10,695 for 2015, a decrease of $2,464 or 23%. The decrease was primarily due to a reduction in legal expenses of approximately $2,500 related to the settlement of certain patent litigation cases in fiscal 2015.
</FONT>
</P>
<P ID=PARA4158 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4159 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Non-GAAP Measures
</B>
</FONT>
</P>
<P ID=PARA4160 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In addition to the results reported in accordance with US GAAP, we also use a non-GAAP measure, adjusted EBITDA, to evaluate operating performance and to facilitate the comparison of our historical results and trends. This financial measure is not a measure of financial performance under US GAAP and should not be considered in isolation or as a substitute for loss as a measure of performance. The calculation of this non-GAAP measure may not be comparable to similarly titled measures used by other companies. Reconciliations to the most directly comparable GAAP measure are provided below.
</FONT>
</P>
<P ID=PARA4161 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4162 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4163 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<TABLE ID=TBL4182 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4182.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4164 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4165 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 62%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4166 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss from operations
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4182.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(10,865
</TD>
<TD ID=TBL4182.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4182.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4182.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(14,859
</TD>
<TD ID=TBL4182.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4182.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.3.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4169 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Add:
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.4.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.4.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4170 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Depreciation and
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	amortization
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,168
</TD>
<TD ID=TBL4182.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,351
</TD>
<TD ID=TBL4182.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4173 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock-based compensation expense
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	742
</TD>
<TD ID=TBL4182.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,247
</TD>
<TD ID=TBL4182.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4176 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Impairment of intangible asset
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4182.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	117
</TD>
<TD ID=TBL4182.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4182.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4179 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Adjusted EBITDA
</FONT>
</P>
</TD>
<TD ID=TBL4182.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4182.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(8,955
</TD>
<TD ID=TBL4182.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4182.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4182.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4182.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(12,144
</TD>
<TD ID=TBL4182.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA4183 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4184 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4185 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Adjusted EBITDA
</I>
</B>
</FONT>
</P>
<P ID=PARA4186 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our adjusted EBITDA loss was $8,955 for 2016, compared to $12,144 for 2015. The reduction in the adjusted EBITDA loss was due primarily to savings realized from our September 2015 restructuring, lower legal expenses due to the settlement of certain patent litigation cases in 2015 and deferral of the start of the CLIRST III trial.
</FONT>
</P>
</EFX_RESULTS_OF_OPERATIONS>
<P ID=PARA4187 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_LIQUIDITY_CAPITAL>
<A NAME="FIS_LIQUIDITY_CAPITAL"></A>
<P ID=PARA4188 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Liquidity and Capital Resources
</U>
</B>
</FONT>
</P>
<P ID=PARA4189 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4190 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, we had cash and cash equivalents of $5,835 and working capital of $7,301. This compared to cash and cash equivalents of $3,357 and working capital of $5,305 at June 30, 2015. We have primarily financed operations through private and public placement of equity and convertible debt securities.
</FONT>
</P>
<P ID=PARA4191 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4192 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our net cash used in operating activities for the year ended June 30, 2016 was $9,625 compared to $10,649 for the year ended June 30, 2015. The decrease was primarily due to savings realized from our September 2015 restructuring, the settlement of certain patent litigation cases and deferral of the start of the CLIRST III trial.
</FONT>
</P>
<P ID=PARA4193 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK4194 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4194 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4194 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	33
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage34"></A>
<A ID=TOCLINK4194 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4194 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4194.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4195 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In February 2016 in exchange for aggregate proceeds of $15 million, the Company sold and issued to Boyalife Investment Inc. and Boyalife (Hong Kong) Limited (i) 735,294 shares of common stock at a purchase price of $3.40 per share (the &#8220;Stock Price&#8221;) for gross proceeds of $2.5 million, (ii) Secured Convertible Debentures for $12.5 million (the &#8220;Debentures&#8221;) convertible into 3,676,471 shares of common stock and (iii) warrants to purchase 3,529,412 additional shares of common stock at an exercise price of $8.00 per share for a period of five years.
</FONT>
</P>
<P ID=PARA4196 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4197 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 31, 2015, the Company sold senior secured convertible debentures in a financing to raise up to $15,000 (&#8220;Thirty-Year Debentures&#8221;), Series A warrants to purchase up to 1,102,942 shares of the Company&#8217;s common stock at an exercise price equal to $13.60 per share for a period of five and one-half years (&#8220;Series A warrants&#8221;) and Series B warrants to purchase up to 606,618 shares of the Company&#8217;s common stock at an exercise price equal to $13.60 per share for a period of eighteen months (&#8220;Series B warrants&#8221;). At the initial closing on August 31, 2015, the Company received gross proceeds of $5,500 and 404,412 Series A warrants vested and 222,427 Series B warrants vested. The second closing for up to an additional $9,500 was dependent on a number of items including receipt by the Company of approval from the California Institute for Regenerative Medicine (&#8220;CIRM&#8221;) for a grant in the amount of $10,000, to support the Company&#8217;s pivotal trial for CLIRST III. The Company applied for the CIRM grant in August 2015. However, the Company withdrew its application for the CIRM grant.
</FONT>
</P>
<P ID=PARA4198 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4199 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In connection with the February 2016 financing transaction described above, the Company concurrently entered into a Consent, Repayment and Release Agreement, pursuant to which the Company repaid the Thirty-Year Debentures and all related interest and liquidated damages. Upon the Company&#8217;s payment of $7.5 million, the Thirty-Year Debentures were deemed repaid in full and cancelled, all liquidated damages due and payable were deemed paid and satisfied in full, the registration rights agreement was terminated and the exercise price of the Series A warrants was changed from $13.60 to $8.00.
</FONT>
</P>
<P ID=PARA4200 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4201 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 3, 2016, the Company sold 600,000 shares of common stock at a price of $4.10 per share.&nbsp;
</FONT>
</P>
<P ID=PARA4202 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The net proceeds to the Company from the sale and issuance of the shares, after deducting the estimated offering expenses borne by the Company are expected to be approximately $2.2 million.&nbsp;
</FONT>
</P>
<P ID=PARA4203 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4204 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 22, 2016, the Company elected to convert all outstanding principal and interest accrued and otherwise payable under the Debentures. Upon conversion, 6,102,941 shares of common stock were issued and the Debentures and all security interest and liens were terminated.
</FONT>
</P>
<P ID=PARA4205 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4206 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Based upon our cash balance, the August 2016 financing, historical trends, expected outflows and projections for revenues, management believes we will have sufficient cash to provide for our projected needs to maintain operations and working capital requirements for at least the next 12 months from the date of filing this annual report. We will need additional funding to support our phase III Critical Limb Ischemia (CLIRST III) trial. As such, management has been exploring additional funding sources including strategic partner relationships.
</FONT>
</P>
<P ID=PARA4207 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4208 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our ability to fund our longer-term cash needs is subject to various risks, many of which are beyond our control. Should we require additional funding, we may need to raise the required additional funds through bank borrowings or public or private sales of debt or equity securities. We cannot guarantee that such funding will be available on a timely basis, in needed quantities or on terms favorable to us, if at all (see Part I Item 1A &#8211; Risk Factors).
</FONT>
</P>
<P ID=PARA4209 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4210 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We generally do not require extensive capital equipment to produce or sell our current cord blood banking products. In fiscal 2016 and 2015, we spent $710 and $587, respectively, primarily for tooling at a contract manufacturer and equipment to be used in our
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	SurgWerks
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	TM
</SUP>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
</SUP>
	development program
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	.
</FONT>
</P>
<P ID=PARA6453.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6453 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6453 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6453 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	34
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage35"></A>
<A ID=TOCLINK6453 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6453 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6453.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA4212 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, we had three distributors/customers that accounted for 57% of accounts receivable. At June 30, 2015, we had four distributors that accounted for 64% of accounts receivable.
</FONT>
</P>
<P ID=PARA4213 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4214 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues from one distributor totaled $2,797 or 23% and $2,358 or 15% of net revenues for the years ended June 30, 2016 and 2015, respectively. Revenues from a customer totaled $2,475 or 21% and $2,549 or 16% for the years ended June 30, 2016 and 2015, respectively. Revenues from another distributor totaled $2,303 or 14% of net revenues for the year ended June 30, 2015.
</FONT>
</P>
<P ID=PARA4215 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4216 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We manage the concentration of credit risk with these customers through a variety of methods including, letters of credit with financial institutions, pre-shipment deposits, credit reference checks and credit limits. Although management believes that these customers are sound and creditworthy, a severe adverse impact on their business operations could have a corresponding material effect on their ability to pay timely and therefore on our net revenues, cash flows and financial condition.
</FONT>
</P>
<P ID=PARA4217 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4218 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Critical Accounting Policies
</I>
</B>
</FONT>
</P>
<P ID=PARA4219 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to stock-based compensation, depreciation, fair values of intangibles and goodwill, bad debts, inventories, warranties, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
</FONT>
</P>
<P ID=PARA4220 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.
</FONT>
</P>
<P ID=PARA4221 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4222 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Goodwill, Intangible Assets and Impairment Assessments
</I>
</B>
</FONT>
</P>
<P ID=PARA4223 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
</I>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Intangible assets that are not considered to have an indefinite useful life are amortized over their useful lives, which generally range from three to ten years. Clinical protocols are not expected to provide economic benefit until they are introduced to the marketplace or licensed to an independent entity. Each period we evaluate the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining periods of amortization.
</FONT>
</P>
<P ID=PARA6698 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA6699 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The carrying amounts of these assets are periodically reviewed for impairment (at least annually) and whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. According to
<I>
	ASC 350, Intangibles-Goodwill and Other
</I>
	, for goodwill and indefinite-lived intangible assets, we can opt to perform a qualitative assessment or a quantitative assessment; however, if the qualitative assessment determines that it is more likely than not (i.e., a likelihood of more than 50 percent) the fair value is less than the carrying amount, a quantitative assessment must be performed. If the quantitative assessment determines that the fair value is less than the carrying amount, an impairment loss equal to the difference would be recorded.
</FONT>
</P>
<P ID=PARA4223 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<STRONG>
<EM>
</EM>
</STRONG>
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK4227 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4227 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4227 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	35
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage36"></A>
<A ID=TOCLINK4227 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4227 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4227.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4228 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Revenue Recognition
</I>
</B>
</FONT>
</P>
<P ID=PARA4229 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues from the sale of our products are recognized when persuasive evidence of an arrangement exists, delivery has occurred (or services have been rendered), the price is fixed or determinable, and collectability is reasonably assured. We generally ship products F.O.B. shipping point. There is no conditional evaluation on any product sold and recognized as revenue. Amounts billed in excess of revenue recognized are recorded as deferred revenue on the consolidated balance sheet.
</FONT>
</P>
<P ID=PARA4230 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4231 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	There is no right of return provided for distributors or customers. For sales of products made to distributors, we consider a number of factors in determining whether revenue is recognized upon transfer of title to the distributor, or when payment is received. These factors include, but are not limited to, whether the payment terms offered to the distributor are considered to be non-standard, the distributor history of adhering to the terms of its contractual arrangements with us, the level of inventories maintained by the distributor, whether we have a pattern of granting concessions for the benefit of the distributor, and whether there are other conditions that may indicate that the sale to the distributor is not substantive. We currently recognize revenue primarily on the sell-in method with our distributors.
</FONT>
</P>
<P ID=PARA4232 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4233 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenue arrangements with multiple deliverables are divided into units of accounting if certain criteria are met, including whether the deliverable item(s) has (have) value to the customer on a stand-alone basis. Revenue for each unit of accounting is recognized as the unit of accounting is delivered. Arrangement consideration is allocated to each unit of accounting based upon the relative estimated selling prices of the separate units of accounting contained within an arrangement containing multiple deliverables. Estimated selling prices are determined using Vendor Specific Objective Evidence (VSOE), when available, or an estimate of selling price when VSOE is not available for a given unit of accounting. Significant inputs for the estimates of the selling price of separate units of accounting include market and pricing trends and a customer&#8217;s geographic location. We account for training and installation, and service agreements and the collection, processing and testing of the umbilical cord blood and the storage as separate units of accounting.
</FONT>
</P>
<P ID=PARA4234 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4235 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Service revenue generated from contracts for providing maintenance of equipment is amortized over the life of the agreement. Revenue generated from storage contracts is deferred and recorded ratably over the life of the agreement, up to 21 years. All other service revenue is recognized at the time the service is completed.
</FONT>
</P>
<P ID=PARA4236 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4237 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues are net of normal discounts. Shipping and handling fees billed to customers are included in net revenues, while the related costs are included in cost of revenues.
</FONT>
</P>
<P ID=PARA4238 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4239 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Stock-Based Compensation
</I>
</B>
</FONT>
</P>
<P ID=PARA4240 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We use the Black-Scholes-Merton option-pricing formula in determining the fair value of our options at the grant date and apply judgment in estimating the key assumptions that are critical to the model such as the expected term, volatility and forfeiture rate of an option. Our estimate of these key assumptions is based on historical information and judgment regarding market factors and trends. If any of the key assumptions change significantly, stock-based compensation expense for new awards may differ materially in the future from that recorded in the current period. The compensation expense is then amortized over the vesting period.
</FONT>
</P>
<P ID=PARA4241 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK4242 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4242 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4242 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	36
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage37"></A>
<A ID=TOCLINK4242 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4242 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4242.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4243 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Income Taxes
</I>
</B>
	&nbsp;
</FONT>
</P>
<P ID=PARA4244 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Our estimates of income taxes and the significant items resulting in the recognition of deferred tax assets and liabilities reflect our assessment of future tax consequences of transactions that have been reflected in the financial statements or tax returns for each taxing jurisdiction in which we operate.&nbsp; We base our provision for income taxes on our current period results of operations, changes in deferred income tax assets and liabilities, income tax rates, and changes in estimates of uncertain tax positions in the jurisdictions in which we operate.&nbsp; We recognize deferred tax assets and liabilities when there are temporary differences between the financial reporting basis and tax basis of assets and liabilities and for the expected benefits of using net operating loss and tax credit loss carryforwards.&nbsp; We establish valuation allowances when necessary to reduce the carrying amount of deferred income tax assets to the amounts that we believe are more likely than not to be realized.&nbsp;We evaluate the need to retain all or a portion of the valuation allowance on recorded deferred tax assets.&nbsp; When a change in the tax rate or tax law has an impact on deferred taxes, we apply the change based on the years in which the temporary differences are expected to reverse.&nbsp; As we operate in more than one state, changes in the state apportionment factors, based on operational results, may affect future effective tax rates and the value of recorded deferred tax assets and liabilities.&nbsp; We record a change in tax rates in the consolidated financial statements in the period of enactment.
</FONT>
</P>
<P ID=PARA4245 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4246 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Income tax consequences that arise in connection with a business combination include identifying the tax basis of assets and liabilities acquired and any contingencies associated with uncertain tax positions assumed or resulting from the business combination.&nbsp; Deferred tax assets and liabilities related to temporary differences of an acquired entity are recorded as of the date of the business combination and are based on our estimate of the appropriate tax basis that will be accepted by the various taxing authorities and its determination as to whether any of the acquired deferred tax liabilities could be a source of taxable income to realize our pre-existing deferred tax assets.
</FONT>
</P>
<P ID=PARA4247 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4248 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Inventory Valuation
</I>
</B>
</FONT>
</P>
<P ID=PARA4249 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We state inventories at lower of cost or market value determined on a first-in, first-out basis. We provide write-downs of inventory when conditions indicate that the selling price could be less than cost due to physical deterioration, obsolescence, changes in price levels, or other causes, which it includes as a component of cost of revenues. Additionally, we provide valuation allowances for excess and slow-moving inventory on hand that are not expected to be sold to reduce the carrying amount of slow-moving inventory to its estimated net realizable value. The valuation allowances are based upon estimates about future demand from our customers and distributors and market conditions. Because some of our products are highly dependent on government and third-party funding, current customer use and validation, and completion of regulatory and field trials, there is a risk that we will forecast incorrectly and purchase or produce excess inventories. As a result, actual demand may differ from forecasts and we may be required to record additional inventory valuation allowances that could adversely impact our gross margins. Conversely, favorable changes in demand could result in higher gross margins when those products are sold.
</FONT>
</P>
<P ID=PARA4250 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4251 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Warranty
</I>
</B>
</FONT>
</P>
<P ID=PARA4252 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We provide for the estimated cost of product warranties at the time revenue is recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers, our warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. Should actual product failure rates, material usage or service delivery costs differ from our estimates, revisions to the estimated warranty liability could have a material impact on our financial position, cash flows or results of operations.
</FONT>
</P>
<P ID=PARA4253 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK4255 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4255 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4255 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	37
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage38"></A>
<A ID=TOCLINK4255 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4255 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4255.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4256 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Off Balance Sheet Arrangements
</U>
</B>
</FONT>
</P>
<P ID=PARA4257 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4258 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have no off-balance sheet arrangements.
</FONT>
</P>
</EFX_LIQUIDITY_CAPITAL>
</EFX_MANAGEMENTS_DISCUSSION>
<P ID=PARA4259 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_MARKET_RISK>
<A NAME="FIS_MARKET_RISK"></A>
<P ID=PARA4260 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6615 NAME="KOOL20160630_10K_HTM_BKMK6615">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	7A
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</U>
</B>
</FONT>
</P>
<P ID=PARA4261 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We are a smaller reporting company as defined by Rule 12b-2 of the SEC Act of 1934 and are not required to provide information under this item.
</FONT>
</P>
</EFX_MARKET_RISK>
<P ID=PARA4262 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS"></A>
<P ID=PARA4263 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6616 NAME="KOOL20160630_10K_HTM_BKMK6616">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
</U>
</B>
</FONT>
</P>
<P ID=PARA4264 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<TABLE ID=TBL4278 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: TOP">
<P ID=PARA4265 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Page
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4266 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6626 HREF="#KOOL20160630_10K_HTM_BKMK6632">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Report of Independent Registered Public Accounting Firm
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4267 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	39
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4268 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6627 HREF="#KOOL20160630_10K_HTM_BKMK6633">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Balance Sheets at June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4269 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	40
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4270 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6628 HREF="#KOOL20160630_10K_HTM_BKMK6634">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4271 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	41
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4272 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6629 HREF="#KOOL20160630_10K_HTM_BKMK6635">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Stockholders&#8217; Equity for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4273 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	42
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4274 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6630 HREF="#KOOL20160630_10K_HTM_BKMK6636">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Cash Flows for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4275 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	43
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 89.7%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4276 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6631 HREF="#KOOL20160630_10K_HTM_BKMK6637">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Notes to Consolidated Financial Statements
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 11.4%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4277 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	44
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4279 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK4280 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4280 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4280 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	38
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage39"></A>
<A ID=TOCLINK4280 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4280 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4280.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<P ID=PARA4281 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6632 NAME="KOOL20160630_10K_HTM_BKMK6632">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	REP
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ORT
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<A ID=BKMK6647 NAME="KOOL20160630_10K_HTM_BKMK6647">
	OF
</A>
	INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</B>
</FONT>
</P>
<P ID=PARA4282 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4283 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4284 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	To the Audit Committee of the
</FONT>
</P>
<P ID=PARA4285 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Board of Directors and Shareholders
</FONT>
</P>
<P ID=PARA4286 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	of Cesca Therapeutics Inc. and Subsidiaries
</FONT>
</P>
<P ID=PARA4287 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4288 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We have audited the accompanying consolidated balance sheets of
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics Inc. and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2016 and 2015, and the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for the years then ended. These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial statements based on our audits.
</FONT>
</P>
<P ID=PARA4289 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4290 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).&nbsp; Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&nbsp; The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.&nbsp; An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.&nbsp; We believe that our audits provide a reasonable basis for our opinion.
</FONT>
</P>
<P ID=PARA4291 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4292 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics Inc. and Subsidiaries, as of June 30, 2016 and 2015 and the consolidated results of their operations and their cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	.
</FONT>
</P>
<P ID=PARA4293 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4294 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Marcum LLP
</FONT>
</P>
<P STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Marcum LLP
</P>
<P ID=PARA4295 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	New York, NY
</FONT>
</P>
<P ID=PARA4296 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	September 20, 2016
<B>
</B>
</FONT>
</P>
<P ID=PARA4297.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4297 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4297 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4297 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	39
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage40"></A>
<A ID=TOCLINK4297 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4297 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_AUDITORS_OPINION>
<P ID=PARA4297.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_BALANCE_SHEET>
<A NAME="FIS_BALANCE_SHEET"></A>
<P ID=PARA4298 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6633 NAME="KOOL20160630_10K_HTM_BKMK6633">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Therapeutics
<A ID=BKMK6648 NAME="KOOL20160630_10K_HTM_BKMK6648">
	Inc
</A>
	.
</B>
</FONT>
</P>
<P ID=PARA4299 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Consolidated
</B>
<B>
	Balance Sheets
</B>
</FONT>
</P>
<P ID=PARA4300 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
	(
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	in thousands, except share and per share amounts
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
	)
</FONT>
</P>
<P ID=PARA4301 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="BALANCE-SHEET" DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL4336 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4336.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4302 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4303 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 70%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4304 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ASSETS
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.2.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.2.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4305 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Current assets:
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.3.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.3.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4306 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash and cash equivalents
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4336.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5,835
</TD>
<TD ID=TBL4336.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4336.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	3,357
</TD>
<TD ID=TBL4336.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4309 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accounts receivable, net of allowance for doubtful accounts of $49 ($46 at June 30, 2015)
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	3,169
</TD>
<TD ID=TBL4336.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	5,133
</TD>
<TD ID=TBL4336.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="MARGIN-BOTTOM: 0PX; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; MARGIN-TOP: 0PX; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4312 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Inventories, net of reserves of $1,437 ($874 at June 30, 2015)
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	3,593
</TD>
<TD ID=TBL4336.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	4,598
</TD>
<TD ID=TBL4336.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4315 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Prepaid expenses and other current assets
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	246
</TD>
<TD ID=TBL4336.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	163
</TD>
<TD ID=TBL4336.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4318 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total current assets
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	12,843
</TD>
<TD ID=TBL4336.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	13,251
</TD>
<TD ID=TBL4336.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.9 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.9.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.10 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4321 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equipment at cost less accumulated depreciation
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.10.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.10.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.10.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	2,962
</TD>
<TD ID=TBL4336.FINROW.10.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	2,937
</TD>
<TD ID=TBL4336.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.11 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4324 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Goodwill
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	13,195
</TD>
<TD ID=TBL4336.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	13,195
</TD>
<TD ID=TBL4336.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.12 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4327 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Intangible assets, net
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.12.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.12.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.12.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	20,821
</TD>
<TD ID=TBL4336.FINROW.12.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.12.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.12.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.12.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	21,295
</TD>
<TD ID=TBL4336.FINROW.12.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.13 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4330 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other assets
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.13.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.13.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.13.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	78
</TD>
<TD ID=TBL4336.FINROW.13.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.13.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.13.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.13.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	79
</TD>
<TD ID=TBL4336.FINROW.13.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.14 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4333 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total assets
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.14.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.14.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4336.FINROW.14.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	49,899
</TD>
<TD ID=TBL4336.FINROW.14.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.14.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.14.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4336.FINROW.14.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	50,757
</TD>
<TD ID=TBL4336.FINROW.14.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.15 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.15.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.16 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4338 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	LIABILITIES AND STOCKHOLDERS&#8217; EQUITY
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.16.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.16.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.17 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.17.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.18 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4339 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Current liabilities:
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.18.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.18.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.19 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4340 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accounts payable
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.19.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.19.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4336.FINROW.19.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,648
</TD>
<TD ID=TBL4336.FINROW.19.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.19.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.19.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4336.FINROW.19.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	5,079
</TD>
<TD ID=TBL4336.FINROW.19.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.20 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4343 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accrued payroll and related expenses
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.20.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.20.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.20.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	449
</TD>
<TD ID=TBL4336.FINROW.20.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.20.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.20.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.20.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	705
</TD>
<TD ID=TBL4336.FINROW.20.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.21 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4346 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Deferred revenue
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.21.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.21.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.21.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	783
</TD>
<TD ID=TBL4336.FINROW.21.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.21.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.21.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.21.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	635
</TD>
<TD ID=TBL4336.FINROW.21.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.22 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4349 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other current liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.22.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.22.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.22.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,662
</TD>
<TD ID=TBL4336.FINROW.22.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.22.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.22.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.22.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,527
</TD>
<TD ID=TBL4336.FINROW.22.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.23 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4352 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total current liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.23.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.23.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.23.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	5,542
</TD>
<TD ID=TBL4336.FINROW.23.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.23.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.23.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.23.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	7,946
</TD>
<TD ID=TBL4336.FINROW.23.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.24 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.24.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.25 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4355 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Noncurrent deferred tax liability
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.25.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.25.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.25.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	7,641
</TD>
<TD ID=TBL4336.FINROW.25.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.25.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.25.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.25.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	7,641
</TD>
<TD ID=TBL4336.FINROW.25.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.26 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4358 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Derivative obligations
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.26.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.26.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.26.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	670
</TD>
<TD ID=TBL4336.FINROW.26.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.26.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.26.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.26.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4336.FINROW.26.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.27 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4361 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Convertible debentures, net
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.27.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.27.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.27.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,489
</TD>
<TD ID=TBL4336.FINROW.27.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.27.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.27.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.27.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4336.FINROW.27.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.28 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4364 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other noncurrent liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.28.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.28.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.28.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,284
</TD>
<TD ID=TBL4336.FINROW.28.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.28.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.28.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.28.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	268
</TD>
<TD ID=TBL4336.FINROW.28.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.29 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4367 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.29.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.29.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.29.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	17,626
</TD>
<TD ID=TBL4336.FINROW.29.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.29.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.29.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.29.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	15,855
</TD>
<TD ID=TBL4336.FINROW.29.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.30 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.30.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.31 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4370 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Commitments and contingencies
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.31.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.31.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.32 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.32.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.33 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4371 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stockholders&#8217; equity:
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.33.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.33.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.34 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4372 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued and outstanding at June 30, 2016
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	and 2015
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.34.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.34.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.34.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4336.FINROW.34.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.34.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.34.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.34.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4336.FINROW.34.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.35 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.35.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.36 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4376 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common stock, $0.001 par value; 350,000,000 shares authorized; 3,010,687 issued and outstanding (2,027,386 at June 30, 2015)
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.36.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.36.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.36.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	3
</TD>
<TD ID=TBL4336.FINROW.36.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.36.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.36.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.36.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	2
</TD>
<TD ID=TBL4336.FINROW.36.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.37 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4379 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Paid in capital in excess of par
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.37.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.37.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.37.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	188,569
</TD>
<TD ID=TBL4336.FINROW.37.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.37.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.37.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.37.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	172,579
</TD>
<TD ID=TBL4336.FINROW.37.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.38 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4382 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accumulated deficit
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.38.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.38.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.38.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(156,262
</TD>
<TD ID=TBL4336.FINROW.38.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4336.FINROW.38.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.38.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.38.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(137,674
</TD>
<TD ID=TBL4336.FINROW.38.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4336.FINROW.39 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4385 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accumulated other comprehensive loss
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.39.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.39.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.39.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(37
</TD>
<TD ID=TBL4336.FINROW.39.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4336.FINROW.39.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.39.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.39.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(5
</TD>
<TD ID=TBL4336.FINROW.39.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4336.FINROW.40 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.40.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.41 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4388 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total stockholders&#8217; equity
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.41.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.41.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.41.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	32,273
</TD>
<TD ID=TBL4336.FINROW.41.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.41.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.41.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.41.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	34,902
</TD>
<TD ID=TBL4336.FINROW.41.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.42 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.42.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4336.FINROW.43 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4391 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total liabilities and stockholders&#8217; equity
</FONT>
</P>
</TD>
<TD ID=TBL4336.FINROW.43.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.43.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4336.FINROW.43.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	49,899
</TD>
<TD ID=TBL4336.FINROW.43.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.43.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4336.FINROW.43.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4336.FINROW.43.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	50,757
</TD>
<TD ID=TBL4336.FINROW.43.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BALANCE_SHEET>
<P ID=PARA4337 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 1PT">
	&nbsp;
</FONT>
</P>
<P ID=PARA4395 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4396 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	See accompanying notes.
</FONT>
</P>
<P ID=PARA4397.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4397 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4397 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4397 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	40
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage41"></A>
<A ID=TOCLINK4397 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4397 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4397.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4398 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6634 NAME="KOOL20160630_10K_HTM_BKMK6634">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Therapeutics
<A ID=BKMK6649 NAME="KOOL20160630_10K_HTM_BKMK6649">
	Inc
</A>
	.
</B>
</FONT>
</P>
<P ID=PARA4399 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Consolid
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	ated Statements of Operations and Comprehensive loss
</B>
</FONT>
</P>
<P ID=PARA4400 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
	(
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	in thousands, except share and per share amounts
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
	)
</FONT>
</P>
<P ID=PARA4401 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<TABLE ID=TBL4403 STYLE="FONT-SIZE: 10PT; BORDER-TOP: #000000 1PX SOLID; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; BORDER-RIGHT: #000000 1PX SOLID; WIDTH: 100%; BORDER-BOTTOM: #000000 1PX SOLID; BORDER-LEFT: #000000 1PX SOLID; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 101.1%; VERTICAL-ALIGN: TOP">
<P ID=PARA4402 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Years ended June 30
</FONT>
</P>
</TD>
</TR>
</TABLE>
<DIV DATA-TD-STATEMENT-TYPE="INCOME" DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL4479 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4479.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4404 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4405 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 70%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4406 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net revenues
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	11,929
</TD>
<TD ID=TBL4479.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	16,042
</TD>
<TD ID=TBL4479.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4409 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cost of revenues
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	9,185
</TD>
<TD ID=TBL4479.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	11,293
</TD>
<TD ID=TBL4479.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4412 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross profit
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	2,744
</TD>
<TD ID=TBL4479.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	4,749
</TD>
<TD ID=TBL4479.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.6.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4415 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expenses:
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.7.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.7.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4416 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and marketing
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,148
</TD>
<TD ID=TBL4479.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,974
</TD>
<TD ID=TBL4479.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.9 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4419 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Research and development
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	3,230
</TD>
<TD ID=TBL4479.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	5,939
</TD>
<TD ID=TBL4479.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.10 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4422 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General and administrative
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.10.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.10.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.10.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	8,231
</TD>
<TD ID=TBL4479.FINROW.10.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	10,695
</TD>
<TD ID=TBL4479.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.11 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4425 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total operating expenses
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	13,609
</TD>
<TD ID=TBL4479.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	19,608
</TD>
<TD ID=TBL4479.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.12 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4428 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss from operations
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.12.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.12.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.12.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(10,865
</TD>
<TD ID=TBL4479.FINROW.12.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.12.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.12.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.12.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(14,859
</TD>
<TD ID=TBL4479.FINROW.12.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.13 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.13.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.14 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4431 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other income (expense):
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.14.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.14.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.15 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4432 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization of debt discount
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.15.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.15.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.15.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(6,127
</TD>
<TD ID=TBL4479.FINROW.15.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.15.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.15.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.15.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4479.FINROW.15.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.16 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4435 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fair value change of derivative instruments
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.16.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.16.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.16.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	3,395
</TD>
<TD ID=TBL4479.FINROW.16.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.16.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.16.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.16.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4479.FINROW.16.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.17 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4438 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Interest expense
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.17.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.17.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.17.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(1,864
</TD>
<TD ID=TBL4479.FINROW.17.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.17.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.17.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.17.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(14
</TD>
<TD ID=TBL4479.FINROW.17.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.18 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4441 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Registration rights liquidated damages
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.18.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.18.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.18.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(1,100
</TD>
<TD ID=TBL4479.FINROW.18.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.18.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.18.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.18.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4479.FINROW.18.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.19 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4444 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on cashless exercise of warrants
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.19.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.19.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.19.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(1,039
</TD>
<TD ID=TBL4479.FINROW.19.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.19.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.19.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.19.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4479.FINROW.19.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.20 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4447 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on extinguishment of debt
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.20.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.20.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.20.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(795
</TD>
<TD ID=TBL4479.FINROW.20.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.20.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.20.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.20.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4479.FINROW.20.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.21 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4450 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on modification of Series A warrants
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.21.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.21.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.21.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(149
</TD>
<TD ID=TBL4479.FINROW.21.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.21.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.21.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.21.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4479.FINROW.21.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.22 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4453 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other income and (expenses)
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.22.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.22.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.22.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(44
</TD>
<TD ID=TBL4479.FINROW.22.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.22.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.22.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.22.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	21
</TD>
<TD ID=TBL4479.FINROW.22.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.23 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4456 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total other income (expense)
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.23.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.23.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.23.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(7,723
</TD>
<TD ID=TBL4479.FINROW.23.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.23.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.23.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.23.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	7
</TD>
<TD ID=TBL4479.FINROW.23.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.24 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.SYMB.B2 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.AMT.B2 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.TRAIL.B2 STYLE="BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.SYMB.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.AMT.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.24.TRAIL.B3 STYLE="BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.25 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4459 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.25.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.25.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.25.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(18,588
</TD>
<TD ID=TBL4479.FINROW.25.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.25.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.25.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.25.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(14,852
</TD>
<TD ID=TBL4479.FINROW.25.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.26 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.26.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.27 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	COMPREHENSIVE LOSS
</TD>
<TD ID=TBL4479.FINROW.27.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.27 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4462 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.27.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4479.FINROW.27.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(18,588
</TD>
<TD ID=TBL4479.FINROW.27.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.27.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.27.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4479.FINROW.27.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(14,852
</TD>
<TD ID=TBL4479.FINROW.27.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.28 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4465 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other comprehensive income:
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.28.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.28.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.29 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4466 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Foreign currency translation adjustments
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.29.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.29.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.29.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(32
</TD>
<TD ID=TBL4479.FINROW.29.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.29.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.29.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.29.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(63
</TD>
<TD ID=TBL4479.FINROW.29.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.30 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4469 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Comprehensive loss
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.30.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.30.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.30.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(18,620
</TD>
<TD ID=TBL4479.FINROW.30.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.30.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.30.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4479.FINROW.30.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(14,915
</TD>
<TD ID=TBL4479.FINROW.30.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.31 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.31.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.32 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4472 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Per share data:
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.32.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.32.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.33 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4473 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Basic and diluted net loss per common share
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.33.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.33.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4479.FINROW.33.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(7.57
</TD>
<TD ID=TBL4479.FINROW.33.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4479.FINROW.33.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.33.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4479.FINROW.33.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(7.36
</TD>
<TD ID=TBL4479.FINROW.33.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4479.FINROW.34 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.34.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4479.FINROW.35 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4476 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted average common shares outstanding &#8211; Basic and diluted
</FONT>
</P>
</TD>
<TD ID=TBL4479.FINROW.35.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.35.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.35.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,455,548
</TD>
<TD ID=TBL4479.FINROW.35.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.35.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.35.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4479.FINROW.35.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,017,597
</TD>
<TD ID=TBL4479.FINROW.35.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA4480 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	See accompanying notes.
</FONT>
</P>
<P ID=PARA6454.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6454 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6454 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6454 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	41
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage42"></A>
<A ID=TOCLINK6454 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6454 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6454.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<P ID=PARA4481 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6635 NAME="KOOL20160630_10K_HTM_BKMK6635">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Therapeutics
<A ID=BKMK6650 NAME="KOOL20160630_10K_HTM_BKMK6650">
	Inc
</A>
	.
</B>
</FONT>
</P>
<P ID=PARA4482 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Conso
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	lidated Statements of Stockholders' Equity
</B>
</FONT>
</P>
<P ID=PARA4483 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	in thousands, except share and per share amounts
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	)
</FONT>
</P>
<P ID=PARA6456 STYLE="MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<DIV DATA-TD-STATEMENT-TYPE="STOCKHOLDERS-EQUITY" DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL4618 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4618.FINROW.1>
<TD STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.LEAD.D3 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.AMT.D3 STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" COLSPAN=6>
	Common Stock
</TD>
<TD ID=TBL4618.FINROW.1.TRAIL.D3 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.LEAD.D4 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.AMT.D4 STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" COLSPAN=2>
<P STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
	Paid in
</P>
<P STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
	capital in
</P>
</TD>
<TD ID=TBL4618.FINROW.1.TRAIL.D4 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.LEAD.D5 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.AMT.D5 STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" COLSPAN=2>
	Accumulated
</TD>
<TD ID=TBL4618.FINROW.1.TRAIL.D5 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.LEAD.D6 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.AMT.D6 STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" COLSPAN=2>
<P STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
	Accumulated other
</P>
<P STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
	comprehensive
</P>
</TD>
<TD ID=TBL4618.FINROW.1.TRAIL.D6 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.LEAD.D7 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.1.AMT.D7 STYLE="VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER" COLSPAN=2>
	Total stockholders&#8217;
</TD>
<TD ID=TBL4618.FINROW.1.TRAIL.D7 STYLE="VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4489 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Shares
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4490 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amount
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D4 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D4 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER" COLSPAN=2>
	excess of par
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D4 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D5 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D5 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER" COLSPAN=2>
	deficit
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D5 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D6 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D6 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER" COLSPAN=2>
<P ID=PARA6458 STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
	(loss) income
</P>
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D6 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.LEAD.D7 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.2.AMT.D7 STYLE="VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER" COLSPAN=2>
	equity
</TD>
<TD ID=TBL4618.FINROW.2.TRAIL.D7 STYLE="VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 28%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4491 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance at June 30, 2014
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,012,326
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4618.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4618.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	171,460
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4618.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(122,822
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4618.FINROW.3.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	58
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.3.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4618.FINROW.3.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	48,698
</TD>
<TD ID=TBL4618.FINROW.3.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.LEAD.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.SYMB.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.AMT.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.4.TRAIL.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="MARGIN-BOTTOM: 0PX; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; MARGIN-TOP: 0PX; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4498 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Issuance of common shares and compensation related to restricted common stock awards, net of&nbsp;stock surrenders
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	12,801
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	414
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.5.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	414
</TD>
<TD ID=TBL4618.FINROW.5.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.LEAD.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.SYMB.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.AMT.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.6.TRAIL.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4505 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock-based compensation expense
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	660
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.7.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	660
</TD>
<TD ID=TBL4618.FINROW.7.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B4 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B5 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B6 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.LEAD.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.SYMB.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.AMT.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.8.TRAIL.B7 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.9 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4512 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common stock issued to directors in lieu of cash compensation
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,259
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	45
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.9.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	45
</TD>
<TD ID=TBL4618.FINROW.9.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.10 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4519 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Foreign currency translation
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(63
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.10.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.10.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(63
</TD>
<TD ID=TBL4618.FINROW.10.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4618.FINROW.11 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4526 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(14,852
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.11.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(14,852
</TD>
<TD ID=TBL4618.FINROW.11.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4618.FINROW.12 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4533 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance at June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,027,386
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	172,579
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(137,674
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(5
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.12.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.12.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	34,902
</TD>
<TD ID=TBL4618.FINROW.12.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.13 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.13.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.14 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4540 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock-based compensation expense, net of stock surrenders
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	11,577
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	710
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.14.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	710
</TD>
<TD ID=TBL4618.FINROW.14.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.15 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.15.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.16 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4547 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Discount due to beneficial conversion features
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	7,262
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.16.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	7,262
</TD>
<TD ID=TBL4618.FINROW.16.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.17 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.17.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.18 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4556 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Discount due to warrants
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4,434
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.18.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	4,434
</TD>
<TD ID=TBL4618.FINROW.18.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.19 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.19.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.20 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4563 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Issuance of common shares and warrants in financing
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	735,294
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,463
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.20.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,464
</TD>
<TD ID=TBL4618.FINROW.20.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.21 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.21.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.22 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4572 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Issuance of common shares for exercise of Series B warrants
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	231,710
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,097
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.22.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,097
</TD>
<TD ID=TBL4618.FINROW.22.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.23 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.23.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.26 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA4590 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common stock issued to directors in lieu of cash compensation
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4,720
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	24
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.26.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	24
</TD>
<TD ID=TBL4618.FINROW.26.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.27 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.27.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.28 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4597 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Foreign currency translation
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(32
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.28.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.28.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(32
</TD>
<TD ID=TBL4618.FINROW.28.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4618.FINROW.29 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B4 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B5 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B6 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.LEAD.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.SYMB.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.AMT.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.29.TRAIL.B7 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.30 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4604 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(18,588
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.30.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(18,588
</TD>
<TD ID=TBL4618.FINROW.30.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4618.FINROW.31 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B2 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B2 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B2 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B3 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B4 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B4 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B4 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B4 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B5 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B5 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B5 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B5 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B6 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B6 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B6 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B6 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.LEAD.B7 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.SYMB.B7 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.AMT.B7 STYLE="BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.31.TRAIL.B7 STYLE="BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4618.FINROW.32 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4611 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance at June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	3,010,687
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4618.FINROW.32.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	3
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4618.FINROW.32.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	188,569
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4618.FINROW.32.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(156,262
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4618.FINROW.32.AMT.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(37
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.6 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4618.FINROW.32.LEAD.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4618.FINROW.32.SYMB.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4618.FINROW.32.AMT.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	32,273
</TD>
<TD ID=TBL4618.FINROW.32.TRAIL.7 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_STOCKHOLDERS_EQUITY>
<P ID=PARA4619 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 3PT">
	&nbsp;
</FONT>
</P>
<P ID=PARA4620 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	See accompanying notes.
</FONT>
</P>
<P ID=PARA6455.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6455 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6455 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6455 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	42
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage43"></A>
<A ID=TOCLINK6455 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6455 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6455.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_CASH_FLOW>
<A NAME="FIS_CASH_FLOW"></A>
<P ID=PARA4621 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6636 NAME="KOOL20160630_10K_HTM_BKMK6636">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Therapeutics
<A ID=BKMK6651 NAME="KOOL20160630_10K_HTM_BKMK6651">
	Inc
</A>
	.
</B>
</FONT>
</P>
<P ID=PARA4622 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Conso
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	lidated Statements of Cash Flows
</B>
</FONT>
</P>
<P ID=PARA4623 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	amounts in thousands, except share and per share amounts
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	)
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<DIV DATA-TD-STATEMENT-TYPE="CASH-FLOWS" DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL4750 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4750.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA4624 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Years ended June 30,
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4625 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4626 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 70%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4627 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from operating activities:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.3.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.3.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4628 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(18,588
</TD>
<TD ID=TBL4750.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(14,852
</TD>
<TD ID=TBL4750.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4631 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Adjustments to reconcile net loss to net cash used in operating activities:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.5.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.5.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4632 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Depreciation and amortization
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,168
</TD>
<TD ID=TBL4750.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,351
</TD>
<TD ID=TBL4750.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4635 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock-based compensation expense
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	742
</TD>
<TD ID=TBL4750.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,247
</TD>
<TD ID=TBL4750.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4638 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Reserve for excess and slow-moving inventories
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	566
</TD>
<TD ID=TBL4750.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	162
</TD>
<TD ID=TBL4750.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.9 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4641 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization of debt discount
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	6,127
</TD>
<TD ID=TBL4750.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.10 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4644 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization of debt issue costs
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.10.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.10.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.10.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	800
</TD>
<TD ID=TBL4750.FINROW.10.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.11 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4647 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Change in fair value of derivative
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(3,395
</TD>
<TD ID=TBL4750.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.11 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
	Non-cash accrued interest
</TD>
<TD ID=TBL4750.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,031
</TD>
<TD ID=TBL4750.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.12 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4650 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on cashless exercise of warrants
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.12.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.12.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.12.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,039
</TD>
<TD ID=TBL4750.FINROW.12.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.12.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.12.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.12.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.12.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.13 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4653 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on extinguishment of debt
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.13.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.13.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.13.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	795
</TD>
<TD ID=TBL4750.FINROW.13.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.13.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.13.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.13.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.13.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.14 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4656 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on modification of Series A warrants
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.14.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.14.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.14.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	149
</TD>
<TD ID=TBL4750.FINROW.14.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.14.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.14.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.14.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.14.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.15 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4659 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Impairment of intangible asset
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.15.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.15.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.15.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.15.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.15.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.15.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.15.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	117
</TD>
<TD ID=TBL4750.FINROW.15.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.16 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4662 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net changes in operating assets and liabilities:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.16.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.16.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.17 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4663 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accounts receivable
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.17.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.17.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.17.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,956
</TD>
<TD ID=TBL4750.FINROW.17.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.17.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.17.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.17.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(459
</TD>
<TD ID=TBL4750.FINROW.17.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.18 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4666 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Inventories, Net
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.18.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.18.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.18.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	375
</TD>
<TD ID=TBL4750.FINROW.18.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.18.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.18.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.18.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	254
</TD>
<TD ID=TBL4750.FINROW.18.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.19 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4669 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Prepaid other assets
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.19.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.19.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.19.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(86
</TD>
<TD ID=TBL4750.FINROW.19.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.19.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.19.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.19.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	54
</TD>
<TD ID=TBL4750.FINROW.19.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.20 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4672 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accounts payable
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.20.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.20.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.20.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(2,420
</TD>
<TD ID=TBL4750.FINROW.20.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.20.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.20.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.20.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	1,410
</TD>
<TD ID=TBL4750.FINROW.20.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.21 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4675 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accrued payroll and related expenses
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.21.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.21.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.21.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(256
</TD>
<TD ID=TBL4750.FINROW.21.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.21.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.21.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.21.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	105
</TD>
<TD ID=TBL4750.FINROW.21.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.22 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4678 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Deferred revenue
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.22.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.22.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.22.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	148
</TD>
<TD ID=TBL4750.FINROW.22.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.22.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.22.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.22.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(3
</TD>
<TD ID=TBL4750.FINROW.22.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.23 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4681 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other current liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.23.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.23.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.23.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	160
</TD>
<TD ID=TBL4750.FINROW.23.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.23.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.23.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.23.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(76
</TD>
<TD ID=TBL4750.FINROW.23.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.24 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 45PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4684 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other noncurrent liabilities
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.24.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.24.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.24.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	64
</TD>
<TD ID=TBL4750.FINROW.24.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.24.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.24.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.24.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	41
</TD>
<TD ID=TBL4750.FINROW.24.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.25 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4687 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net cash (used in) operating activities
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.25.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.25.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.25.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(9,625
</TD>
<TD ID=TBL4750.FINROW.25.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.25.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.25.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.25.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(10,649
</TD>
<TD ID=TBL4750.FINROW.25.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.26 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4690 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from investing activities:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.26.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.26.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.27 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4691 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Capital expenditures
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.27.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.27.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.27.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(710
</TD>
<TD ID=TBL4750.FINROW.27.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.27.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.27.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.27.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(587
</TD>
<TD ID=TBL4750.FINROW.27.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.28 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4694 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net cash (used in) investing activities
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.28.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.28.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.28.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(710
</TD>
<TD ID=TBL4750.FINROW.28.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.28.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.28.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.28.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(587
</TD>
<TD ID=TBL4750.FINROW.28.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.29 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4697 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash flows from financing activities:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.29.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.29.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.30 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4698 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross proceeds from convertible debentures
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.30.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.30.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.30.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	18,000
</TD>
<TD ID=TBL4750.FINROW.30.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.30.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.30.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.30.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.30.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.31 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4701 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Payment of financing cost &#8211; convertible debentures
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.31.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.31.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.31.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(961
</TD>
<TD ID=TBL4750.FINROW.31.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.31.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.31.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.31.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.31.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.32 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4704 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Repayment of convertible debentures
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.32.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.32.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.32.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(6,444
</TD>
<TD ID=TBL4750.FINROW.32.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.32.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.32.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.32.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.32.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.33 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4707 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Payment to extinguish derivative obligations
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.33.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.33.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.33.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(159
</TD>
<TD ID=TBL4750.FINROW.33.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.33.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.33.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.33.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.33.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.34 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4710 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Payments on capital lease obligations
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.34.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.34.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.34.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(67
</TD>
<TD ID=TBL4750.FINROW.34.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.34.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.34.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.34.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(60
</TD>
<TD ID=TBL4750.FINROW.34.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.35 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4713 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Proceeds from issuance of common stock, net
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.35.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.35.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.35.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,463
</TD>
<TD ID=TBL4750.FINROW.35.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.35.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.35.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.35.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.35.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.36 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4716 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Repurchase of common stock
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.36.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.36.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.36.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(8
</TD>
<TD ID=TBL4750.FINROW.36.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.36.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.36.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.36.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(129
</TD>
<TD ID=TBL4750.FINROW.36.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.37 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4719 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net cash (used in) provided by financing activities
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.37.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.37.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.37.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	12,824
</TD>
<TD ID=TBL4750.FINROW.37.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.37.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.37.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.37.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(189
</TD>
<TD ID=TBL4750.FINROW.37.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.38 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4722 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Effects of foreign currency rate changes on cash and cash equivalents
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.38.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.38.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.38.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(11
</TD>
<TD ID=TBL4750.FINROW.38.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL4750.FINROW.38.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.38.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.38.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	(29
</TD>
<TD ID=TBL4750.FINROW.38.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.39 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4725 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net (decrease)increase in cash and cash equivalents
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.39.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.39.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.39.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	2,478
</TD>
<TD ID=TBL4750.FINROW.39.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.39.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.39.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.39.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	(11,454
</TD>
<TD ID=TBL4750.FINROW.39.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL4750.FINROW.40 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4728 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash and cash equivalents at beginning of year
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.40.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.40.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.40.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	3,357
</TD>
<TD ID=TBL4750.FINROW.40.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.40.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.40.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.40.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	14,811
</TD>
<TD ID=TBL4750.FINROW.40.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.41 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4731 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cash and cash equivalents at end of year
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.41.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.41.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.41.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	5,835
</TD>
<TD ID=TBL4750.FINROW.41.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.41.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.41.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.41.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	3,357
</TD>
<TD ID=TBL4750.FINROW.41.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.43 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA4734 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Supplemental non-cash financing and investing information:
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.43.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.43.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.44 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4735 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Derivative obligation related to issuance of warrants
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.44.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.44.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.44.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	4,282
</TD>
<TD ID=TBL4750.FINROW.44.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.44.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.44.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.44.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.44.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.45 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4738 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Reclassification of derivative liability to equity
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.45.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.45.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4750.FINROW.45.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	58
</TD>
<TD ID=TBL4750.FINROW.45.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.45.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.45.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4750.FINROW.45.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.45.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.46 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4741 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Transfer of inventories to equipment
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.46.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.46.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.46.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	18
</TD>
<TD ID=TBL4750.FINROW.46.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.46.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.46.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.46.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	539
</TD>
<TD ID=TBL4750.FINROW.46.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.47 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4744 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equipment acquired by capital lease
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.47.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.47.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4750.FINROW.47.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4750.FINROW.47.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.47.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.47.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL4750.FINROW.47.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #CCEEFF">
	208
</TD>
<TD ID=TBL4750.FINROW.47.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4750.FINROW.48 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4747 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Retirement of equipment
</FONT>
</P>
</TD>
<TD ID=TBL4750.FINROW.48.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.48.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.48.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	1,109
</TD>
<TD ID=TBL4750.FINROW.48.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.48.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4750.FINROW.48.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL4750.FINROW.48.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 36PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4750.FINROW.48.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CASH_FLOW>
<P ID=PARA4751 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	See accompanying notes.
</FONT>
</P>
<P ID=PARA4752.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4752 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4752 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4752 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	43
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage44"></A>
<A ID=TOCLINK4752 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4752 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4752.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4753 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6637 NAME="KOOL20160630_10K_HTM_BKMK6637">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Therapeutics
<A ID=BKMK6652 NAME="KOOL20160630_10K_HTM_BKMK6652">
	Inc
</A>
	.
</B>
</FONT>
</P>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<P ID=PARA4754 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	FINANCIAL STATEMENTS
</B>
</FONT>
</P>
<P ID=PARA4755 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands
</B>
<B>
	except shares and per share amounts
</B>
<B>
	)
</B>
</FONT>
</P>
<P ID=PARA4756 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<TABLE ID=MTAB4758 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4759 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	1.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4760 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Description of Business and Basis of Presentation
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4761 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
	&nbsp;
</I>
</FONT>
</P>
<P ID=PARA4762 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Organization and Basis of Presentation
</I>
</B>
</FONT>
</P>
<P ID=PARA4763 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics Inc. (Cesca, the Company) develops and markets integrated cellular therapies and delivery systems that advance the safe and effective practice of regenerative medicine. Cesca is a leader in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.
</FONT>
</P>
<P ID=PARA4764 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4765 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Reverse Stock Split
</I>
</B>
</FONT>
</P>
<P ID=PARA4766 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On March 4, 2016, the Company effected a one (1) for twenty (20) reverse split of its issued and outstanding common stock. There were no changes to its authorized number of shares of common stock of 350,000,000.
</FONT>
</P>
<P ID=PARA4767 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4768 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	All historical share amounts disclosed herein have been retroactively recast to reflect the reverse split. No fractional shares were issued; fractional shares of common stock were rounded up to the nearest whole share.
</FONT>
</P>
<P ID=PARA4769 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4770 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Liquidity
</I>
</B>
</FONT>
</P>
<P ID=PARA4771 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 3, 2016, the Company sold 600,000 shares of common stock at a price of $4.10 per share.&nbsp;
</FONT>
</P>
<P ID=PARA4772 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The net proceeds to the Company from the sale and issuance of the shares, after deducting the estimated offering expenses borne by the Company are expected to be approximately $2.2 million.&nbsp;
</FONT>
</P>
<P ID=PARA4773 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4774 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 22, 2016, the Company elected to convert all outstanding principal and interest accrued and otherwise payable under the secured convertible debentures. Upon conversion, 6,102,941 shares of common stock were issued and the Debentures and all security interest and liens were terminated.
</FONT>
</P>
<P ID=PARA4775 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4776 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, the Company had cash and cash equivalents of $5,835 and working capital of $7,301. The Company has incurred recurring operating losses and as of June 30, 2016 had an accumulated deficit of $156,262. The Company has primarily financed operations to date through the sale of equity securities and the sale of certain non-core assets. In February 2016, the Company completed a financing transaction (&#8220;the Financing Transaction&#8221;) for gross proceeds of $15 million. Half, or $7.5 million, of the proceeds were used to pay the investors in the August 2015 financing to repay the convertible debentures, liquidated damages and interest. Net proceeds after the repayment and issue costs were $7.3 million. Based upon the Company&#8217;s cash balance, the August 2016 Financing, historical trends, expected outflows and projections for revenues, management believes it will have sufficient cash to provide for its projected needs to maintain operations and working capital requirements for at least the next 12 months from the date of filing this annual report.
</FONT>
</P>
<P ID=PARA4777 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4778 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company will need additional funding to support its phase III Critical Limb Ischemia (CLIRST III) trial. As such, management has been exploring additional funding sources including strategic partner relationships. The Company cannot assure that such funding will be available on a timely basis, in needed quantities, or on favorable terms, if at all.&nbsp;
</FONT>
</P>
<P ID=PARA4779.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4779 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4779 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4779 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	44
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage45"></A>
<A ID=TOCLINK4779 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4779 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4779.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4780 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4781 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4782 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands
</B>
<B>
	except shares and per share amounts
</B>
<B>
	)
</B>
</FONT>
</P>
<P ID=PARA4783 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB4785 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4786 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	1.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4787 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Description of Business and Basis of Presentation (continued)
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4788 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4789 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Principles of Consolidation
</I>
</B>
</FONT>
</P>
<P ID=PARA4790 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The consolidated financial statements include the accounts of Cesca Therapeutics Inc., and the Company&#8217;s wholly-owned subsidiaries, TotipotentRX Cell Therapy, Pvt. Ltd. and TotipotentSC
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Scientific Product Pvt. Ltd. All significant intercompany accounts and transactions have been eliminated upon consolidation.
</FONT>
</P>
<P ID=PARA4792 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
</DIV>
<P ID=PARA4792 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<P ID=PARA4793 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<TABLE ID=MTAB4795 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA4796 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA4797 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Summary of Significant Accounting Policies
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4798 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
</I>
</B>
</FONT>
</P>
<P ID=PARA4800 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Use of Estimates
</I>
</B>
</FONT>
</P>
<P ID=PARA4801 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but not limited to, the allowance for doubtful accounts, slow-moving inventory reserves, depreciation, warranty costs, assumptions made in valuing equity instruments issued for services or acquisitions, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company&#8217;s consolidated financial statements. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying consolidated financial statements through the date of issuance.
</FONT>
</P>
<P ID=PARA4802 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4803 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Revenue Recognition
</I>
</B>
</FONT>
</P>
<P ID=PARA4804 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues from the sale of the Company&#8217;s products and services are recognized when persuasive evidence of an arrangement exists, delivery has occurred (or services have been rendered), the price is fixed or determinable, and collectability is reasonably assured. The Company generally ships products F.O.B. shipping point. There is no conditional evaluation on any product sold and recognized as revenue. Amounts billed in excess of revenue recognized are recorded as deferred revenue on the balance sheet.
</FONT>
</P>
<P ID=PARA4805 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4806 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company&#8217;s sales are generally through distributors. There is no right of return provided for distributors. For sales of products made to distributors, the Company considers a number of factors in determining whether revenue is recognized upon transfer of title to the distributor, or when payment is received. These factors include, but are not limited to, whether the payment terms offered to the distributor are considered to be non-standard, the distributor history of adhering to the terms of its contractual arrangements with us, the level of inventories maintained by the distributor, whether the Company has a pattern of granting concessions for the benefit of the distributor, and whether there are other conditions that may indicate that the sale to the distributor is not substantive. The Company currently recognizes revenue primarily on the sell-in method with its distributors.
</FONT>
</P>
<P ID=PARA4807.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4807 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4807 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4807 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	45
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage46"></A>
<A ID=TOCLINK4807 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4807 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4807.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA4809 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4810 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4811 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4812 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4813 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4814 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4815 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Revenue Recognition
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA4816 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenue arrangements with multiple deliverables are divided into units of accounting if certain criteria are met, including whether the deliverable item(s) has (have) value to the customer on a stand-alone basis. Revenue for each unit of accounting is recognized as the unit of accounting is delivered. Arrangement consideration is allocated to each unit of accounting based upon the relative estimated selling prices of the separate units of accounting contained within an arrangement containing multiple deliverables. Estimated selling prices are determined using vendor specific objective evidence of value (VSOE), when available, or an estimate of selling price when VSOE is not available for a given unit of accounting. Significant inputs for the estimates of the selling price of separate units of accounting include market and pricing trends and a customer&#8217;s geographic location. The Company accounts for training and installation, and service agreements and the collection, processing and testing of the umbilical cord blood and the storage as separate units of accounting.
</FONT>
</P>
<P ID=PARA4817 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4818 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Service revenue generated from contracts for providing maintenance of equipment is amortized over the life of the agreement. Revenue generated from storage contracts is deferred and recorded ratably over the life of the agreement, up to 21 years. All other service revenue is recognized at the time the service is completed.
</FONT>
</P>
<P ID=PARA4819 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4820 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues are net of normal discounts. Shipping and handling fees billed to customers are included in net revenues, while the related costs are included in cost of revenues.
</FONT>
</P>
<P ID=PARA4821 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4822 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Cash and Cash Equivalents
</I>
</B>
</FONT>
</P>
<P ID=PARA4823 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company considers all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. The Company&#8217;s cash is maintained in checking accounts, money market funds and certificates of deposits with reputable financial institutions that may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation. The Company has cash and cash equivalents of $104 and $247 at June 30, 2016 and 2015, respectively in India. The Company has not experienced any realized losses on the Company&#8217;s deposits of cash and cash equivalents.
</FONT>
</P>
<P ID=PARA4824 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4825 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Foreign Currency Translation
</I>
</B>
</FONT>
</P>
<P ID=PARA4826 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company&#8217;s reporting currency is the US dollar. The functional currency of the Company&#8217;s subsidiaries in India is the Indian rupee (INR). Assets and liabilities are translated into US dollars at period end exchange rates. Revenue and expenses are translated at average rates of exchange prevailing during the periods presented. Cash flows are also translated at average exchange rates for the period, therefore, amounts reported on the consolidated statement of cash flows do not necessarily agree with changes in the corresponding balances on the consolidated balance sheet. Equity accounts other than retained earnings are translated at the historic exchange rate on the date of investment. A translation loss of $32 and $63 was recorded for the years ended June 30, 2016 and 2015, respectively, as a component of other comprehensive income.
</FONT>
</P>
<P ID=PARA4827.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4827 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4827 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4827 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	46
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage47"></A>
<A ID=TOCLINK4827 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4827 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4827.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4828 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4829 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4830 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4831 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4832 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4835 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</P>
<P ID=PARA6700 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Goodwill, Intangible Assets and Impairment Assessments
</B>
</I>
</FONT>
</P>
</FONT>
<P ID=PARA4843 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Intangible assets that are not considered to have an indefinite useful life are amortized over their useful lives, which generally range from three to ten years. Clinical protocols are not expected to provide economic benefit until they are introduced to the marketplace or licensed to an independent entity. Each period the Company evaluates the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining periods of amortization.
</FONT>
</P>
<P ID=PARA6714 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA6715 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For goodwill and indefinite-lived intangible assets (clinical protocols), the carrying amounts are periodically reviewed for impairment (at least annually) and whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. According to
<I>
	ASC 350, Intangibles-Goodwill and Other
</I>
	, the Company can opt to perform a qualitative assessment or a quantitative assessment; however, if the qualitative assessment determines that it is more likely than not (i.e., a likelihood of more than 50 percent) the fair value is less than the carrying amount, a quantitative assessment must be performed. If the quantitative assessment determines that the fair value is less than the carrying amount, an impairment loss equal to the difference would be recorded.
</FONT>
</P>
<P ID=PARA6716 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6717 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company performed a quantitative assessment as of April 1, 2016 and computed a fair value based on a combination of the income approach and market approach, which determined that the fair value exceeded the carrying amount. Accordingly, there was no impairment of goodwill or the indefinite-lived intangible assets.
</FONT>
</P>
<P ID=PARA6718 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6719 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For the definite-lived intangible assets, there were no facts or changes in circumstances that indicated the carrying value may not be recoverable. As such, no assessment was required and there was no impairment of these assets.
</FONT>
</P>
<P ID=PARA6720 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	&nbsp;
</B>
</I>
</FONT>
</P>
<P ID=PARA6721 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Fair Value of Financial Instruments
</B>
</I>
</FONT>
</P>
<P ID=PARA6722 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In accordance with ASC 820,
<I>
	Fair Value Measurements and Disclosures
</I>
	, fair value is defined as the exit price, or the amount that would be received for the sale of an as
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	set or paid to transfer a liability in an orderly transaction between market participants as of the measurement date.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
</FONT>
<P ID=PARA4844 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the factors that market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:
</FONT>
</P>
<P ID=PARA4845 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 1: Quoted market prices in active markets for identical assets or liabilities.
</FONT>
</P>
<P ID=PARA4846 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 81PT; LINE-HEIGHT: 1.25; TEXT-INDENT: -45PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 2: Other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
</FONT>
</P>
<P ID=PARA4847 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.
</FONT>
</P>
<P ID=PARA6459.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6459 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6459 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6459 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	47
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage48"></A>
<A ID=TOCLINK6459 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6459 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6459.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA4851 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4852 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4853 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4854 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4855 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4856 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4857 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Fair Value of Financial Instruments
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA4858 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The carrying values of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their short duration. The fair value of the Company&#8217;s derivative obligation liability is classified as Level 3 within the fair value hierarchy since the valuation model of the derivative obligation is based on unobservable inputs.
</FONT>
</P>
<P ID=PARA4859 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4860 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Accounts Receivable and Allowance for Doubtful Accounts
</I>
</B>
</FONT>
</P>
<P ID=PARA4861 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company&#8217;s receivables are recorded when billed and represent claims against third parties that will be settled in cash. The carrying value of the Company&#8217;s receivables, net of the allowance for doubtful accounts, represents their estimated net realizable value. The Company estimates the allowance for doubtful accounts based on historical collection trends, age of outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that a specific receivable balance may be impaired, further consideration is given to the collectability of those balances and the allowance is adjusted accordingly. A customer&#8217;s receivable balance is considered past-due based on its contractual terms. Past-due receivable balances are written-off when the Company&#8217;s internal collection efforts have been unsuccessful in collecting the amount due.
</FONT>
</P>
<P ID=PARA4862 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4863 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Inventories
</I>
</B>
</FONT>
</P>
<P ID=PARA4864 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined on the first-in, first-out basis. The Company writes-down to its estimated net realizable value when conditions indicate that the selling price could be less than cost due to physical deterioration, obsolescence, changes
<FONT STYLE="TEXT-TRANSFORM: UPPERCASE">
<B>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	in price levels, or other causes, which it includes as a component of cost of revenues. Additionally, the Company provides valuation allowances for excess and slow-moving inventory on hand that are not expected to be sold to reduce the carrying amount of slow-moving inventory to its estimated net realizable value. The valuation allowances are based upon estimates about future demand from its customers and distributors and market conditions. Because some of the Company&#8217;s products are highly dependent on government and third-party funding, current customer use and validation, and completion of regulatory and field trials, there is a risk that the Company will forecast incorrectly and purchase or produce excess inventories. As a result, actual demand may differ from forecasts and the Company may be required to record additional inventory valuation allowances that could adversely impact its gross margins. Conversely, favorable changes in demand could result in higher gross margins when those products are sold.
</FONT>
</FONT>
</P>
<P ID=PARA4865 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4866 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Equipment
</I>
</B>
</FONT>
</P>
<P ID=PARA4867 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equipment consisting of office furniture, computer, machinery and equipment is recorded at cost. Repairs and maintenance costs are expensed as incurred. Depreciation for office furniture, computer, machinery and equipment is computed under the straight-line method over the estimated useful lives. Leasehold improvements are amortized under the straight line method over their estimated useful lives or the remaining lease period, whichever is shorter.
</FONT>
</P>
<P ID=PARA4868.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4868 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4868 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4868 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	48
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage49"></A>
<A ID=TOCLINK4868 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4868 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4868.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4869 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4870 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4871 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4872 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4873 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4874 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4875 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Warranty
</I>
</B>
</FONT>
</P>
<P ID=PARA4876 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company provides for the estimated cost of product warranties at the time revenue is recognized. The Company&#8217;s warranty obligation is calculated based on estimated product failure rates, material usage and estimated service delivery costs incurred in correcting a product failure.
</FONT>
</P>
<P ID=PARA4877 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4878 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Debt Issue Costs
</I>
</B>
</FONT>
</P>
<P ID=PARA4879 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company amortizes debt issue costs to interest expense over the life of the associated debt instrument, using the straight-line method which approximates the interest rate method.
</FONT>
</P>
<P ID=PARA4880 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4881 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Debt
</I>
</B>
<B>
<I>
	Discount
</I>
</B>
<B>
<I>
</I>
</B>
</FONT>
</P>
<P ID=PARA4882 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company amortizes debt discount over the life of the associated debt instrument, using the straight-line method which approximates the interest rate method. Such amortized cost is included with the other income (expense) in the accompanying consolidated statements of operations.
</FONT>
</P>
<P ID=PARA4883 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4884 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Derivative Financial Instruments
</I>
</B>
</FONT>
</P>
<P ID=PARA4885 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In connection with the sale of convertible debt and equity instruments, the Company may also issue freestanding warrants. If freestanding warrants are issued and accounted for as derivative instrument liabilities (rather than as equity), the proceeds are first allocated to the fair value of those instruments. The remaining proceeds, if any, are then allocated to the convertible instrument, usually resulting in that instrument being recorded at a discount from its face amount. Derivative financial instruments are initially measured at their fair value using a Binomial Lattice Valuation Model and then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.
</FONT>
</P>
<P ID=PARA4886 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4887 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Stock-Based Compensation
</I>
</B>
</FONT>
</P>
<P ID=PARA4888 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company has two stock-based compensation plans, which are described more fully in Note 8.
</FONT>
</P>
<P ID=PARA4889 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4890 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Valuation and Amortization Method &#8211; The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The formula does not include a discount for post-vesting restrictions, as we have not issued awards with such restrictions.&nbsp;&nbsp;&nbsp;
</FONT>
</P>
<P ID=PARA4891 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4892 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected Term &#8211; For options which the Company has limited available data, the expected term of the option is based on the simplified method. This simplified method averages an award&#8217;s vesting term and its contractual term. For all other options, the Company's expected term represents the period that the Company's stock-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior.
</FONT>
</P>
<P ID=PARA4893 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4894 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected Volatility &#8211; Expected volatility is based on historical volatility. Historical volatility is computed using daily pricing observations for recent periods that corresponded to the expected term of the options.
</FONT>
</P>
<P ID=PARA4895 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK4897 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4897 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4897 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	49
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage50"></A>
<A ID=TOCLINK4897 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4897 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4897.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4898 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4899 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4900 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4901 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4902 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4903 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4904 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Stock-Based Compensation
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA4905 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected Dividend &#8211; The Company has not declared dividends and does not anticipate declaring any dividends in the foreseeable future. Therefore, the Company uses a zero value for the expected dividend value factor to determine the fair value of options granted.
</FONT>
</P>
<P ID=PARA4906 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4907 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risk-Free Interest Rate &#8211; The Company bases the risk-free interest rate used in the valuation method on the implied yield currently available on U.S. Treasury zero-coupon issues with the same expected term.
</FONT>
</P>
<P ID=PARA4908 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4909 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Estimated Forfeitures &#8211; When estimating forfeitures, the Company considers voluntary and involuntary termination behavior as well as analysis of actual option forfeitures.
</FONT>
</P>
<P ID=PARA4910 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4911 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Research and Development
</I>
</B>
</FONT>
</P>
<P ID=PARA4912 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Research and development costs, consisting of salaries and benefits, costs of clinical trials, costs of disposables, facility costs, contracted services and stock-based compensation from the engineering, regulatory, scientific and clinical affairs departments, that are useful in developing and clinically testing new products, services, processes or techniques, as well as expenses for activities that may significantly improve existing products or processes are expensed as incurred. Costs to acquire technologies that are utilized in research and development and that have no future benefit are expensed when incurred.
</FONT>
</P>
<P ID=PARA4913 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4914 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	A
</I>
</B>
<B>
<I>
	cquired In-Process Research and Development
</I>
</B>
</FONT>
</P>
<P ID=PARA4915 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Acquired in-process research and development (&#8220;clinical protocols&#8221;) that the Company acquires through business combinations represents the fair value assigned to incomplete research projects which, at the time of acquisition, have not reached technological feasibility. The amounts are capitalized and are accounted for as indefinite-lived intangible assets, subject to impairment testing until completion or abandonment of the projects. Upon successful completion of each project, the Company will make a determination as to the then useful life of the intangible asset, generally determined by the period in which the substantial majority of the cash flows are expected to be generated, and begin amortization. The Company tests clinical protocols for impairment at least annually, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that the fair value of the clinical protocols intangible asset is less than its carrying amount. If the Company concludes it is more likely than not that the fair value is less than the carrying amount, a quantitative test that compares the fair value of the clinical protocol intangible asset with its carrying value is performed. If the fair value is less than the carrying amount, an impairment loss is recognized in operating results. The Company conducted the fiscal 2016 annual impairment assessment as of April 1, 2016. As the fair value exceeded book value, the Company concluded there was no impairment of the subject clinical protocol.
</FONT>
</P>
<P ID=PARA4916 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4917 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Patent Costs
</I>
</B>
</FONT>
</P>
<P ID=PARA4918 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The costs incurred in connection with patent applications, in defending and maintaining intellectual property rights and litigation proceedings are expensed as incurred.
</FONT>
</P>
<P ID=PARA4919.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK4919 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4919 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4919 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	50
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage51"></A>
<A ID=TOCLINK4919 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4919 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4919.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4920 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4921 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4922 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4923 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4924 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4925 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4926 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Credit Risk
</I>
</B>
</FONT>
</P>
<P ID=PARA4927 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company&#8217;s customers. The Company believes that adequate
</FONT>
</P>
<P ID=PARA4928 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has not experienced significant credit related losses.
</FONT>
</P>
<P ID=PARA4929 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4930 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Segment Reporting
</I>
</B>
</FONT>
</P>
<P ID=PARA4931 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company has one reportable business segment: the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine.
</FONT>
</P>
<P ID=PARA4932 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4933 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Income Taxes
</I>
</B>
</FONT>
</P>
<P ID=PARA4934 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The tax years 2012-2014 remain open to examination by the major taxing jurisdictions to which the Company is subject; however, there is no current examination. The Company&#8217;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, there have been no interest or penalties charged to the Company in relation to the underpayment of income taxes. There were no unrecognized tax benefits during the periods presented.
</FONT>
</P>
<P ID=PARA4935 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4936 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company&#8217;s estimates of income taxes and the significant items resulting in the recognition of deferred tax assets and liabilities reflect the Company&#8217;s assessment of future tax consequences of transactions that have been reflected in the financial statements or tax returns for each taxing jurisdiction in which the Company operates.&nbsp; The Company bases the provision for income taxes on the Company&#8217;s current period results of operations, changes in deferred income tax assets and liabilities, income tax rates, and changes in estimates of uncertain tax positions in the jurisdictions in which the Company operates.&nbsp; The Company recognizes deferred tax assets and liabilities when there are temporary differences between the financial reporting basis and tax basis of assets and liabilities and for the expected benefits of using net operating loss and tax credit loss carryforwards.&nbsp; The Company establishes valuation allowances when necessary to reduce the carrying amount of deferred income tax assets to the amounts that the Company believes are more likely than not to be realized.&nbsp;The Company evaluates the need to retain all or a portion of the valuation allowance on recorded deferred tax assets.&nbsp; When a change in the tax rate or tax law has an impact on deferred taxes, the Company applies the change based on the years in which the temporary differences are expected to reverse.&nbsp; As the Company operates in more than one state, changes in the state apportionment factors, based on operational results, may affect future effective tax rates and the value of recorded deferred tax assets and liabilities.&nbsp; The Company records a change in tax rates in the consolidated financial statements in the period of enactment.
</FONT>
</P>
<P ID=PARA4937 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4938 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Income tax consequences that arise in connection with a business combination include identifying the tax basis of assets and liabilities acquired and any contingencies associated with uncertain tax positions assumed or resulting from the business combination.&nbsp; Deferred tax assets and liabilities related to temporary differences of an acquired entity are recorded as of the date of the business combination and are based on the Company&#8217;s estimate of the appropriate tax basis that will be accepted by the various taxing authorities and its determination as to whether any of the acquired deferred tax liabilities could be a source of taxable income to realize the Company&#8217;s pre-existing deferred tax assets.
</FONT>
</P>
<P ID=PARA6460.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6460 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6460 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6460 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	51
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage52"></A>
<A ID=TOCLINK6460 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6460 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6460.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
</B>
</FONT>
	&nbsp;
</P>
<P ID=PARA4941 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4942 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4943 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4944 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4945 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4946 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4947 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Net Loss per Share
</I>
</B>
</FONT>
</P>
<P ID=PARA4948 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net loss per share is computed by dividing the net loss to common stockholders by the weighted average number of common shares outstanding. The calculation of the basic and diluted earnings per share is the same for all periods presented, as the effect of the potential common stock equivalents is anti-dilutive due to the Company&#8217;s net loss position for all periods presented. Anti-dilutive securities consisted of the following at June 30:
</FONT>
</P>
<P ID=PARA4949 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL4974 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 90%; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL4974.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4950 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA4951 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 66%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4952 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Common stock equivalents of convertible debentures
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	3,676,471
</TD>
<TD ID=TBL4974.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4974.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4955 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Vested Series A warrants
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	404,412
</TD>
<TD ID=TBL4974.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL4974.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4958 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Unvested Series A warrants
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	698,529
</TD>
<TD ID=TBL4974.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	(1)
</SUP>
</TD>
<TD ID=TBL4974.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL4974.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4962 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warrants &#8211; other
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	3,725,782
</TD>
<TD ID=TBL4974.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	252,620
</TD>
<TD ID=TBL4974.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4965 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock options
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	104,378
</TD>
<TD ID=TBL4974.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	147,609
</TD>
<TD ID=TBL4974.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA4968 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Restricted stock awards
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	63,566
</TD>
<TD ID=TBL4974.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	72,589
</TD>
<TD ID=TBL4974.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL4974.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA4971 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total
</FONT>
</P>
</TD>
<TD ID=TBL4974.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	8,673,138
</TD>
<TD ID=TBL4974.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL4974.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 14%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	472,818
</TD>
<TD ID=TBL4974.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA4975 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL6638 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 27PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6639>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(1)
</FONT>
</P>
</TD>
<TD STYLE="MARGIN-BOTTOM: 0PX; VERTICAL-ALIGN: TOP; MARGIN-TOP: 0PX">
<P ID=PARA6640 STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The unvested Series A warrants were subject to vesting based upon the amount of funds actually received by the Company in the second close of the August 2015 financing which never occurred. The warrants will remain outstanding but unvested until they expire in February 2021.
</FONT>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA4980 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4981 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Reclassification
</I>
</B>
</FONT>
</P>
<P ID=PARA4982 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certain account totals and other figures from prior year have been reclassified to conform to current period presentation.
</FONT>
</P>
<P ID=PARA4983 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4984 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Recently Adopted Accounting Pronouncements
</I>
</B>
</FONT>
</P>
<P ID=PARA4985 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (&#8220;ASU&#8221;) 2015-03, "
<I>
	Interest -Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs
</I>
	." ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability, consistent with debt discounts, instead of being presented as an asset. ASU 2015-03 is effective for the Company on January 1, 2016 and early adoption is permitted. The Company has decided to early adopt this standard. As a result, the debt issue costs of $160 at June 30, 2016 is a reduction to convertible debentures in the consolidated balance sheets. There were no corresponding debt issue costs in prior years.
</FONT>
</P>
<P ID=PARA4986 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4987 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In August 2014, the FASB issued ASU 2014-15, &#8220;
<I>
	Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern
</I>
	&#8221;. ASU 2014-15 is intended to define management&#8217;s responsibility to evaluate whether there is substantial doubt about an organization&#8217;s ability to continue as a going concern and to provide related footnote disclosures. For all entities, the ASU is effective for annual periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016. Early adoption is permitted. The Company has decided to early adopt this standard.
</FONT>
</P>
<P ID=PARA4988 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK4991 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR4991 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM4991 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	52
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage53"></A>
<A ID=TOCLINK4991 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR4991 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA4991.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA4992 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA4993 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA4994 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA4995 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA4996 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA4997 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA4998 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Recently Issued Accounting Pronouncements
</I>
</B>
</FONT>
</P>
<P ID=PARA4999 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In August 2016, the FASB issued ASU 2016-15, &#8220;
<I>
	Classification of Certain Cash Receipts and Cash Payment
</I>
<I>
	s&#8221;
</I>
	, seeking to eliminate diversity in practice related to how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments in ASU 2016-15 address eight specific cash flow issues and apply to all entities that are required to present a statement of cash flows under FASB
<I>
	Accounting Standards Codification
</I>
	(FASB ASC) 230, &#8220;
<I>
	Statement of Cash Flows
</I>
<I>
	&#8221;
</I>
<I>
	.
</I>
	The amendments in ASU 2016-15 are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years.&nbsp; Early adoption is permitted, including adoption in an interim period.
</FONT>
</P>
<P ID=PARA5000 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5001 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In May 2016, the FASB issued ASU 2016-12,
<I>
	&#8220;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients&#8221;.
</I>
<I>
</I>
	ASU 2016-12 is intended to clarify certain provisions in ASU 2014-09 &#8220;
<I>
	Revenue from Contracts with Customers
</I>
<I>
	(Topic 606)
</I>
	&#8221;. ASUC 2016-12 is effective for annual periods beginning after December 15, 2017 and interim periods within those annual periods. The Company has not yet determined the effect that ASU 2016-12 will have on its results of operations, statement of financial position or financial statement disclosures.
</FONT>
</P>
<P ID=PARA5002 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5003 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In March 2016, the FASB issued ASU 2016-09, &#8220;
<I>
	Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#8221;.
</I>
	ASU 2016-09 simplifies several aspects of the accounting for share-based payment award transactions, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016 and interim periods within those annual periods. Early adoption is permitted. The Company has not yet determined the effect that ASU 2016-09 will have on its results of operations, statement of financial position or financial statement disclosures.
</FONT>
</P>
<P ID=PARA5004 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5005 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In February 2016, the FASB issued ASU 2016-02,
<I>
	&#8220;Leases (Topic 842)&#8221;
</I>
	. ASU 2016-02 requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods therein. The Company has not yet determined the effect that ASU 2016-02 will have on its results of operations, statement of financial position or financial statement disclosures.
</FONT>
</P>
<P ID=PARA5006.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK5006 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5006 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5006 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	53
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage54"></A>
<A ID=TOCLINK5006 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5006 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5006.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5007 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5008 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5009 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5010 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5011 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5012 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5013 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Recently Issued Accounting Pronouncements (Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5014 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In January 2016, the FASB issued Accounting Standards Update (ASU) 2016-01, "
<I>
	Recognition and Measurement of Financial Assets and Liabilities
</I>
	." ASU 2016-01 requires equity investments (excluding equity method investments and investments that are consolidated) to be measured at fair value with changes in fair value recognized in net income. Equity investments that do not have a readily determinable fair value may be measured at cost, adjusted for impairment and observable price changes. The ASU also simplifies the impairment assessment of equity investments, eliminates the disclosure of the assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at cost on the balance sheet and requires the exit price to be used when measuring fair value of financial instruments for disclosure purposes. Under ASU 2016-01, changes in fair value (resulting from instrument-specific credit risk) will be presented separately in other comprehensive income for liabilities measured using the fair value option and financial assets and liabilities will be presented separately by measurement category and type either on the balance sheet or in the financial statement disclosures. ASU 2016-01 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The Company has not yet determined the effect that ASU 2016-01 will have on its results of operations, statement of financial position or financial statement disclosures.
</FONT>
</P>
<P ID=PARA5016 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5015 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In November 2015, the FASB issued ASU 2015-17, "
<I>
	Income Taxes - Balance Sheet Classification of Deferred Taxes
</I>
	." ASU 2015-17 requires companies to present deferred tax assets and deferred tax liabilities as noncurrent in the statement of financial position. ASU 2015-17 is effective for financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted at the beginning of an interim or annual reporting period. The Company has not yet determined the effect that ASU 2015-17 will have on its statement of financial position or financial statement disclosures.
</FONT>
</P>
<P ID=PARA5017 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5018 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In July 2015, the FASB issued ASU No. 2015-11, &#8220;
<I>
	Inventory: Simplifying the Measurement of Inventory
</I>
	&#8221;, that requires inventory not measured using either the last in, first out (LIFO) or the retail inventory method to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. The new standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, and will be applied prospectively. Early adoption is permitted. The Company is evaluating the impact that this standard will have on its consolidated financial statements.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<P ID=PARA6653 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In June 2014, FASB issued ASU No. 2014-12, &#8220;
<I>
	Compensation - Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period
</I>
	&#8221;. The amendments in&nbsp;ASU 2014-12 apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. For all entities, the amendments in ASU 2014-12 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted.
</FONT>
</P>
<P ID=PARA5019 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK6461 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6461 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6461 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	54
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage55"></A>
<A ID=TOCLINK6461 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6461 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5022 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5023 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	C
</B>
<B>
	esca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5024 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5025 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5026 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<TABLE ID=MTAB5028 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT; VERTICAL-ALIGN: TOP">
<P ID=PARA5029 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	2.
</B>
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA5030 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	Summary of Significant Accounting Policies (Continued)
</U>
</B>
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA5031 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5032 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Recently Issued Accounting Pronouncements (Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5033 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Entities may apply the amendments in ASU 2014-12 (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. If retrospective transition is adopted, the cumulative effect of applying ASU 2014-12 as of the beginning of the earliest annual period presented in the financial statements should be recognized as an adjustment to the opening retained earnings balance at that date. Additionally, if retrospective transition is adopted, an entity may use hindsight in measuring and recognizing the compensation cost. The Company is currently reviewing the provisions of ASU 2014-12 to determine if there will be any impact on its results of operations, cash flows or financial condition.&nbsp;
</FONT>
</P>
<P ID=PARA5034 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5035 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In May 2014, the FASB issued ASU 2014-09, &#8220;
<I>
	Revenue from Contracts with Customers
</I>
<I>
	(Topic 606)
</I>
	&#8221; which provides comprehensive guidance for revenue recognition. ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. The core principle of the guidance provides that a company should recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, using either a full retrospective or modified retrospective method of adoption. The Company is currently evaluating the transition method it will adopt and the impact of the adoption of ASU 2014-09 on its consolidated financial statements.
</FONT>
</P>
<P ID=PARA5036.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5036.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5036 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5036 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5036 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	55
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage56"></A>
<A ID=TOCLINK5036 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5036 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5036.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
</B>
</FONT>
	&nbsp;
</P>
<P ID=PARA5038 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5039 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5040 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5041 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5042 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5043 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5043 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Intangible Assets
</U>
</B>
</FONT>
</P>
<P ID=PARA5044 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5045 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Intangible assets consist of the following based on the Company&#8217;s determination of the fair value of identifiable assets acquired:
</FONT>
</P>
<P ID=PARA5046 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 18PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5091 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5091.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=14>
<P ID=PARA5047 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5048 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Period
<BR>
	(in Years)
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5049 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Carrying
</FONT>
</P>
<P ID=PARA5050 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amount
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5051 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accumulated
</FONT>
</P>
<P ID=PARA5052 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.2.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.2.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5053 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.2.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 52%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5054 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Trade names
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7
</TD>
<TD ID=TBL5091.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5091.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	29
</TD>
<TD ID=TBL5091.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5091.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	10
</TD>
<TD ID=TBL5091.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5091.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	19
</TD>
<TD ID=TBL5091.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5059 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Licenses
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	7
</TD>
<TD ID=TBL5091.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	462
</TD>
<TD ID=TBL5091.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	157
</TD>
<TD ID=TBL5091.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	305
</TD>
<TD ID=TBL5091.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5064 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Customer relationships
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	3
</TD>
<TD ID=TBL5091.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	424
</TD>
<TD ID=TBL5091.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	335
</TD>
<TD ID=TBL5091.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	89
</TD>
<TD ID=TBL5091.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5069 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Device registration
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	7
</TD>
<TD ID=TBL5091.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	86
</TD>
<TD ID=TBL5091.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	49
</TD>
<TD ID=TBL5091.FINROW.6.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	37
</TD>
<TD ID=TBL5091.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5074 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Covenants not to compete
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5
</TD>
<TD ID=TBL5091.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	955
</TD>
<TD ID=TBL5091.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	454
</TD>
<TD ID=TBL5091.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	501
</TD>
<TD ID=TBL5091.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5079 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortizable intangible assets
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.8.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,956
</TD>
<TD ID=TBL5091.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,005
</TD>
<TD ID=TBL5091.FINROW.8.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.8.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	951
</TD>
<TD ID=TBL5091.FINROW.8.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.9 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5083 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Clinical protocols
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.9.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	19,870
</TD>
<TD ID=TBL5091.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5091.FINROW.9.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.9.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	19,870
</TD>
<TD ID=TBL5091.FINROW.9.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5091.FINROW.10 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5087 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total
</FONT>
</P>
</TD>
<TD ID=TBL5091.FINROW.10.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 3PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5091.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	21,826
</TD>
<TD ID=TBL5091.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5091.FINROW.10.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,005
</TD>
<TD ID=TBL5091.FINROW.10.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5091.FINROW.10.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5091.FINROW.10.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	20,821
</TD>
<TD ID=TBL5091.FINROW.10.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5092 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5137 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5137.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=14>
<P ID=PARA5093 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5094 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted Average Amortization Period
<BR>
	(in Years)
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5095 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Gross Carrying
</FONT>
</P>
<P ID=PARA5096 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amount
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5097 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Accumulated
</FONT>
</P>
<P ID=PARA5098 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortization
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.2.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.2.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5099 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.2.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 52%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5100 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Trade names
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7
</TD>
<TD ID=TBL5137.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5137.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	30
</TD>
<TD ID=TBL5137.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5137.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6
</TD>
<TD ID=TBL5137.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5137.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	24
</TD>
<TD ID=TBL5137.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5105 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Licenses
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	7
</TD>
<TD ID=TBL5137.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	490
</TD>
<TD ID=TBL5137.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	96
</TD>
<TD ID=TBL5137.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	394
</TD>
<TD ID=TBL5137.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5110 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Customer relationships
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	3
</TD>
<TD ID=TBL5137.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	449
</TD>
<TD ID=TBL5137.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	206
</TD>
<TD ID=TBL5137.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	243
</TD>
<TD ID=TBL5137.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5115 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Device registration
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	7
</TD>
<TD ID=TBL5137.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	92
</TD>
<TD ID=TBL5137.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	20
</TD>
<TD ID=TBL5137.FINROW.6.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	72
</TD>
<TD ID=TBL5137.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5120 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Covenants not to compete
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5
</TD>
<TD ID=TBL5137.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	955
</TD>
<TD ID=TBL5137.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	263
</TD>
<TD ID=TBL5137.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	692
</TD>
<TD ID=TBL5137.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5125 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amortizable intangible assets
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.8.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,016
</TD>
<TD ID=TBL5137.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	591
</TD>
<TD ID=TBL5137.FINROW.8.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.8.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,425
</TD>
<TD ID=TBL5137.FINROW.8.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.9 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5129 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Clinical protocols
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.9.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	19,870
</TD>
<TD ID=TBL5137.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5137.FINROW.9.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.9.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	19,870
</TD>
<TD ID=TBL5137.FINROW.9.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5137.FINROW.10 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5133 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total
</FONT>
</P>
</TD>
<TD ID=TBL5137.FINROW.10.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5137.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	21,886
</TD>
<TD ID=TBL5137.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5137.FINROW.10.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	591
</TD>
<TD ID=TBL5137.FINROW.10.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5137.FINROW.10.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5137.FINROW.10.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	21,295
</TD>
<TD ID=TBL5137.FINROW.10.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5138 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5139 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5139 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5139 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	56
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage57"></A>
<A ID=TOCLINK5139 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5139 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5139.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5140 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5141 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5142 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5143 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5144 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Intangible Assets (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5145 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5146 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The change in the gross carrying amount is due to foreign currency exchange fluctuations. Amortization of intangible assets was $438 and $458 for the years ended June 30, 2016 and 2015. Clinical protocols have not yet been introduced to the market place and are therefore not yet subject to amortization. The Company&#8217;s estimated future amortization expense for subsequent years are as follows:
</FONT>
</P>
<P ID=PARA5147 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5161 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5161.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 81%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5148 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Year Ended June 30,
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.1.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.1.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.1.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: LEFT">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.1.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.2>
<TD>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.2.LEAD.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.2.SYMB.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.2.AMT.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.2.TRAIL.B2>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.3>
<TD>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.3.LEAD.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.3.SYMB.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.3.AMT.B2>
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.3.TRAIL.B2>
	&nbsp;
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR ID=TBL5161.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<P ID=PARA5149 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2017
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5161.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	358
</TD>
<TD ID=TBL5161.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5151 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2018
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	269
</TD>
<TD ID=TBL5161.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5153 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2019
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	197
</TD>
<TD ID=TBL5161.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5155 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2020
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	78
</TD>
<TD ID=TBL5161.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5157 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2021
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	49
</TD>
<TD ID=TBL5161.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5161.FINROW.9 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5159 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total
</FONT>
</P>
</TD>
<TD ID=TBL5161.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5161.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5161.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	951
</TD>
<TD ID=TBL5161.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<P ID=PARA5162 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5162 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA5163 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5163 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Equipment
</U>
</B>
</FONT>
</P>
<P ID=PARA5164 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5165 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Equipment consisted of the following at June 30:
</FONT>
</P>
<P ID=PARA5166 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5193 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5167 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5168 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.1.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=4>
<P ID=PARA5169 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Estimated Useful Life
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	(in years)
</P>
</TD>
<TD ID=TBL5193.FINROW.1.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5170 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Machinery and equipment
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5193.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6,604
</TD>
<TD ID=TBL5193.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5193.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5,895
</TD>
<TD ID=TBL5193.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.2.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2.5
</TD>
<TD ID=TBL5193.FINROW.2.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	-
</TD>
<TD ID=TBL5193.FINROW.2.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	10
</TD>
<TD ID=TBL5193.FINROW.2.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5174 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Computer and software
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	397
</TD>
<TD ID=TBL5193.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	897
</TD>
<TD ID=TBL5193.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2
</TD>
<TD ID=TBL5193.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	-
</TD>
<TD ID=TBL5193.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	5
</TD>
<TD ID=TBL5193.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5178 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Office equipment
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	260
</TD>
<TD ID=TBL5193.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	741
</TD>
<TD ID=TBL5193.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5
</TD>
<TD ID=TBL5193.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	-
</TD>
<TD ID=TBL5193.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	10
</TD>
<TD ID=TBL5193.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 18PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5182 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Leasehold improvements
</FONT>
</P>
</TD>
<TD ID=TBL5193.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	149
</TD>
<TD ID=TBL5193.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	339
</TD>
<TD ID=TBL5193.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.5.AMT.B4 STYLE="MARGIN-BOTTOM: 0PX; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; MARGIN-TOP: 0PX; BACKGROUND-COLOR: #FFFFFF" COLSPAN=3>
	Shorter of 5 years or remaining lease term
</TD>
<TD ID=TBL5193.FINROW.5.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7,410
</TD>
<TD ID=TBL5193.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7,872
</TD>
<TD ID=TBL5193.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.6.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	Less accumulated depreciation and amortization
</TD>
<TD ID=TBL5193.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(4,448
</TD>
<TD ID=TBL5193.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5193.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(4,935
</TD>
<TD ID=TBL5193.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5193.FINROW.7.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.7.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 55%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5193.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,962
</TD>
<TD ID=TBL5193.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5193.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 12%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,937
</TD>
<TD ID=TBL5193.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 4%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5193.FINROW.8.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5194 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5195 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Depreciation and amortization expense for the years ended June 30, 2016 and 2015 was $630 and $850, respectively.
</FONT>
</P>
<P ID=PARA5196 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
</DIV>
<P ID=PARA5196 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<P ID=PARA5197 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5198 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5198 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Convertible Debentures
</U>
</B>
</FONT>
</P>
<P ID=PARA5199 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5200 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Convertible debentures consist of the following as of June 30, 2016:
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5209 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 72PT; MARGIN-RIGHT: 20%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5209.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5201 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Convertible debentures
</FONT>
</P>
</TD>
<TD ID=TBL5209.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5209.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	12,500
</TD>
<TD ID=TBL5209.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5209.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5203 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Unamortized debt discount
</FONT>
</P>
</TD>
<TD ID=TBL5209.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(9,851
</TD>
<TD ID=TBL5209.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5209.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5205 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Unamortized debt issue costs
</FONT>
</P>
</TD>
<TD ID=TBL5209.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(160
</TD>
<TD ID=TBL5209.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5209.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5207 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Convertible debentures, net
</FONT>
</P>
</TD>
<TD ID=TBL5209.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5209.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5209.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,489
</TD>
<TD ID=TBL5209.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5210 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK6462 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6462 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6462 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	57
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage58"></A>
<A ID=TOCLINK6462 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6462 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6462.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
</I>
</B>
</FONT>
	&nbsp;
</P>
<P ID=PARA5215 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5216 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5217 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5218 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5219 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Convertible Debentures
</U>
</B>
<B>
<U>
	(Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5220 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5221 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	February 2016
</I>
</B>
<B>
<I>
	Financing Transaction
</I>
</B>
</FONT>
</P>
<P ID=PARA5222 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In February 2016 in exchange for aggregate proceeds of $15 million, the Company sold and issued to Boyalife Investment Inc. and Boyalife (Hong Kong Limited) (i) 735,294 shares of common stock at a purchase price of $3.40 per share (the &#8220;Stock Price&#8221;) for gross proceeds of $2.5 million, (ii) Secured Convertible Debentures for $12.5 million (the &#8220;Debentures&#8221;) convertible into 3,676,471 shares of common stock and (iii) warrants to purchase 3,529,412 additional shares of common stock at an exercise price of $8.00 per share for a period of five years. The amount of warrants was based on 80% coverage of the shares issued or to be issued for the equity transaction in (i) and the debt transaction in (ii) above. The warrants are exercisable on August 13, 2016. Total issue costs of $220 were allocated proportionately between the debt and equity proceeds, $183 and $37, respectively.
</FONT>
</P>
<P ID=PARA5223 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5224 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Debentures will be due in three years or February 13, 2019 and bear simple interest at a rate per annum of 22% of the principal amount outstanding. The Debentures may not be prepaid prior to maturity without the prior consent of the investor. Additionally, the Company&#8217;s obligations under the Debentures are secured by a first priority, senior lien over all of the Company&#8217;s assets. In accordance with the terms of the nomination and voting agreement entered into in connection with the financing, Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group and Chairman of Boyalife Investment Inc. and Boyalife (Hong Kong Limited), was appointed to the Board of Directors of the Company in March 2016.
</FONT>
</P>
<P ID=PARA5225 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5226 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	All outstanding principal and accrued and unpaid interest (as well as all interest that would have accrued after the conversion and up to and including maturity in the event conversion occurs prior to maturity) under the Debentures will be convertible into the Company&#8217;s common stock at the Stock Price per share at the option of the investor at maturity or prior to maturity if (i) for 15 days upon and after the time that the Company&#8217;s cash balance and short-term investments, net of short term debt, are less than $2.1 million, (ii) the Company effects certain changes in control, or (iii) the Company&#8217;s common stock is delisted from Nasdaq&#8217;s markets. All outstanding principal and accrued and unpaid interest under the Debentures will also be convertible into shares of the Company&#8217;s common stock at the Stock Price per share at the option of the Company at any time prior to maturity, provided that (i) the 20-day simple moving average price of the Company&#8217;s common stock on the date of conversion is at least 125% of the Stock Price and (ii) the volume weighted average trading price of the Company&#8217;s common stock has been greater than the Stock Price for ten consecutive days.
</FONT>
</P>
<P ID=PARA5227 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5228 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The warrants were classified as an equity instrument. Accordingly, the Company valued the warrants using the Black-Scholes option pricing model with the following assumptions: closing stock price on the measurement date of $4.00; warrant term of five years based on contractual term of the warrant; expected volatility based on historical volatility of 91% and discount rate based on the U.S. Treasury zero-coupon issues with equivalent terms of 1.2%.
</FONT>
</P>
<P ID=PARA5229 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK5234 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5234 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5234 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	58
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage59"></A>
<A ID=TOCLINK5234 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5234 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5234.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA5236 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5237 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5238 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5239 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5240 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	5
</B>
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Convertible Debentures (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5241 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5242 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	February 2016
</I>
</B>
<B>
<I>
	Financing Transaction
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5243 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For financial reporting purposes, the net proceeds from the debt of $12,319 was allocated first to the relative fair value of the warrants, amounting to $4,434, then to the intrinsic value of the beneficial conversion feature on the Debentures of $6,824, resulting in an initial carrying value of the Debentures of $1,061. The initial debt discount on the Debentures totaled $11,258 and is being amortized over the three year life of the Debentures.
</FONT>
</P>
<P ID=PARA5244 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5245 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	During the year ended June 30, 2016, the Company amortized $1,407 of the debt discount, $23 of the debt issue costs and accrued $1,031 in interest expense.
</FONT>
</P>
<P ID=PARA5246 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5247 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In August 2016, the Company converted the Debentures to common stock. See subsequent events footnote 12.
</FONT>
</P>
<P ID=PARA5248 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5249 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Thirty-Year Debenture Restructuring Transaction&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5250 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 31, 2015, the Company sold senior secured convertible debentures in a financing to raise up to $15,000 (&#8220;Thirty-Year Debentures&#8221;), Series A warrants to purchase up to 1,102,942 shares of the Company&#8217;s common stock at an exercise price equal to $13.60 per share for a period of five and one-half years (&#8220;Series A warrants&#8221;) and Series B warrants to purchase up to 606,618 shares of the Company&#8217;s common stock at an exercise price equal to $13.60 per share for a period of eighteen months (&#8220;Series B warrants&#8221;). At the initial closing on August 31, 2015, the Company received gross proceeds of $5,500 and 404,412 Series A warrants vested and 222,427 Series B warrants vested. The second closing for up to an additional $9,500 was dependent on a number of items including receipt by the Company of approval from the California Institute for Regenerative Medicine (&#8220;CIRM&#8221;) for a grant in the amount of $10,000, to support the Company&#8217;s pivotal trial for CLIRST III. The Company applied for the CIRM grant in August 2015. The Company withdrew its application for the CIRM grant.
</FONT>
</P>
<P ID=PARA5251 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5252 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For financial reporting purposes, the net proceeds of $4,720 was allocated first to the residual fair value of the Series A warrants, amounting to $3,385, then to the residual fair value of the obligation to issue the Series B warrants of $897, the remaining value to the intrinsic value of the beneficial conversion feature on the Thirty-Year Debentures of $438, resulting in an initial carrying value of the Thirty-Year Debentures of $0. The initial debt discount on the Thirty-Year Debentures totaled $4,720 and was amortized over the 30 year life of the convertible debentures.
</FONT>
</P>
<P ID=PARA5253 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5254 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company entered into a registration rights agreement pursuant to which the Company agreed to register all of the shares of common stock then issued and issuable upon conversion in full of the Thirty-Year Debentures and all warrant shares issuable upon exercise of the Series A warrants and Series B warrants. The holders were entitled to receive liquidated damages upon the occurrence of a number of events relating to filing, getting an effective and maintaining an effective registration statement, including the failure of the Company to have such registration statement declared effective by October 26, 2015. As the Company did not file an effective registration statement until November 24, 2015 and the Company was precluded by the SEC from registering all of the registrable securities on a single registration statement, management considered it probable that five months of liquidated damages would be due and accrued $1,100 during the year ended June 30, 2016. Management made one liquidated damages payment of $220 during the three months ended December 31, 2015.
</FONT>
</P>
<P ID=PARA6463.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6463 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6463 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6463 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	59
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage60"></A>
<A ID=TOCLINK6463 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6463 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6463.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5257 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5258 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5259 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5260 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5261 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Convertible Debentures (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5262 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5263 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 7.7PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Thirty-Year Debenture Restructuring Transaction&nbsp;
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5264 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In connection with the February 2016 financing transaction described above, the Company concurrently entered into a Consent, Repayment and Release Agreement, pursuant to which the Company repaid the Thirty-Year Debentures and all related interest and liquidated damages. Upon the Company&#8217;s payment of $7.5 million, the Thirty-Year Debentures were deemed repaid in full and cancelled, all liquidated damages due and payable were deemed paid and satisfied in full, the registration rights agreement was terminated and the exercise price of the Series A warrants was changed from $13.60 to $8.00. The Company recomputed the fair value of the Series A warrants before and after the modification using the Binomial option pricing model with the following assumptions: expected volatility of 91%, discount rate of 1.2%, contractual term of 5 years and dividend rate of 0%. The loss on modification of $149 was recorded in the accompanying consolidated statements of operations and comprehensive loss.
</FONT>
</P>
<P ID=PARA5265 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5266 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Pursuant to the terms of the Consent Repayment and Release Agreement, the holders of the Series B warrants made a single, one-time cashless exercise of Series B warrants for 125,000 shares of common stock. The Company recomputed the fair value of the Series B warrants using the Binomial option pricing model with the assumptions listed in Note 6 for February 16, 2016. All remaining Series B warrants valued at $159 were cancelled.
</FONT>
</P>
<P ID=PARA5267 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5268 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	This restructuring transaction occurred on February 16, 2016 and the Company recorded a loss on extinguishment of debt of $795 during the year ended June 30, 2016. The loss on extinguishment was calculated as follows:
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<P ID=PARA5269 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5282 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5282.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5270 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Payment
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5282.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7,500
</TD>
<TD ID=TBL5282.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5282.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5272 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Repayment of Thirty-Year debentures
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(5,500
</TD>
<TD ID=TBL5282.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5282.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5274 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Payment of accrued liquidated damages and interest
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(897
</TD>
<TD ID=TBL5282.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5282.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5276 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on modification of Series A warrants
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(149
</TD>
<TD ID=TBL5282.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5282.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5278 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cancellation of Series B derivative obligation
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(159
</TD>
<TD ID=TBL5282.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5282.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5280 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss on extinguishment of debt
</FONT>
</P>
</TD>
<TD ID=TBL5282.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5282.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5282.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	795
</TD>
<TD ID=TBL5282.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5284 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5285 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At the time of the repayment, the remaining debt discount of $4,648 and debt issue costs of $765 were fully amortized. For the year ended June 30, 2016, the Company amortized $4,720 of debt discount and $777 of debt issue costs.
</FONT>
</P>
<P ID=PARA5286 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5287 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Beneficial Conversion Features
</I>
</B>
</FONT>
</P>
<P ID=PARA5288 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The beneficial conversion feature value was calculated as the difference resulting from subtracting the effective conversion price from the market price of the common stock on the issuance date, multiplied by the number of common shares into which the initial funding of the Debentures or Thirty-Year Debentures are convertible. The Company believes that the investor&#8217;s ability to resell the common shares resulting from the conversion option is severely limited. As such, the Company did not consider the beneficial conversion feature to be an embedded derivative.
</FONT>
</P>
<P ID=PARA5289.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5289.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5289 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5289 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5289 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	60
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage61"></A>
<A ID=TOCLINK5289 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5289 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5289.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5290 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5291 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5292 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5293 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5294 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5294 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Derivative Obligations
</U>
</B>
</FONT>
</P>
<P ID=PARA5295 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5296 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Series A and Series B Warrants
</I>
</B>
</FONT>
</P>
<P ID=PARA5297 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Series A warrants and Series B warrants to purchase 404,412 and 222,427 common shares, respectively, were issued and vested during the year ended June 30, 2016 (see Note 5). At the time of issuance, the Company determined that as such warrants can be settled for cash at the holders&#8217; option in a future fundamental transaction they constituted a derivative liability. The Company estimated the fair value of the derivative liability aggregating approximately $4,282, using a Binomial Lattice Valuation Model and the following assumptions:
</FONT>
</P>
<P ID=PARA5298 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5336 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5336.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5299 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Series A
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5300 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Series B
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5336.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5301 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	August 31,
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5302 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30,
</FONT>
</P>
<P ID=PARA5303 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5304 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	August 31,
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.2.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.2.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5305 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	February 16,
<BR>
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.2.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5336.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 52%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5306 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Market price of common stock
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5336.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	13.60
</TD>
<TD ID=TBL5336.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5336.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2.93
</TD>
<TD ID=TBL5336.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5336.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	13.60
</TD>
<TD ID=TBL5336.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5336.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	4.00
</TD>
<TD ID=TBL5336.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5336.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5311 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected volatility
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	72
</TD>
<TD ID=TBL5336.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	99
</TD>
<TD ID=TBL5336.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	62
</TD>
<TD ID=TBL5336.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	137
</TD>
<TD ID=TBL5336.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
</TR>
<TR ID=TBL5336.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5316 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Contractual term (years)
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5.5
</TD>
<TD ID=TBL5336.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	4.7
</TD>
<TD ID=TBL5336.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1.5
</TD>
<TD ID=TBL5336.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1
</TD>
<TD ID=TBL5336.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5336.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5321 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Discount rate
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1.54
</TD>
<TD ID=TBL5336.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1.01
</TD>
<TD ID=TBL5336.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.6.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	0.57
</TD>
<TD ID=TBL5336.FINROW.6.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	0.5
</TD>
<TD ID=TBL5336.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
</TR>
<TR ID=TBL5336.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5326 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dividend rate
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	0
</TD>
<TD ID=TBL5336.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	0
</TD>
<TD ID=TBL5336.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	0
</TD>
<TD ID=TBL5336.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
<TD ID=TBL5336.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	0
</TD>
<TD ID=TBL5336.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
</TR>
<TR ID=TBL5336.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5331 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercise price
</FONT>
</P>
</TD>
<TD ID=TBL5336.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5336.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	13.60
</TD>
<TD ID=TBL5336.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5336.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	8.00
</TD>
<TD ID=TBL5336.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5336.FINROW.8.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	13.60
</TD>
<TD ID=TBL5336.FINROW.8.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5336.FINROW.8.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5336.FINROW.8.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	13.60
</TD>
<TD ID=TBL5336.FINROW.8.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5337 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5338 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected volatilities are based on the historical volatility of the Company&#8217;s common stock. Contractual term is based on remaining term of the respective warrants. The discount rate represents the yield on U.S. Treasury bonds with a maturity equal to the contractual term.
</FONT>
</P>
<P ID=PARA5339 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5340 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company recorded a gain of approximately $3,395 during the year ended June 30, 2016, representing the net change in the fair value of the derivative liability, which is presented as fair value change of derivative instruments, in the accompanying consolidated statements of operations and comprehensive loss.
</FONT>
</P>
<P ID=PARA5341 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5342 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On February 16, 2016, the holders of the Series B warrants exercised 26,528 warrants on a cashless basis and received 125,000 shares of common stock. These warrants had an aggregate exercise date fair value of $25. The Company recomputed the fair value of these warrants using the Binomial option pricing model with the assumptions noted above for February 16, 2016. During the year ended June 30, 2016, an additional 25,185 Series B warrants were exercised on a cashless basis and the holders of the warrants received 106,711 shares of common stock. These warrants had an aggregate exercise date fair value of $33. The Company recomputed the fair value of these warrants using the Binomial option pricing model (Level 3 inputs) using the following weighted average assumptions: expected volatility of 88%, discount rate of 0.57%, contractual term of 1.2 years and dividend rate of 0%. The Company recorded a loss on cashless exercise of warrants of $1,039 for the year ended June 30, 2016, based on the difference between the fair market value of the Company&#8217;s common stock at the time of exercise and the fair value of the warrants exercised.
</FONT>
</P>
<P ID=PARA5343 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5344 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In conjunction with the Consent, Repayment and Release Agreement, the Series A exercise price was changed from $13.60 to $8.00 and the remaining Series B warrants were cancelled (see Note 5).
</FONT>
</P>
<P ID=PARA5345 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5346 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In accordance with U.S. GAAP, the following table represents the Company&#8217;s fair value hierarchy for its financial liabilities measured at fair value on a recurring basis as of June 30, 2016:
</FONT>
</P>
<P ID=PARA6464.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6464 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6464 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6464 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	61
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage62"></A>
<A ID=TOCLINK6464 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6464 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6464.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<P ID=PARA5349 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5350 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5351 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5352 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5353 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Derivative Obligations (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5354 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 18.7PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5399 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5399.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5357 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance at
</FONT>
</P>
<P ID=PARA5358 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5399.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5361 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 1
</FONT>
</P>
</TD>
<TD ID=TBL5399.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5364 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 2
</FONT>
</P>
</TD>
<TD ID=TBL5399.FINROW.1.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5367 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Level 3
</FONT>
</P>
</TD>
<TD ID=TBL5399.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5399.FINROW.2>
<TD>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.LEAD.B2>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.SYMB.B2>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.AMT.B2>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.TRAIL.B2>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.LEAD.B3>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.SYMB.B3>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.AMT.B3>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.TRAIL.B3>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.LEAD.B4>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.SYMB.B4>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.AMT.B4>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.TRAIL.B4>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.LEAD.B5>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.SYMB.B5>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.AMT.B5>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.2.TRAIL.B5>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5399.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 52%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5386 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Derivative obligation
</FONT>
</P>
</TD>
<TD ID=TBL5399.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5399.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	670
</TD>
<TD ID=TBL5399.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5399.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	-
</TD>
<TD ID=TBL5399.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5399.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	-
</TD>
<TD ID=TBL5399.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5399.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5399.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	670
</TD>
<TD ID=TBL5399.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5400 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 18.7PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5401 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following table reflects the change in fair value of the Company&#8217;s derivative liabilities for the year ended June 30, 2016:
</FONT>
</P>
<P ID=PARA5402 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 18.7PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5429 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5429.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5405 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amount
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5429.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 84%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5407 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance &#8211; July 1, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5429.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5429.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5429.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5411 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Addition of derivative obligation at fair value on date of issuance
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4,282
</TD>
<TD ID=TBL5429.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5429.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5416 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Reclassification of derivative obligation for exercised warrants
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(58
</TD>
<TD ID=TBL5429.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5429.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5418 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Extinguishment of derivative obligation
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(159
</TD>
<TD ID=TBL5429.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5429.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5420 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Change in fair value of derivative obligation
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(3,395
</TD>
<TD ID=TBL5429.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5429.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5425 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance &#8211; June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5429.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5429.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5429.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	670
</TD>
<TD ID=TBL5429.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5430 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5430 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA5431 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5431 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Commitments and Contingencies
</U>
</B>
</FONT>
</P>
<P ID=PARA5432 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5433 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Operating Leases
</I>
</B>
</FONT>
</P>
<P ID=PARA5434 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company leases the Rancho Cordova, Emeryville and Gurgaon, India facilities pursuant to operating leases, which contain scheduled rent increases. The leases expire in May 2019, September 2016 and March 2018, respectively. The Company recognizes rent expense on a straight-line basis over the term of the facility lease. The annual future minimum lease payments for the Company&#8217;s non-cancelable operating leases are as follows:
</FONT>
</P>
<P ID=PARA5435 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5444 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5444.FINROW.1 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 81%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5436 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2017
</FONT>
</P>
</TD>
<TD ID=TBL5444.FINROW.1.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.1.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.1.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	428
</TD>
<TD ID=TBL5444.FINROW.1.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5444.FINROW.2 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5438 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2018
</FONT>
</P>
</TD>
<TD ID=TBL5444.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	305
</TD>
<TD ID=TBL5444.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5444.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5440 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2019
</FONT>
</P>
</TD>
<TD ID=TBL5444.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	260
</TD>
<TD ID=TBL5444.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5444.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5442 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total
</FONT>
</P>
</TD>
<TD ID=TBL5444.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5444.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5444.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	993
</TD>
<TD ID=TBL5444.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5445 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5446 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Rent expense was $657 and $652 for the years ended June 30, 2016 and 2015, respectively.
</FONT>
</P>
<P ID=PARA5447 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5448 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Financial Covenants
</I>
</B>
</FONT>
</P>
<P ID=PARA5449 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Effective September 30, 2015, the Company entered into a Fifth Amended and Restated Technology License and Escrow Agreement with Cord Blood Registry Systems, Inc. which modified the financial covenant that the Company must meet in order to avoid an event of default: cash balance and short-term investments net of debt or borrowed funds that are payable within one year of not less than $2,000 must be maintained. The Company is in compliance with this financial covenant as of June 30, 2016.
</FONT>
</P>
<P ID=PARA5450 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5451 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Employee
</I>
</B>
<B>
<I>
	and Severance
</I>
</B>
<B>
<I>
	Agreements
</I>
</B>
</FONT>
</P>
<P ID=PARA5452 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	As of June 30, 2016, the Company had employment agreements in place with two of its key executives. The agreements provide, among other things, for the payment of twelve to twenty-four months of severance compensation for termination under certain circumstances. With respect to these agreements at June 30, 2016, potential severance amounted to $1,147.
</FONT>
</P>
<P ID=PARA6465.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6465 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6465 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6465 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	62
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage63"></A>
<A ID=TOCLINK6465 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6465 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5454 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5455 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5456 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5457 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5458 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5459 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Commitments and Contingencies (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5460 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5461 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Employee
</I>
</B>
<B>
<I>
	and Severance
</I>
</B>
<B>
<I>
	Agreements
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5462 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In September 2015, in connection with the resignation of the Company&#8217;s President, the Company and the President entered into a general release and waiver agreement in which the Company agreed to make severance payments over 18 months as long as the President actively abided by the terms of the agreement. As of June 30, 2016, approximately $265 remained to be paid out under this agreement.
</FONT>
</P>
<P ID=PARA5463 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5464 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Contingencies
</I>
</B>
</FONT>
</P>
<P ID=PARA5465 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5466 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In the normal course of operations, the Company may have disagreements or disputes with customers, employees or vendors. Such potential disputes are seen by management as a normal part of business. As of June 30, 2016, management believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company&#8217;s consolidated financial position, operating results or cash flows.
</FONT>
</P>
<P ID=PARA5467 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5468 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Warranty
</I>
</B>
</FONT>
</P>
<P ID=PARA5469 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company offers a warranty on all of the Company&#8217;s non-disposable products of one to two years. The Company warrants disposable products through their expiration date. The Company periodically assesses the adequacy of the Company&#8217;s recorded warranty liabilities and adjusts the amounts as necessary.
</FONT>
</P>
<P ID=PARA5470 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5471 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Changes in the Company&#8217;s product liability which is included in other current liabilities during the period are as follows:
</FONT>
</P>
<P ID=PARA5472 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5491 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 95%; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 5%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5491.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5473 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT 2.75PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	For years ended June 30,
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5491.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5474 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT 2.75PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5475 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT 2.75PT 0PT 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5491.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 68%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5476 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Beginning balance
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5491.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	627
</TD>
<TD ID=TBL5491.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5491.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	498
</TD>
<TD ID=TBL5491.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5491.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5479 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warranties issued during the period
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	97
</TD>
<TD ID=TBL5491.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	258
</TD>
<TD ID=TBL5491.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5491.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5482 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Settlements made during the period
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(287
</TD>
<TD ID=TBL5491.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5491.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(168
</TD>
<TD ID=TBL5491.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5491.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5485 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Changes in liability for pre-existing warranties during the period
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	129
</TD>
<TD ID=TBL5491.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	39
</TD>
<TD ID=TBL5491.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5491.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5488 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Ending balance
</FONT>
</P>
</TD>
<TD ID=TBL5491.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5491.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	566
</TD>
<TD ID=TBL5491.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5491.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5491.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 13%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	627
</TD>
<TD ID=TBL5491.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5492 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
</DIV>
<P ID=PARA5492 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5493 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5493 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5493 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	63
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage64"></A>
<A ID=TOCLINK5493 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5493 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5493.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5494 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5495 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5496 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5497 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5498 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5498 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Stockholders&#8217; Equity
</U>
</B>
</FONT>
</P>
<P ID=PARA5499 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<P ID=PARA5500 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Warrants
</I>
</B>
</FONT>
</P>
<P ID=PARA5501 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A summary of warrant activity is as follows:
</FONT>
</P>
<P ID=PARA5502 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5539 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 90%; MARGIN-LEFT: 36PT; MARGIN-RIGHT: 10%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5539.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5503 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5504 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5505 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	of Shares
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5506 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercise
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Price Per
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Share
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5507 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	of Shares
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.2.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.2.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5508 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercise
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Price Per
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Share
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.2.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 44%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5509 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Beginning balance
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	252,620
</TD>
<TD ID=TBL5539.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5539.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	44.18
</TD>
<TD ID=TBL5539.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	255,671
</TD>
<TD ID=TBL5539.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5539.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	44.18
</TD>
<TD ID=TBL5539.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5514 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warrants granted
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	5,238,971
</TD>
<TD ID=TBL5539.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5539.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	9.83
</TD>
<TD ID=TBL5539.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5539.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5539.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5519 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warrants exercised (cashless)
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(51,712
</TD>
<TD ID=TBL5539.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5539.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5539.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	13.60
</TD>
<TD ID=TBL5539.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5539.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5539.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5524 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Warrants expired/canceled
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(611,156
</TD>
<TD ID=TBL5539.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5539.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5539.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	17.21
</TD>
<TD ID=TBL5539.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(3,051
</TD>
<TD ID=TBL5539.FINROW.6.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5539.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5539.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	43.00
</TD>
<TD ID=TBL5539.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5529 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	4,828,723
</TD>
<TD ID=TBL5539.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5539.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	9.37
</TD>
<TD ID=TBL5539.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	252,620
</TD>
<TD ID=TBL5539.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5539.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	44.18
</TD>
<TD ID=TBL5539.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5539.FINROW.8 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5534 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercisable at June 30
</FONT>
</P>
</TD>
<TD ID=TBL5539.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	600,782
</TD>
<TD ID=TBL5539.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5539.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	19.02
</TD>
<TD ID=TBL5539.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	252,620
</TD>
<TD ID=TBL5539.FINROW.8.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5539.FINROW.8.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5539.FINROW.8.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 11%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	44.18
</TD>
<TD ID=TBL5539.FINROW.8.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5541 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5542 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5543 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Equity Plans and Agreements
</I>
</B>
</FONT>
</P>
<P ID=PARA5544 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On July 7, 2016, the Compensation Committee of the Board of Directors adopted the 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;) under which up to 325,000 shares may be issued pursuant to grants of shares, options, or other forms of incentive compensation. The 2016 Plan remains subject to stockholder approval, which must be received by July 7, 2017.
</FONT>
</P>
<P ID=PARA5545 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5546 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The 2012 Independent Director Plan (&#8220;2012 Plan&#8221;) permits the grant of stock or options to independent directors. A total of 25,000 shares were approved by the stockholders for issuance under the 2012 Plan. Options are granted at prices that are equal to 100% of the fair market value on the date of grant, and expire over a term not to exceed ten years. Options generally vest in monthly increments over one year, unless otherwise determined by the Board of Directors. As of June 30, 2016, there were 3,209 shares available for issuance.
</FONT>
</P>
<P ID=PARA5547 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5548 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The 2006 Equity Incentive Plan (&#8220;2006 Plan&#8221;) permits the grant of options, restricted stock, stock bonuses and stock appreciation rights to employees, directors and consultants. Under the 2006 Plan, the number of shares of common stock equal to 6% of the number of outstanding shares of the Company, are authorized to be issued. The number of shares available to grant for awards adjusts at the beginning of each fiscal year if additional options to purchase shares of common stock were issued in the preceding fiscal year. As of June 30, 2016, there have been 392,320 shares approved under the 2006 Plan for issuance and 177,189 available for issuance.
</FONT>
</P>
<P ID=PARA5549.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK5549 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5549 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5549 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	64
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage65"></A>
<A ID=TOCLINK5549 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5549 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5549.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5550 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5551 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5552 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5553 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5554 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Stockholders&#8217; Equity (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5555 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA6659 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On July 7, 2016, the Compensation Committee also adopted a short term incentive plan under which cash awards and shares of common stock may be granted to employees of the Company (the &#8220;Short Term Plan&#8221;). The aggregate amount of the cash awards issuable pursuant to the Short Term Plan is approximately $276. Up to 104,000 shares of common stock from the Company&#8217;s 2006 Plan, subject to vesting, are issuable pursuant to the Short Term Plan. On July 26, 2016, 93,002 shares and $266 of cash awards were granted under the Short Term Plan. The cash awards granted pursuant to the Short Term Plan will be payable and the shares of common stock issued pursuant to the Short Term Plan will fully vest on July 1, 2017, provided, that such award recipients are employed by the Company as of such date or immediately if terminated without cause. The named executive officers of the Company are participating in the Short Term Plan.
</FONT>
</P>
<P ID=PARA6660 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA6661 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Upon the appointment as Chief Executive Officer (CEO) in June 2015, in accordance with his employment agreement, the Company&#8217;s CEO received restricted stock units representing 50,000 shares of restricted common stock vesting in four equal installments based upon a combination of time and milestone based targets and a seven year option to acquire 50,000 shares of common stock, 25% of which vested immediately with the balance vesting in equal monthly installments during the following 24 months.
</FONT>
</P>
<P ID=PARA6662 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6663 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<I>
<B>
	Stock Options
</B>
</I>
</FONT>
</P>
<P STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Upon the separation with the Company&#8217;s former Chief Executive Officer in October 2014, in accordance with his employment agreement, all outstanding options and restricted stock awards which would have otherwise vested by July 31, 2015, immediately vested. As a result, the Company recognized $158 of stock compensation expense in general and administrative during the year ended June 30, 2015 as the vesting accelerated on 8,334 options and 3,500 restricted stock awards.
</FONT>
</P>
<P ID=PARA6665 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5600 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5600.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5565 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number of
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Shares
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5566 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercise
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Price
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5567 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Remaining
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Contractual Life
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.1.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5568 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Aggregate
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Intrinsic
</FONT>
</P>
<P ID=PARA5569 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Value
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5570 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	147,609
</TD>
<TD ID=TBL5600.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	25.51
</TD>
<TD ID=TBL5600.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.LEAD.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.SYMB.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.AMT.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.2.TRAIL.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 48%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.LEAD.B2 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.SYMB.B2 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.AMT.B2 STYLE="WIDTH: 10%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.TRAIL.B2 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.LEAD.B3 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.SYMB.B3 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.AMT.B3 STYLE="WIDTH: 10%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.TRAIL.B3 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.LEAD.B4 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.SYMB.B4 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.AMT.B4 STYLE="WIDTH: 10%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.TRAIL.B4 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.LEAD.B5 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.SYMB.B5 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.AMT.B5 STYLE="WIDTH: 10%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.3.TRAIL.B5 STYLE="WIDTH: 1%; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5573 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Granted
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	55,875
</TD>
<TD ID=TBL5600.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	9.64
</TD>
<TD ID=TBL5600.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.LEAD.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.SYMB.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.AMT.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.4.TRAIL.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5576 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Forfeited/cancelled
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(93,855
</TD>
<TD ID=TBL5600.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5600.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5600.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	27.02
</TD>
<TD ID=TBL5600.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.LEAD.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.SYMB.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.AMT.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.5.TRAIL.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5579 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expired
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(5,251
</TD>
<TD ID=TBL5600.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5600.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	41.47
</TD>
<TD ID=TBL5600.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.LEAD.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.SYMB.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.AMT.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.6.TRAIL.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5582 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercised
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5600.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 0PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5600.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 0PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.LEAD.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.SYMB.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.AMT.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.TRAIL.B4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.LEAD.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.SYMB.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.AMT.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.7.TRAIL.B5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 0PX; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5585 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	104,378
</TD>
<TD ID=TBL5600.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	14.85
</TD>
<TD ID=TBL5600.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5.8
</TD>
<TD ID=TBL5600.FINROW.8.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.8.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.8.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5600.FINROW.8.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.9 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #FFFFFF; TEXT-INDENT: -9PT">
<P ID=PARA5590 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Vested and Expected to Vest at June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	91,810
</TD>
<TD ID=TBL5600.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5600.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	15.34
</TD>
<TD ID=TBL5600.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	5.7
</TD>
<TD ID=TBL5600.FINROW.9.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.9.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5600.FINROW.9.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5600.FINROW.9.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5600.FINROW.10 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 48%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5595 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exercisable at June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5600.FINROW.10.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	61,271
</TD>
<TD ID=TBL5600.FINROW.10.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.10.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	16.15
</TD>
<TD ID=TBL5600.FINROW.10.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5.5
</TD>
<TD ID=TBL5600.FINROW.10.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5600.FINROW.10.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5600.FINROW.10.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	--
</TD>
<TD ID=TBL5600.FINROW.10.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5601 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	&nbsp;
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5602 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5602 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5602 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	65
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage66"></A>
<A ID=TOCLINK5602 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5602 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5602.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5603 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5604 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5605 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5606 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5607 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Stockholders&#8217; Equity (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5608 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<P ID=PARA5609 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Stock Options (Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5610 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company's common stock. There were no options that were exercised during the years ended June 30, 2016 and 2015.
</FONT>
</P>
<P ID=PARA5611 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5612 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-vested stock option activity for the year ended June 30, 2016, is as follows:
</FONT>
</P>
<P ID=PARA5613 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5631 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 85%; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 15%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5631.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5614 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Non-vested Stock
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Options
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5615 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Grant Date Fair Value
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5631.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 64%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5616 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	89,198
</TD>
<TD ID=TBL5631.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5631.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	13.07
</TD>
<TD ID=TBL5631.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5631.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5619 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Granted
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	55,875
</TD>
<TD ID=TBL5631.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5631.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	5.75
</TD>
<TD ID=TBL5631.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5631.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5622 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Vested
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(53,496
</TD>
<TD ID=TBL5631.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5631.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5631.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	9.79
</TD>
<TD ID=TBL5631.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5631.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5625 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Forfeited
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(48,470
</TD>
<TD ID=TBL5631.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5631.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5631.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	13.35
</TD>
<TD ID=TBL5631.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5631.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5628 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5631.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	43,107
</TD>
<TD ID=TBL5631.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5631.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5631.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	7.66
</TD>
<TD ID=TBL5631.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5632 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5633 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The fair value of the Company&#8217;s stock options granted for the years ended June 30, 2016 and 2015 was estimated using the following weighted-average assumptions:
</FONT>
</P>
<P ID=PARA5634 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5649 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 20%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5649.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5635 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5636 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5649.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 62%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5637 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected life (years)
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5
</TD>
<TD ID=TBL5649.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5
</TD>
<TD ID=TBL5649.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5649.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5640 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Risk-free interest rate
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1.5
</TD>
<TD ID=TBL5649.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5649.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1.5
</TD>
<TD ID=TBL5649.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
</TR>
<TR ID=TBL5649.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5643 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Expected volatility
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	80
</TD>
<TD ID=TBL5649.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
<TD ID=TBL5649.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	75
</TD>
<TD ID=TBL5649.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	%
</TD>
</TR>
<TR ID=TBL5649.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5646 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dividend yield
</FONT>
</P>
</TD>
<TD ID=TBL5649.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	0
</TD>
<TD ID=TBL5649.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
<TD ID=TBL5649.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5649.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	0
</TD>
<TD ID=TBL5649.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	%
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5650 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5651 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The weighted average grant date fair value of options granted during the years ended June 30, 2016 and 2015 was $5.75 and $12.40, respectively.
</FONT>
</P>
<P ID=PARA5652 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5653 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, the total compensation cost related to options granted under the Company's stock option plans but not yet recognized was $212. This cost will be amortized on a straight-line basis over a weighted-average period of approximately one and a half years and will be adjusted for subsequent changes in estimated forfeitures. The total fair value of options vested during the years ended June 30, 2016 and 2015 was $354 and $678.
</FONT>
</P>
<P ID=PARA5654 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5655 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5655 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5655 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	66
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage67"></A>
<A ID=TOCLINK5655 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5655 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5655.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5656 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5657 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5658 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5659 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5660 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Stockholders&#8217; Equity (Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5661 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	&nbsp;
</I>
</B>
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<P ID=PARA5662 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Common Stock Restricted Awards
</I>
</B>
</FONT>
</P>
<P ID=PARA5663 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following is a summary of restricted stock activity:
</FONT>
</P>
<P ID=PARA5664 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5696 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5696.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5665 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.1.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.1.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=6>
<P ID=PARA5666 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.1.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: MIDDLE; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.2>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5667 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number of
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Shares
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.2.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5668 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Grant Date
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fair Value
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.2.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.LEAD.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.AMT.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5669 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Number of
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Shares
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.2.TRAIL.D4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.LEAD.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.2.AMT.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5670 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Weighted-
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Average
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Grant Date
</FONT>
</P>
<P STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fair Value
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.2.TRAIL.D5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.3 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 52%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5671 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Balance at June 30
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	72,589
</TD>
<TD ID=TBL5696.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	22.40
</TD>
<TD ID=TBL5696.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	40,190
</TD>
<TD ID=TBL5696.FINROW.3.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.3.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.3.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	38.00
</TD>
<TD ID=TBL5696.FINROW.3.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.4 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5676 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Granted
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	10,000
</TD>
<TD ID=TBL5696.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5696.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2.98
</TD>
<TD ID=TBL5696.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	54,850
</TD>
<TD ID=TBL5696.FINROW.4.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.4.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5696.FINROW.4.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	16.60
</TD>
<TD ID=TBL5696.FINROW.4.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.5 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5681 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Vested
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(6,120
</TD>
<TD ID=TBL5696.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5696.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	28.94
</TD>
<TD ID=TBL5696.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(18,828
</TD>
<TD ID=TBL5696.FINROW.5.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5696.FINROW.5.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.5.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.5.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	36.40
</TD>
<TD ID=TBL5696.FINROW.5.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.6 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5686 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Forfeited
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(12,903
</TD>
<TD ID=TBL5696.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5696.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5696.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	41.15
</TD>
<TD ID=TBL5696.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(3,623
</TD>
<TD ID=TBL5696.FINROW.6.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5696.FINROW.6.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.6.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5696.FINROW.6.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	35.40
</TD>
<TD ID=TBL5696.FINROW.6.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5696.FINROW.7 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5691 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Outstanding at June 30
</FONT>
</P>
</TD>
<TD ID=TBL5696.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	63,566
</TD>
<TD ID=TBL5696.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	14.96
</TD>
<TD ID=TBL5696.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.LEAD.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.SYMB.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.AMT.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	72,589
</TD>
<TD ID=TBL5696.FINROW.7.TRAIL.4 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.LEAD.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5696.FINROW.7.SYMB.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5696.FINROW.7.AMT.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 9%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	22.40
</TD>
<TD ID=TBL5696.FINROW.7.TRAIL.5 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5697 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5698 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In connection with the vesting of the restricted stock awards, the election was made by some of the employees to satisfy the applicable federal income tax withholding obligation by a net share settlement, pursuant to which the Company withheld 1,300 and 6,098 shares for the years ended June 30, 2016 and 2015, respectively and used the deemed proceeds from those shares to pay the income tax withholding. The net share settlement is deemed to be a repurchase by the Company of its common stock.
</FONT>
</P>
<P ID=PARA5699 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5700 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<I>
	Common Stock Restricted Awards
</I>
</B>
<B>
<I>
	(Continued)
</I>
</B>
</FONT>
</P>
<P ID=PARA5701 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	As of June 30, 2016, the Company had $375 in total unrecognized compensation expense related to the Company&#8217;s restricted stock awards, which will be recognized over a weighted average period of approximately six months.
</FONT>
</P>
<P ID=PARA5702 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
</DIV>
<P ID=PARA5702 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<P ID=PARA5703 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5703 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Concentrations
</U>
</B>
</FONT>
</P>
<P ID=PARA5704 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5705 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	One distributor had an accounts receivable balance of $901 or 28% and $1,423 or 28% at June 30, 2016 and 2015, respectively. A customer had an accounts receivable balance of $620 or 19% and $615 or 12% at June 30, 2016 and 2015, respectively. A second distributor had an accounts receivable balance of $320 or 10% and $520 or 10% at June 30, 2016 and 2015, respectively. A third distributor had an accounts receivable balance of $697 or 14% at June 30, 2015.
</FONT>
</P>
<P ID=PARA5706 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5707 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Revenues from one distributor totaled $2,797 or 23% and $2,358 or 15% of net revenues for the years ended June 30, 2016 and 2015, respectively. Revenues from a customer totaled $2,475 or 21% and $2,549 or 16% for the years ended June 30, 2016 and 2015, respectively. Revenues from another distributor totaled $2,303 or 14% of net revenues for the year ended June 30, 2015.
</FONT>
</P>
<P ID=PARA5708.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK5708 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5708 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5708 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	67
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage68"></A>
<A ID=TOCLINK5708 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5708 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5708.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA5710 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5711 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5712 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5713 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5714 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Concentrations
</U>
</B>
<B>
<U>
	(Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5715 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5716 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following represents the Company&#8217;s revenues by product platform for the years ended June 30:
</FONT>
</P>
<P ID=PARA5717 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5737 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 85%; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 15%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5737.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5718 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5719 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 64%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5720 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	AXP
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5737.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6,932
</TD>
<TD ID=TBL5737.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5737.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	6,612
</TD>
<TD ID=TBL5737.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5723 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	BioArchive
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,465
</TD>
<TD ID=TBL5737.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	4,241
</TD>
<TD ID=TBL5737.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5726 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Manual Disposables
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,507
</TD>
<TD ID=TBL5737.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,810
</TD>
<TD ID=TBL5737.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5729 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Bone Marrow
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	459
</TD>
<TD ID=TBL5737.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,621
</TD>
<TD ID=TBL5737.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5732 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other
</FONT>
</P>
</TD>
<TD ID=TBL5737.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	566
</TD>
<TD ID=TBL5737.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	758
</TD>
<TD ID=TBL5737.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5737.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5737.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	11,929
</TD>
<TD ID=TBL5737.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5737.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5737.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	16,042
</TD>
<TD ID=TBL5737.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5738 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5739 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company had sales to customers as follows for the years ended June 30:
</FONT>
</P>
<P ID=PARA5740 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5760 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 85%; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 15%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5760.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5741 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5742 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 64%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5743 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	United States
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5760.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5,122
</TD>
<TD ID=TBL5760.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5760.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	8,428
</TD>
<TD ID=TBL5760.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5746 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	China
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,797
</TD>
<TD ID=TBL5760.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,500
</TD>
<TD ID=TBL5760.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5749 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Asia - other
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,955
</TD>
<TD ID=TBL5760.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,955
</TD>
<TD ID=TBL5760.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5752 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Europe
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	1,343
</TD>
<TD ID=TBL5760.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,147
</TD>
<TD ID=TBL5760.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5755 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other
</FONT>
</P>
</TD>
<TD ID=TBL5760.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	712
</TD>
<TD ID=TBL5760.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,012
</TD>
<TD ID=TBL5760.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5760.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5760.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	11,929
</TD>
<TD ID=TBL5760.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5760.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5760.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	16,042
</TD>
<TD ID=TBL5760.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5761 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5762 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company attributes revenue to different geographic areas based on where items are shipped or services are performed.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<P ID=PARA6667 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Two suppliers accounted for 65% and 21% of total inventory purchases during the year ended June 30, 2016 and three suppliers accounted for 45%, 17% and 13% of total inventory purchases during the year ended June 30, 2015.
</FONT>
</P>
<P ID=PARA6668 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<P ID=PARA5765 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company has a contract manufacturer in Costa Rica that produces certain disposables. The Company provides AXP equipment to its distributor in China for use by end-user customers. The Company&#8217;s equipment, net of accumulated depreciation, is summarized below by geographic area:
</FONT>
</P>
<P ID=PARA5767 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5788 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 85%; MARGIN-LEFT: 45PT; MARGIN-RIGHT: 15%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5788.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5768 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5769 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 64%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5770 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	United States
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5788.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,030
</TD>
<TD ID=TBL5788.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5788.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,409
</TD>
<TD ID=TBL5788.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5773 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Costa Rica
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	367
</TD>
<TD ID=TBL5788.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	594
</TD>
<TD ID=TBL5788.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5776 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	India
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	279
</TD>
<TD ID=TBL5788.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	296
</TD>
<TD ID=TBL5788.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5779 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	China
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	225
</TD>
<TD ID=TBL5788.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	524
</TD>
<TD ID=TBL5788.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5782 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	All other countries
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	61
</TD>
<TD ID=TBL5788.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	114
</TD>
<TD ID=TBL5788.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5788.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5785 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total equipment, net
</FONT>
</P>
</TD>
<TD ID=TBL5788.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5788.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,962
</TD>
<TD ID=TBL5788.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5788.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5788.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,937
</TD>
<TD ID=TBL5788.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5789 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
</DIV>
<P ID=PARA5789 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
</P>
<DIV ID=PGBK5790 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5790 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5790 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	68
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage69"></A>
<A ID=TOCLINK5790 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5790 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA5790.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5791 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5792 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5793 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5794 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5795 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5795 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Income Taxes
</U>
</B>
</FONT>
</P>
<P ID=PARA5796 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5797 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Loss before income tax benefits was comprised of $17,789 from US and $799 from foreign jurisdictions in 2016 and $14,041 from US and $811 from foreign jurisdictions in 2015.
</FONT>
</P>
<P ID=PARA5798 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5799 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The reconciliation of federal income tax attributable to operations computed at the federal statutory tax rate of 34% to income tax benefit is as follows for the years ended June 30:
</FONT>
</P>
<P ID=PARA5800 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5821 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 80%; MARGIN-LEFT: 18PT; MARGIN-RIGHT: 20%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5821.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5801 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2016
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5802 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2015
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5821.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 62%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5803 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Statutory federal income tax benefit
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.2.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.2.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5821.FINROW.2.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(6,300
</TD>
<TD ID=TBL5821.FINROW.2.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5821.FINROW.2.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.2.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5821.FINROW.2.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(5,046
</TD>
<TD ID=TBL5821.FINROW.2.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5821.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.3.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5821.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 9PT; BACKGROUND-COLOR: #CCEEFF; TEXT-INDENT: -9PT">
<P ID=PARA5806 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Unbenefited net operating losses and credits
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	3,391
</TD>
<TD ID=TBL5821.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	5,091
</TD>
<TD ID=TBL5821.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5821.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5809 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Disallowed financing costs
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	2,607
</TD>
<TD ID=TBL5821.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5821.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5821.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5812 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	State and local taxes
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	69
</TD>
<TD ID=TBL5821.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(33
</TD>
<TD ID=TBL5821.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5821.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5815 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	233
</TD>
<TD ID=TBL5821.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(12
</TD>
<TD ID=TBL5821.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: MEDIUM NONE; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5821.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.LEAD.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.SYMB.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.AMT.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.TRAIL.B2 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.LEAD.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.SYMB.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.AMT.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.8.TRAIL.B3 STYLE="BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5821.FINROW.9 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5818 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total income tax expense
</FONT>
</P>
</TD>
<TD ID=TBL5821.FINROW.9.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.9.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5821.FINROW.9.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5821.FINROW.9.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.9.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5821.FINROW.9.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5821.FINROW.9.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 16%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	--
</TD>
<TD ID=TBL5821.FINROW.9.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5822 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5823 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A deferred income tax expense of $0 was recorded for the year ended June 30, 2016. No tax benefit has been recorded through June 30, 2016 because of the net operating losses incurred and a full valuation allowance has been provided. A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized.
</FONT>
</P>
<P ID=PARA5824 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5825 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, the Company had net operating loss carryforwards for federal and state income tax purposes of $110,819 and $45,284 respectively that are available to offset future income. The federal and state loss carryforwards expire in various years between 2017 and 2036.
</FONT>
</P>
<P ID=PARA5826 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5827 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	At June 30, 2016, the Company has research and experimentation credit carryforwards of $1,418 for federal tax purposes that expire in various years between 2019 and 2036, and $1,437 for state income tax purposes that do not have an expiration date.
</FONT>
</P>
<P ID=PARA5828 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5829 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Significant components of the Company&#8217;s deferred tax assets and liabilities for federal and state income taxes are as follows:
</FONT>
</P>
<P ID=PARA5830 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<DIV DATA-TD-TAGGABLE-TABLE="">
<TABLE ID=TBL5859 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 85%; MARGIN-LEFT: 27PT; MARGIN-RIGHT: 15%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR ID=TBL5859.FINROW.1>
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.1.LEAD.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.1.AMT.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5831 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2016
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.1.TRAIL.D2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.1.LEAD.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.1.AMT.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT" COLSPAN=2>
<P ID=PARA5832 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	June 30, 2015
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.1.TRAIL.D3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 1PX">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.2 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 64%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5833 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Deferred tax assets:
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.2.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.2.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.3 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5834 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net operating loss carryforwards
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.3.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.3.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5859.FINROW.3.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	41,023
</TD>
<TD ID=TBL5859.FINROW.3.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.3.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.3.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	$
</TD>
<TD ID=TBL5859.FINROW.3.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	38,317
</TD>
<TD ID=TBL5859.FINROW.3.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.4 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5837 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Income tax credit carryforwards
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.4.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.4.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.4.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,367
</TD>
<TD ID=TBL5859.FINROW.4.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.4.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.4.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.4.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	2,143
</TD>
<TD ID=TBL5859.FINROW.4.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.5 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5840 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Stock compensation
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.5.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.5.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.5.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	874
</TD>
<TD ID=TBL5859.FINROW.5.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.5.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.5.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.5.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	916
</TD>
<TD ID=TBL5859.FINROW.5.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.6 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5843 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Other
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.6.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.6.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.6.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,345
</TD>
<TD ID=TBL5859.FINROW.6.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.6.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.6.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.6.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	1,479
</TD>
<TD ID=TBL5859.FINROW.6.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.7 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5846 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Valuation allowance
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.7.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.7.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.7.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(45,892
</TD>
<TD ID=TBL5859.FINROW.7.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5859.FINROW.7.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.7.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.7.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(42,408
</TD>
<TD ID=TBL5859.FINROW.7.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5859.FINROW.8 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="MARGIN-BOTTOM: 0PX; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; MARGIN-TOP: 0PX; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5849 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Total deferred taxes
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.8.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.8.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.8.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(283
</TD>
<TD ID=TBL5859.FINROW.8.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5859.FINROW.8.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.8.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.8.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	447
</TD>
<TD ID=TBL5859.FINROW.8.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.9 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.LEAD.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.SYMB.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.AMT.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.TRAIL.B2 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.LEAD.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.SYMB.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.AMT.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.9.TRAIL.B3 STYLE="BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.10 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5852 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Deferred tax liabilities
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.10.LEAD.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.SYMB.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.AMT.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.TRAIL.B2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.LEAD.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.SYMB.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.AMT.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.10.TRAIL.B3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
</TR>
<TR ID=TBL5859.FINROW.11 STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA5853 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Depreciation and amortization
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.11.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.11.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.11.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(7,358
</TD>
<TD ID=TBL5859.FINROW.11.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
<TD ID=TBL5859.FINROW.11.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.11.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.11.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF">
	(8,088
</TD>
<TD ID=TBL5859.FINROW.11.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 1PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #FFFFFF" NOWRAP>
	)
</TD>
</TR>
<TR ID=TBL5859.FINROW.12 STYLE="BACKGROUND-COLOR: #CCEEFF">
<TD STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; VERTICAL-ALIGN: TOP; PADDING-LEFT: 27PT; BACKGROUND-COLOR: #CCEEFF">
<P ID=PARA5856 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Net deferred taxes and liabilities
</FONT>
</P>
</TD>
<TD ID=TBL5859.FINROW.12.LEAD.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.12.SYMB.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5859.FINROW.12.AMT.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(7,641
</TD>
<TD ID=TBL5859.FINROW.12.TRAIL.2 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
<TD ID=TBL5859.FINROW.12.LEAD.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BACKGROUND-COLOR: #CCEEFF">
	&nbsp;
</TD>
<TD ID=TBL5859.FINROW.12.SYMB.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	$
</TD>
<TD ID=TBL5859.FINROW.12.AMT.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 15%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 3PX DOUBLE; TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF">
	(7,641
</TD>
<TD ID=TBL5859.FINROW.12.TRAIL.3 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 1%; VERTICAL-ALIGN: BOTTOM; PADDING-BOTTOM: 3PX; MARGIN-LEFT: 0PT; BACKGROUND-COLOR: #CCEEFF" NOWRAP>
	)
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA5860 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK6466 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6466 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6466 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	69
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage70"></A>
<A ID=TOCLINK6466 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6466 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6466.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA5861 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<B>
	Cesca Therapeutics Inc.
</B>
</FONT>
</P>
<P ID=PARA5862 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
</B>
</FONT>
</P>
<P ID=PARA5863 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	(in thousands except shares and per share amounts)
</B>
</FONT>
</P>
<P ID=PARA5864 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5865 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Income Taxes
</U>
</B>
<B>
<U>
	(Continued)
</U>
</B>
</FONT>
</P>
<P ID=PARA5866 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5867 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The valuation allowance increased by $3,484 in 2016. As of June 30, 2016, the Company has a benefit of $219 related to stock option deductions, which will be credited to paid-in capital when realized.
</FONT>
</P>
<P ID=PARA5868 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5869 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In August 2016, the conversion of the debentures with Boyalife Investment Inc. (see subsequent events footnote 12) effected an &#8220;ownership change&#8221; as defined under the provisions of the Tax Reform Act of 1986. As a result, any net operating loss and credit carryovers existing at that date will be subject to an annual limitation regarding their utilization against taxable income in future periods. Additionally, before the conversion of the debentures, it is possible that &#8220;ownership changes&#8221; occurred, which could create additional imitations on the use of our net operating losses and credit carryovers.
</FONT>
</P>
<P ID=PARA5870 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
</DIV>
<P ID=PARA5870 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<P ID=PARA5871 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5871 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	11
</B>
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Employee Retirement Plan
</U>
</B>
</FONT>
</P>
<P ID=PARA5872 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5873 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Company sponsors an Employee Retirement Plan, generally available to all employees, in accordance with Section 401(k) of the Internal Revenue Code. Employees may elect to contribute up to the Internal Revenue Service annual contribution limit. Under this Plan, at the discretion of the Board of Directors, the Company may match a portion of the employees&#8217; contributions. The Company made no discretionary or matching contributions to the Plan for the years ended June 30, 2016 and 2015.
</FONT>
</P>
<P ID=PARA5874 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5874 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA5875 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
</P>
<DIV DATA-TD-STATEMENT-TYPE="NOTE">
<P ID=PARA5875 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	Subsequent Event
</U>
</B>
<B>
<U>
	s
</U>
</B>
</FONT>
</P>
<P ID=PARA5876 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5877 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 3, 2016, the Company sold 600,000 shares of common stock at a price of $4.10 per share.&nbsp;
</FONT>
</P>
<P ID=PARA5878 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The net proceeds to the Company from the sale and issuance of the shares, after deducting the estimated offering expenses borne by the Company are expected to be approximately $2.2 million.&nbsp;
</FONT>
</P>
<P ID=PARA5879 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5880 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	On August 22, 2016, the Company notified Boyalife Investment Inc., that it elected to convert all outstanding principal and interest accrued and otherwise payable under the Debentures, which included the conversion of $12,500 of principal and $8,250 of interest up to and including the maturity date of the Debentures. Upon conversion, 6,102,941 shares of common stock were issued and the Debentures and all security interest and liens were terminated.
</FONT>
</P>
<P ID=PARA5881.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
</DIV>
<P ID=PARA5881.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
</P>
<DIV ID=PGBK5881 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5881 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5881 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	70
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage71"></A>
<A ID=TOCLINK5881 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5881 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
</EFX_FINANCIAL_STATEMENTS>
<P ID=PARA5881.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_ACCOUNTING_CHANGES>
<A NAME="FIS_ACCOUNTING_CHANGES"></A>
<P ID=PARA5883 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6617 NAME="KOOL20160630_10K_HTM_BKMK6617">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	9
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
</U>
</B>
<B>
	&nbsp;
</B>
<B>
<U>
	ACCOUNTING AND FINANCIAL DISCLOSURE.
</U>
</B>
</FONT>
</P>
<P ID=PARA5884 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 54PT; LINE-HEIGHT: 1.25; TEXT-INDENT: -54PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5885 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	None.
</FONT>
</P>
</EFX_ACCOUNTING_CHANGES>
<P ID=PARA5886 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 54PT; LINE-HEIGHT: 1.25; TEXT-INDENT: -54PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_CONTROL_AND_PROCEDURES>
<A NAME="FIS_CONTROL_AND_PROCEDURES"></A>
<P ID=PARA5887 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6618 NAME="KOOL20160630_10K_HTM_BKMK6618">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	9A
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	CONTROLS AND PROCEDURES.
</U>
</B>
</FONT>
</P>
<P ID=PARA5888 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5889 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Dis
</B>
<B>
	c
</B>
<B>
	losure Controls and Procedures
</B>
</FONT>
</P>
<P ID=PARA5890 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We carried out an evaluation, under the supervision and with the participation of management, including the our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of disclosure controls and procedures (as defined by Exchange Act Rule 13a-15(e) and 15d-15(e)) as of the end of our fiscal quarter pursuant to Exchange Act Rule 13a-15. The term &#8220;disclosure controls and procedures&#8221; means controls and other procedures designed to ensure that information required for disclosure in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2016.
</FONT>
</P>
<P ID=PARA5891 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5892 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Management&#8217;s Report on Internal Control over Financial Reporting
</B>
</FONT>
</P>
<P ID=PARA5893 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive and Financial Officers, we conducted an evaluation of the effectiveness of its internal control over financial reporting as of June 30, 2016 based on criteria established in the framework in
<I>
	Internal Control &#8211; Integrated Framework
</I>
	issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of June 30, 2016.
</FONT>
</P>
<P ID=PARA5894 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5895 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.
</FONT>
</P>
</EFX_CONTROL_AND_PROCEDURES>
<P ID=PARA5896 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION_2"></A>
<P ID=PARA5897 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Attestation Report of Independent Registered Public Accounting Firm
</B>
</FONT>
</P>
<P ID=PARA5898 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Not applicable.
</FONT>
</P>
<P ID=PARA5899 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA5900 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Changes in Internal Control over Financial Reporting
</B>
	&nbsp;
</FONT>
</P>
<P ID=PARA5901 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	There have been no changes in our internal controls over financial reporting that occurred during the fiscal quarter ended June 30, 2016, that have materially affected, or are reasonably likely to materially affect our internal controls over financial reporting. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been detected.
</FONT>
</P>
<P ID=PARA6467.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6467 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6467 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6467 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	71
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage72"></A>
<A ID=TOCLINK6467 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6467 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_AUDITORS_OPINION>
<P ID=PARA6467.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
</B>
</FONT>
	&nbsp;
</P>
<EFX_OTHER_INFORMATION>
<A NAME="FIS_OTHER_INFORMATION"></A>
<P ID=PARA5906 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6619 NAME="KOOL20160630_10K_HTM_BKMK6619">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	9B
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	OTHER INFORMATION.
</U>
</B>
</FONT>
</P>
<P ID=PARA5907 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5908 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	None.
</FONT>
</P>
</EFX_OTHER_INFORMATION>
</EFX_PART_II>
<EFX_PART_III>
<A NAME="FIS_PART_III"></A>
<P ID=PARA5909 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PART III
</B>
</FONT>
</P>
<P ID=PARA5910 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_DIRECTORS_AND_OFFICERS>
<A NAME="FIS_DIRECTORS_AND_OFFICERS"></A>
<P ID=PARA5911 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6620 NAME="KOOL20160630_10K_HTM_BKMK6620">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	10
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
</U>
</B>
</FONT>
</P>
<P ID=PARA5912 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5913 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information required by this Item will be included in and is hereby incorporated by reference from our Proxy Statement for the 2016 Annual Meeting of Stockholders. We have adopted a Code of Ethics applicable to all employees including our CEO and CFO. A copy of the Code of Ethics is available at www.cescatherapeutics.com.
</FONT>
</P>
</EFX_DIRECTORS_AND_OFFICERS>
<P ID=PARA5914 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_COMPENSATION>
<A NAME="FIS_COMPENSATION"></A>
<P ID=PARA5915 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6621 NAME="KOOL20160630_10K_HTM_BKMK6621">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	11
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	EXECUTIVE COMPENSATION.
</U>
</B>
</FONT>
</P>
<P ID=PARA5916 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5917 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information required by this Item will be included in and is hereby incorporated by reference from our Proxy Statement for the 2016 Annual Meeting of Stockholders.
</FONT>
</P>
</EFX_COMPENSATION>
<P ID=PARA5918 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_SECURITY_OWNERS>
<A NAME="FIS_SECURITY_OWNERS"></A>
<P ID=PARA5919 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6622 NAME="KOOL20160630_10K_HTM_BKMK6622">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	12
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
</U>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
</U>
</B>
</FONT>
</P>
<P ID=PARA5921 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5922 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information required by this Item will be included in and is hereby incorporated by reference from our Proxy Statement for the 2016 Annual Meeting of Stockholders.
</FONT>
</P>
</EFX_SECURITY_OWNERS>
<P ID=PARA5923 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_OFFICER_TRANSACTIONS>
<A NAME="FIS_OFFICER_TRANSACTIONS"></A>
<P ID=PARA5924 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6623 NAME="KOOL20160630_10K_HTM_BKMK6623">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	13
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
</U>
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	INDEPENDENCE.
</U>
</B>
</FONT>
</P>
<P ID=PARA5926 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5927 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information required by this Item will be included in and is hereby incorporated by reference from our Proxy Statement for the 2016 Annual Meeting of Stockholders.
</FONT>
</P>
</EFX_OFFICER_TRANSACTIONS>
<P ID=PARA5928 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_ACCOUNTANT_FEES>
<A NAME="FIS_ACCOUNTANT_FEES"></A>
<P ID=PARA5929 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6624 NAME="KOOL20160630_10K_HTM_BKMK6624">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	14
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	PRINCIPAL ACCOUNTING FEES AND SERVICES.
</U>
</B>
</FONT>
</P>
<P ID=PARA5930 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5931 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information required by this Item will be included in and is hereby incorporated by reference from our Proxy Statement for the 2016 Annual Meeting of Stockholders.
</FONT>
</P>
<P ID=PARA5932.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK5932 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5932 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5932 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	72
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage73"></A>
<A ID=TOCLINK5932 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5932 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_ACCOUNTANT_FEES>
</EFX_PART_III>
<P ID=PARA5932.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;
</P>
<EFX_PART_IV>
<A NAME="FIS_PART_IV"></A>
<P ID=PARA5934 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PART IV
</B>
</FONT>
</P>
<P ID=PARA5935 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<P ID=PARA5936 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=BKMK6625 NAME="KOOL20160630_10K_HTM_BKMK6625">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	ITEM
</B>
</FONT>
</A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	15
</B>
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B>
<B>
<U>
	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
</U>
</B>
</FONT>
</P>
<P ID=PARA5937 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA5938 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The following documents are filed as a part of this report on Form 10-K.
</FONT>
</P>
<P ID=PARA5939 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<TABLE ID=TBL6523 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 99.9%; MARGIN-LEFT: 0.09%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; TEXT-ALIGN: CENTER">
<U>
	Page Number
</U>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6498 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a)&nbsp; (1)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6499 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Financial Statements
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6500 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6641 HREF="#KOOL20160630_10K_HTM_BKMK6647">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Report of Independent Registered Public Accounting Firm
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6501 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	39
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6502 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6642 HREF="#KOOL20160630_10K_HTM_BKMK6648">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Balance Sheets at June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6503 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	40
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6505 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6643 HREF="#KOOL20160630_10K_HTM_BKMK6649">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6506 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	41
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6508 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6644 HREF="#KOOL20160630_10K_HTM_BKMK6650">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Stockholders&#8217; Equity for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6509 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	42
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6511 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6645 HREF="#KOOL20160630_10K_HTM_BKMK6651">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consolidated Statements of Cash Flows for the years ended June 30, 2016 and 2015
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6512 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	43
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6513 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<A ID=LINK6646 HREF="#KOOL20160630_10K_HTM_BKMK6652">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Notes to Consolidated Financial Statements
</FONT>
</A>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6514 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	44
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 90%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF" COLSPAN=3>
<P ID=PARA6515 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Management&#8217;s Report on Internal Control over Financial Reporting is contained as part of this report under Item 9A &#8220;Controls and Procedures.&#8221;
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6516 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a)&nbsp; (2)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6517 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Financial Statement Schedules
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF" COLSPAN=2>
<P ID=PARA6518 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Financial statement schedules have been omitted because they are not required.
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6519 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(b)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6520 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Exhibits
</P>
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
<P ID=PARA6521 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF" COLSPAN=2>
<P ID=PARA6522 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index on the next page, which are incorporated herein by this reference.
</FONT>
</P>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: #FFFFFF">
<TD STYLE="WIDTH: 5%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 85%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BACKGROUND-COLOR: #FFFFFF">
	&nbsp;
</TD>
</TR>
</TABLE>
<P ID=PARA6526 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
</P>
<P ID=PARA6525 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
	&nbsp;
</P>
<DIV ID=PGBK5968 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR5968 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM5968 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	73
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage74"></A>
<A ID=TOCLINK5968 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR5968 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_EXHIBITS>
</EFX_PART_IV>
<P ID=PARA5968.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_EXHIBIT_INDEX>
<A NAME="FIS_EXHIBIT_INDEX"></A>
<P ID=PARA5969 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	EXHIBIT INDEX
</B>
</FONT>
</P>
<P ID=PARA5970 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<TABLE ID=TBL6037 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5971 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Exhibit No.
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5972 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Document Description
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5973 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Incorporation by Reference
</B>
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5974 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5975 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Plan of Merger Agreement and Reorganization Agreement between ThermoGenesis Corp. and TotipotentRX, dated July 15, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5976 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated July 16
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	,
</SUP>
	2013
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5977 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5978 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cesca Therapeutics Inc.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5979 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated July 25, 2015
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5980 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.2
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5981 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Bylaws of Cesca Therapeutics Inc.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5982 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated April 25, 2014 filed with the SEC on May 1, 2014
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5983 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.2.2
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5984 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Restated Bylaws of Cesca Therapeutics Inc.
<SUP STYLE="VERTICAL-ALIGN: BASELINE; POSITION: RELATIVE; BOTTOM:.33EM;">
	(1)
</SUP>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5985 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated October 24, 2014 filed with the SEC on October 30, 2014
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5986 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.3
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5987 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cesca Therapeutics Inc.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5988 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Cesca&#8217;s Current Report on Form 8-K filed with the SEC on August 26, 2010.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5989 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.3.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5990 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certificate of Amendment to the Sixth Amended and Restated Certificate of Incorporation
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5991 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on March 4, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5992 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.4
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5993 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certificate of Merger.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5994 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Cesca Therapeutics Inc. Current Report Form 8-K filed with the SEC on February 18, 2014.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5995 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.5
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5996 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cesca Therapeutics Inc.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5997 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on November 5, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5998 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	4.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA5999 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Stock Grant Agreement; Common Stock Agreement
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6000 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Cesca&#8217;s Current Report on Form 8-K filed with the SEC on November 5, 2010.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6001 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6002 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	License Agreement with Pall/Medsep Corporation
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6003 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated April 14, 1997.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6004 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.2.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6005 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	License and Escrow Agreement between Cesca Therapeutics Inc. and CBR Systems, Inc., effective June 15, 2010
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6006 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Cesca&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2010.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6007 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.2.2
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6008 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	First Amendment to Technology License and Escrow Agreement between Cesca Therapeutics Inc. and CBR Systems, Inc., effective February 6, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6009 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporate by reference to Form 8-K dated February 12, 2013.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6010 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.2.3
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6011 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Extension Addendum to Escrow Agreement, effective July 26, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6012 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 1, 2013.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6013 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.2.4
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6014 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Forbearance Agreement to Technology License and Escrow Agreement dated November 26, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6015 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed with the SEC on November 26, 2013
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6016 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.3
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6017 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amended 2002 Independent Directors Equity Incentive Plan
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6018 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated December 15, 2004.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6019 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.6
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6020 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amended and Restated 2006 Equity Incentive Plan
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6021 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated April 25, 2014 filed with the SEC on May 1, 2014.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6022 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.10+
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6023 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Product Purchase and International Distribution Agreement between Cesca Therapeutics Inc. and Golden Meditech Holdings, Limited
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6024 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 24, 2012 and amended October 24, 2012.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6025 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.11
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6026 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2012 Independent Director Plan
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6027 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit A of the Company&#8217;s Definitive Proxy Statement filed October 23, 2012.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6028 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.13
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6029 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employment Agreement between Cesca Therapeutics Inc. and Mitchel Sivilotti dated July 15, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6030 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated July 16, 2013.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6031 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.13.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6032 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General Release and Waiver between the Company and Mitchel Sivilotti
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6033 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on December 16, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6034 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.13.2
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6035 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consulting Agreement between the Company and Mitchel Sivilotti
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6036 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on December 16, 2015.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA6038 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
</FONT>
	&nbsp;
</P>
<DIV ID=PGBK6527 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6527 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6527 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	74
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage75"></A>
<A ID=TOCLINK6527 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6527 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6527.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_29"></A>
<TABLE ID=TBL6105 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6039 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Exhibit No.
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6040 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Document Description
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6041 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Incorporation by Reference
</B>
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6042 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.14
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6043 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employment Agreement between Cesca Therapeutics Inc. and Kenneth Harris dated July 15, 2013
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6044 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated July 16, 2013.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6045 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.18
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6046 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Sales and Purchase Agreement between ThermoGenesis Corp and CBR Systems, Inc. dated December 31, 2013+
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6047 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated January 7, 2014.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6048 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.19
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6049 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employment Agreement with Robin C. Stracey
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6050 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated June 15, 2015
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6051 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.22
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6052 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Debenture
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6053 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 31, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6054 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.22.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6055 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Amendment to Senior Secured Convertible Debenture
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6056 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on September 29, 2015
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6057 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.23
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6058 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Series A Warrant
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6059 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 31, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6060 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.23.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6061 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Series A Warrant Amendment
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6062 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6063 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.24
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6064 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Series B Warrant
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6065 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 31, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6066 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.25
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6067 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Registration Rights Agreement
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6068 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 31, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6069 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.26
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6070 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Security Agreement
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6071 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 31, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6072 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.27
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6073 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	General Release and Waiver between the Company and Kenneth L. Harris
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6074 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on September 30, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6075 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.28
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6076 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consulting Agreement between the Company and Kenneth L. Harris
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6077 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on September 30, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6078 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.29
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6079 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Fifth Amended and Restated Technology License and Escrow Agreement between the Company and CBR Systems, effective September 30, 2015
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6080 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on October 28, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6081 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.30
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6082 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Employment Agreement with Michael Bruch
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6083 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K filed on October 28, 2015.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6084 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.31
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6085 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Purchase Agreement between the Company and Boyalife Investment Inc. and Boyalife (Hong Kong) Limited
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6086 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6087 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.32
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6088 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Debenture betweent he Company and Boyalife Investment Inc. and Boyalife (Hong Kong) Limited
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6089 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6090 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.33
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6091 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Warrant
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6092 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6093 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.34
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6094 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Nomination and Voting Agreement
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6095 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6096 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.35
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6097 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Security Agreement
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6098 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6099 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.36
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6100 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consent, Repayment and Release Agreement dated February 2, 2016 between the Company and Sabby Healthcare Master Fund, Ltd. And Sabby Volatility Warrant Master Fund, Ltd.
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6101 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6102 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.37
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6103 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Release
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6104 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on February 3, 2016.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA6106.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6106 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6106 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6106 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	75
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage76"></A>
<A ID=TOCLINK6106 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6106 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6106.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_30"></A>
<TABLE ID=TBL6142 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6108 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Exhibit No.
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6109 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Document Description
</B>
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6110 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Incorporation by Reference
</B>
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6111 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.38
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6112 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Securities Purchase Agreement between Cesca Therapeutics Inc. and certain institutional accredited investors, dated August 3, 2016
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6113 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 3, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6114 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	10.39
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6115 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Form of Placement Agency Agreement between Cesca Therapeutics Inc. and Maxim Group LLC, dated August 3, 2016
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6116 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Incorporated by reference to Form 8-K dated August 3, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6117 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	23.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6118 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Consent of Marcum LLP, Independent Registered
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6119 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Filed herewith.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6120 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Public Accounting Firm
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6121 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	31.1
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6122 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certification by the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6123 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Filed herewith.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6124 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	31.2
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6125 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certification by the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6126 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Filed herewith.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6127 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	32
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6128 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6129 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Filed herewith.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6130 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.INS
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 44%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6131 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Instance Document&#8225;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6132 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.SCH
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 46%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6133 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Taxonomy Extension Schema Document&#8225;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6134 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.CAL
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 46%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6135 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Taxonomy Extension Calculation Linkbase Document&#8225;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6136 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.DEF
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 46%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6137 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Taxonomy Extension Definition Linkbase Document&#8225;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6138 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.LAB
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 46%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6139 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Taxonomy Extension Label Linkbase Document&#8225;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 10%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6140 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	101.PRE
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 46%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID" COLSPAN=3>
<P ID=PARA6141 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL Taxonomy Extension Presentation Linkbase Document&#8225;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</EFX_UNIDENTIFIED_TABLE>
<P ID=PARA6143 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 27PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	Footnotes to Exhibit Index
</B>
</FONT>
</P>
<TABLE ID=MTAB6145 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 27PT">
<P ID=PARA6528 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6146 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&#8225;
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6147 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	XBRL information is furnished and not filed for purpose of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<TABLE ID=MTAB6149 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 27PT">
<P ID=PARA6529 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA6150 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	+
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA6151 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The SEC has granted confidential treatment with respect to certain portions of this exhibit. Omitted portions have been filed separately with the SEC.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA6152.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6152 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6152 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6152 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	76
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage77"></A>
<A ID=TOCLINK6152 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6152 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6152.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA6153 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
<U>
	GLOSSARY OF CERTAIN TECHNICAL TERMS
</U>
</B>
</FONT>
</P>
<P ID=PARA6154 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6155 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	510(k): Formal notification to FDA to obtain clearance to market the medical device. The device must be substantially equivalent to devices manufactured prior to 1976, or which have been found substantially equivalent after that date.
</FONT>
</P>
<P ID=PARA6156 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6157 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ADULT STEM CELLS: All non-embryonic stem cells.
</FONT>
</P>
<P ID=PARA6158 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6159 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	AUTOLOGOUS: Autogenous; related to self; originating within an organism itself, as obtaining blood from the patient for use in the same patient.
</FONT>
</P>
<P ID=PARA6160 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6161 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	BONE MARROW ASPIRATE: A volume of marrow obtained from a long bone using a specialized instrument.
</FONT>
</P>
<P ID=PARA6162 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6163 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	CE Mark
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	:
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	A CE logo and four digit identification number of the notified body which assessed the conformity of a product to the European directives, or regulatory system, which is applicable to a given medical device (and other products) in the European Economic Area. It is a symbol of free marketability in that region, and is recognizable worldwide as the European equivalent of compliance with FDA regulatory requirements. One key distinction, however, is that the CE system focuses primarily on safety, whereas the FDA focuses on both safety and efficacy of a given product.
</FONT>
</P>
<P ID=PARA6164 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6165 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	CRITICAL LIMB ISCHEMIA (&#8220;CLI&#8221;): A severe obstruction of the arteries that seriously decreases blood flow to the extremities (arms, hands, legs, feet) and has progressed to the point of severe pain and even skin ulcers of sores.
</FONT>
</P>
<P ID=PARA6166 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6167 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	CRYOPRESERVATION: Maintaining the life of excised tissue or organs by freezing and storing at very low temperatures.
</FONT>
</P>
<P ID=PARA6168 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6169 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	HAPLOIDENTICAL: Half-matched family members; the donor and recipient have the same set of closely linked HLA genes on one of the two Number 6 chromosomes they inherited from their parents. Parents are always a half-match for their children and vice versa.
</FONT>
</P>
<P ID=PARA6170 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6171 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	HEMATOPOIETIC: The formation of blood.
</FONT>
</P>
<P ID=PARA6172 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6173 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	IN VITRO: Occurring in an artificial environment outside a living organism.
</FONT>
</P>
<P ID=PARA6174 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6175 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	IN VIVO: Occurring or made to occur within a living organism or natural setting.
</FONT>
</P>
<P ID=PARA6176 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA6177 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	ISCHEMIA: Deficient supply of blood and oxygen to a body part.
</FONT>
</P>
<P ID=PARA6178 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	&nbsp;
</B>
</FONT>
</P>
<P ID=PARA6179 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	MONONUCLEAR CELLS (&#8220;MNCs&#8221;): A term used to refer to blood cells that under a microscope can be seen to have a large round shaped nucleus. These cells include monocytes and lymphocytes which are involved in fighting infections in the body and also stem cells which have the potential to replicate and to generate new tissues as part of the body&#8217;s healing process.
</FONT>
</P>
<P ID=PARA6180 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6181 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	PERIPHERAL BLOOD: A term used to describe the blood that is contained in the body&#8217;s circulatory system. It can be collected by a health care professional by inserting a needle into a vein.
</FONT>
</P>
<P ID=PARA6182 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6183 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	PMA Classification
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	:
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The most stringent type of medical device marketing application required by the FDA (one category above 510(k) pre-market notification). Unlike the 510(k) pathway, the manufacturer must submit an exhaustive application to the FDA and must receive approval prior to beginning commercial marketing of a device. The PMA application includes information on how the device was designed and manufactured, as well as preclinical and clinical studies, demonstrating that it is safe and effective for its intended use.
</FONT>
</P>
<P ID=PARA6530.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6530 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6530 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6530 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	77
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage78"></A>
<A ID=TOCLINK6530 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6530 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
<P ID=PARA6530.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
</P>
<P ID=PARA6185 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	REGENERATIVE MEDICINE: The process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects.
</FONT>
</P>
<P ID=PARA6186 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6187 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	STEM CELLS: Undifferentiated, primitive cells in the bone marrow or cord blood with the ability both to multiply and to differentiate into specific blood or tissue cells.
</FONT>
</P>
<P ID=PARA6189.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<DIV ID=PGBK6189 STYLE="WIDTH: 100%; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT">
<DIV ID=PGFTR6189 STYLE="WIDTH: 100%; TEXT-ALIGN: CENTER">
	&nbsp;
</DIV>
<DIV ID=PGNUM6189 STYLE="FONT-SIZE: 10PT; WIDTH: 100%; TEXT-ALIGN: CENTER">
	78
</DIV>
<HR STYLE="HEIGHT: 2PX; WIDTH: 100%; PAGE-BREAK-AFTER: ALWAYS; COLOR: #000000" NOSHADE="">
<A NAME="eolPage79"></A>
<A ID=TOCLINK6189 HREF="#KOOL20160630_10K_HTM_TOC">
	Table Of Contents
</A>
<DIV ID=PGHDR6189 STYLE="WIDTH: 100%; TEXT-ALIGN: LEFT">
	&nbsp;
</DIV>
</DIV>
</EFX_EXHIBIT_INDEX>
<P ID=PARA6189.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<P ID=PARA6188 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	SIGNATURES
</B>
</FONT>
</P>
<P ID=PARA6190 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6191 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
</FONT>
</P>
<P ID=PARA6192 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL6198 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 49%; VERTICAL-ALIGN: TOP" COLSPAN=2>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; VERTICAL-ALIGN: TOP">
<P ID=PARA6193 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Cesca Therapeutics Inc.
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 49%; VERTICAL-ALIGN: TOP" COLSPAN=2>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 49%; VERTICAL-ALIGN: TOP" COLSPAN=2>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 49%; VERTICAL-ALIGN: BOTTOM" COLSPAN=2>
<P ID=PARA6194 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6195 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By:/s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6196 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Craig W. Moore
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 49%; VERTICAL-ALIGN: TOP" COLSPAN=2>
	&nbsp;
</TD>
<TD STYLE="WIDTH: 9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40%; VERTICAL-ALIGN: TOP">
<P ID=PARA6197 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Craig W. Moore, Chairman of the Board
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA6199 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6200 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
</FONT>
</P>
<P STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	&nbsp;
</P>
<TABLE ID=TBL6231 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 98.9%; MARGIN-LEFT: 0%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6201 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By:/s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6202 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Craig W. Moore
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6203 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
<P ID=PARA6204 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Craig W. Moore, Chairman of the Board
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6205 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By:/s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6206 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Robin S. Stracey
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6207 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
<P ID=PARA6208 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Robin S. Stracey,&nbsp;Chief Executive Officer and Director
</FONT>
</P>
<P ID=PARA6209 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(Principal Executive Officer)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
<P ID=PARA6210 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By:/s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6211 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	&nbsp;Michael Bruch
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6212 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA6213 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Michael Bruch, Interim Chief Financial Officer
</FONT>
</P>
<P ID=PARA6214 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(Principal Financial and Accounting Officer)
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6215 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By: /s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6216 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	Mark Bagnall&nbsp;
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6217 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA6218 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mark Bagnall, Director
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6219 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By: /s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6220 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
</FONT>
	Denis Michael Rhein&nbsp;
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6221 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
<P ID=PARA6222 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Denis Michael Rhein, Director
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6223 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By: /s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6224 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Mahendra Rao
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6225 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA6226 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Mahendra Rao, Director
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6227 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	By: /s/
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA6228 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
	Xiaochun Xu
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA6229 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 8.9%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 40.8%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA6230 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Xiaochun Xu, Director
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 2.8%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 48.6%; VERTICAL-ALIGN: BOTTOM">
	&nbsp;
</TD>
</TR>
</TABLE>
<P ID=PARA6232.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA6232.2 STYLE="MARGIN-BOTTOM: 0PX; TEXT-ALIGN: CENTER; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;79
</FONT>
</P>
</EFX_SIGNATURES>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage80"></A>
<A NAME="EX23-1_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23"></A>
<P ID=PARA3046 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: RIGHT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibit 23.1
</FONT>
</P>
<P ID=PARA3037 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT"></A>
<P ID=PARA3058 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; TEXT-TRANSFORM: UPPERCASE">
<U>
	Independent Registered Public Accounting Firm&#8217;s Consent
</U>
</FONT>
</P>
<P ID=PARA3059 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3060 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	We consent to the incorporation by reference in the Registration Statement of Cesca Therapeutics Inc. on Form S-8 (File No. 333-187197) pertaining to 2006 Equity Incentive Plan and 2012 Independent Director Equity Plan, Form S-8 (File No. 333-171564) pertaining to the Cesca Therapeutics Inc. 2006 Employee Equity Incentive Plan, Form S-8 (No. 333-140668) pertaining to the Cesca Therapeutics Inc. 2006 Employee Equity Incentive Plan, Form S-8 (No. 333-105191) pertaining to the Cesca Therapeutics Inc. Amended 1998 Employee Equity Incentive Plan, Form S-8 (File Nos. 333-46911 and 333-37228) pertaining to the Cesca Therapeutics Inc. 1998 Employee Equity Incentive Plan, Form S-8 (No. 333-82900) pertaining to the Cesca Therapeutics Inc. Amended 1998 Employee Equity Incentive Plan, 2002 Independent Directors Equity Incentive Plan, and Non-Qualified Independent Director Stock Option Agreement, and Form S-8 (File No. 333-122761) pertaining to the Cesca Therapeutics Inc. Amended 2002 Independent Directors Equity Incentive Plan and amendment No. 1 to Form S-3 (File No. 333-212314) Cesca Therapeutics Inc. of our report dated September 20, 2016 with respect to our audits of the consolidated financial statements of Cesca Therapeutics Inc. as of June 30, 2016 and 2015 and for the years ended June 30, 2016 and 2015, which report is included in this Annual Report on Form 10-K of Cesca Therapeutics Inc. for the year ended June 30, 2016.
</FONT>
</P>
<P ID=PARA3061 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3062 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Marcum
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	llp
</FONT>
</FONT>
</P>
<P ID=PARA3063 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA3064 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Marcum
<FONT STYLE="FONT-VARIANT: SMALL-CAPS">
	llp
</FONT>
</FONT>
</P>
<P ID=PARA3065 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	New York, NY
</FONT>
</P>
<P ID=PARA3066 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	September 20, 2016
</FONT>
</P>
</EFX_EXPERTS_CONSENT>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage81"></A>
<A NAME="EX31-1_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31"></A>
<P ID=PARA1 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibit 31.1
</FONT>
</P>
<P ID=PARA2 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION"></A>
<P ID=PARA3 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PRINCIPAL EXECUTIVE OFFICER&#8217;S CERTIFICATIONS
<BR>
	PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
</B>
</FONT>
</P>
<P ID=PARA5 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	I, Robin C. Stracey, certify that:
</FONT>
</P>
<P ID=PARA7 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;I have reviewed this annual report on Form 10-K of Cesca Therapeutics Inc.;
</FONT>
</P>
<P ID=PARA9 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA8 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</P>
<P ID=PARA11 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA10 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
</FONT>
</P>
<P ID=PARA13 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA12 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</P>
<P ID=PARA15 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA14 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</P>
<P ID=PARA17 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA16 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</P>
<P ID=PARA19 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA18 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</P>
<P ID=PARA21 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA20 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
</FONT>
</P>
<P ID=PARA23 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA22 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
</FONT>
</P>
<P ID=PARA25 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA24 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
</FONT>
</P>
<P ID=PARA27 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA26 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
</FONT>
</P>
<P ID=PARA28 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA29 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
<P ID=PARA30 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL33 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 50%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA31 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Robin C. Stracey
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 50%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA32 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Robin C. Stracey, Chief Executive Officer
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
</TR>
</TABLE>
</EFX_CERTIFICATION>
<P ID=PARA34.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA34.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage82"></A>
<A NAME="EX31-2_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31_2"></A>
<P ID=PARA1 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibit 31.2
</FONT>
</P>
<P ID=PARA2 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_2"></A>
<P ID=PARA3 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	PRINCIPAL FINANCIAL OFFICER&#8217;S CERTIFICATIONS
<BR>
	PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
</B>
</FONT>
</P>
<P ID=PARA5 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	I, Michael Bruch, certify that:
</FONT>
</P>
<P ID=PARA7 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA6 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;I have reviewed this annual report on Form 10-K of Cesca Therapeutics Inc.;
</FONT>
</P>
<P ID=PARA9 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA8 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</P>
<P ID=PARA11 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA10 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
</FONT>
</P>
<P ID=PARA13 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA12 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</P>
<P ID=PARA15 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA14 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</P>
<P ID=PARA17 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA16 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</P>
<P ID=PARA19 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA18 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</P>
<P ID=PARA21 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA20 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT 0PT 0PT 36PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
</FONT>
</P>
<P ID=PARA23 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA22 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
</FONT>
</P>
<P ID=PARA25 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA24 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
</FONT>
</P>
<P ID=PARA27 STYLE="MARGIN-BOTTOM: 0PT; MARGIN-TOP: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA26 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
</FONT>
</P>
<P ID=PARA28 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA29 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
<P ID=PARA30 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL33 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 50%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA31 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Michael Bruch
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 50%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA32 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Michael Bruch, Interim Chief Financial Officer
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
	&nbsp;
</TD>
</TR>
</TABLE>
</EFX_CERTIFICATION>
<P ID=PARA34 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA35.1 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
<P ID=PARA35.2 STYLE="MARGIN-BOTTOM: 0PX; MARGIN-TOP: 0PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
	&nbsp;
</FONT>
</P>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage83"></A>
<A NAME="EX32_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32"></A>
<P ID=PARA1 STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Exhibit 32
</FONT>
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_3"></A>
<P ID=PARA2 STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
<B>
	CERTIFICATION PURSUANT TO
<BR>
	18 U.S.C. SECTION 1350,
<BR>
	AS ADOPTED PURSUANT TO
<BR>
	SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
</B>
</FONT>
</P>
<P ID=PARA3 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA4 STYLE="TEXT-ALIGN: JUSTIFY; MARGIN: 0PT; LINE-HEIGHT: 1.25; TEXT-INDENT: 18PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	In connection with the annual report of Cesca Therapeutics Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended June 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C.&nbsp;&#167;&nbsp;1350, as adopted pursuant to &#167;&nbsp;906 of the Sarbanes-Oxley Act of 2002, that, to such officer&#8217;s knowledge:
</FONT>
</P>
<P ID=PARA5 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB7 STYLE="TEXT-INDENT: 0;FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA8 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(1)
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA9 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: LEFT; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The Report fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA10 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=MTAB12 STYLE="TEXT-INDENT: 0;FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 36PT">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 18PT; VERTICAL-ALIGN: TOP">
<P ID=PARA13 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	(2)
</FONT>
</P>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP">
<P ID=PARA14 STYLE="MARGIN-BOTTOM: 0PT; TEXT-ALIGN: JUSTIFY; MARGIN-TOP: 0PT; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
</FONT>
</P>
</TD>
</TR>
</TABLE>
<P ID=PARA15 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<P ID=PARA16 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
<TABLE ID=TBL24 STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF; WIDTH: 100%; TEXT-INDENT: 0PX" CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA17 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 4.5PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA18 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Robin C. Stracey
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
<P ID=PARA19 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA20 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Robin C. Stracey, Chief Executive Officer
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: BOTTOM">
<P ID=PARA21 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT 0PT 0PT 4.5PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Dated: September 20, 2016
</FONT>
</P>
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX SOLID">
<P ID=PARA22 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	/s/ Michael Bruch
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: #000000 1PX">
<P ID=PARA23 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	Michael Bruch, Chief Financial Officer
</FONT>
</P>
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 18.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 38.5%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
<TD STYLE="WIDTH: 43.3%; VERTICAL-ALIGN: TOP">
	&nbsp;
</TD>
</TR>
</TABLE>
</EFX_CERTIFICATION>
<P ID=PARA25 STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PT; LINE-HEIGHT: 1.25">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN, TIMES, SERIF">
	&nbsp;
</FONT>
</P>
</EFX_EXHIBIT_32>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
